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Background 
At its 13th Session, in November 2003, the FAO Panel of Experts on Forest Gene Resources 
reviewed the relevance and discussed the feasibility of a global review of biotechnology in forestry, 
as part of an FAO effort to assess the global status and trends of forest tree genetic diversity. This 
paper is the first attempt to provide statistical information on the extent and patterns of biotechnology 
research and applications in forest trees, worldwide. Other studies are anticipated, in particular 
analyses of economic and other forces driving biotechnology development in forestry. 
Disclaimer 
The Forest Genetic Resources Working Papers report on issues and act1v1t1es related to the 
conservation, sustainable use and management of forest tree genetic diversity. The purpose of these 
papers is to provide early infonnation on on-going developments in the field , and to stimulate 
discussion. 
The designations employed and the presentation of material in this publication do not imply the expression of 
any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations concerning 
the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its 
frontiers or boundaries. As a Working Paper, this document does not necessarily reflect the views of F AO. 
Quantitative information has been compiled according to sources, methodologies and protocols identified and 
selected by the authors . For standardized methodologies and assessments on forest resources, please refer to 
FAQ, 2005. State of the World's Forests 2005; and to FAQ, 2001 . Global Forest Resources Assessment 2000 
(FRA 2000). FAQ Forestry Paper No 140 . 
Biotechnology techniques and products in use or in the pipeline in developing countries and countries with 
economies in transition described in this Working Paper have been added to the searchable database FAO-
BioDeC where they can be consulted for more details (www.fao.org/biotech/inventory admin/dep/default.asp). 
Information can also be found on the FAO website (www.fao.org) , in particular regarding biotechnology 
(www.fao.org/biotech/sector5.asp) and forest genetic resources (www.fao.org/forestry/fgr) . 
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Executive summary 
Nicholas Wheeler 
The overall objective of the F AO work programme on forest biotechnology is to contribute to 
a global assessment of the discipline's status and trends. The purpose of this document is to 
provide a summary of four F AO-sponsored reports on global forest biotechnology research 
activities and their applications. Individual reports are provided in Appendixes 2.1-2.4. 
Information compiled in these reports came from questionnaires, systematic searches of CAB 
Abstracts I and other scientific databases, Internet searches of public and private websites, and 
personal communications. Though no doubt incomplete, the resulting data set of over 
2 700 major biotechnology activities (from the last 10 years) and responses to questionnaires 
provides a comprehensive summary of worldwide activities, particularly those in the public 
domain. 
The term biotechnology, as used here, is defined as "any technological application that uses 
biological systems, living organisms, or derivatives thereof, to make or modify products or 
processes for specific use "2. As noted in FAO's 2004 report on the state of the world's food 
and agriculture ('SOFA 2004')3, "biotechnology is more than genetic engineering". Indeed, a 
significant majority (81 percent) of all biotechnology activities in forestry over the last 
10 years was not related to genetic modification. During that period, major forest 
biotechnology activities were reported for 142 genera in over 80 countries, with activities 
relatively evenly spread among major categories: genetic modification, 19 percent; 
characterizing genetic diversity, 26 percent; genomics, genetic maps and marker-assisted 
selection (MAS), 21 percent; and vegetative propagation or micropropagation, 34 percent. 
The majority of cited activities excluding genetic modification occurred in developed 
countries (71 percent of the total), though China (6 percent) and India (9 percent) were 
exceptionally well represented in developing countries and countries with economies in 
transition. Regionally, forest biotechnology activities excluding genetic modification were 
most numerous in Europe (39 percent), Asia (24 percent) and North America (23 percent), 
and least numerous in Oceania (6 percent), South America (5 percent), Africa (3 percent) and 
the Near East (less than one percent) . The majority of major biotechnology activity 
(64 percent) has been focused on only six genera (Pinus, Populus, Eucalyptus, Picea, Quercus 
and Acacia). 
Worldwide, more than 210 field trials of genetically modified (GM) trees exist in 
16 countries, but the great majority occurs in the United States. Field trials of GM trees are 
restricted largely to four genera (Populus, 51 percent; Pinus, 23 percent; Liquidambar, 
11 percent; and Eucalyptus, 7 percent). Approximately half of all reported tree genetic 
modification activities are related to methods development (e.g. gene stability, gene 
expression) or basic biological questions ( e.g. functional genomics, tissue culture). Of the 
remaining activities, herbicide tolerance (13 percent), biotic resistance (12 percent), wood 
chemistry (9 percent) and fertility issues (6 percent) dominate the most studied groups of 
traits. Only China has reported the commercial release of GM trees ( ea 1.4 million plants on 
300-500 ha in 2002). These releases followed two stages of field trials and required 
government regulatory approval. 
1 www.cabi-publishing.org/ 
2 F AO. 200 I. Glossary of biotechnology for food and agriculture: a revised and augmented edition of the 
flossary of biotechnology and genetic engineering. FAO Research and Technology Paper No. 9. Rome. 
FAO. 2004. The state a/food and agriculture (SOFA) 2003-2004. Agricultural biotechnology: meeting the 
needs of the poor? FAO Agriculture Series No. 35. Rome. 
Pini 1\1" \H\ RI \II\\ tl lllllll l'll'Ol (H,\ I, HWI '- I H\ 
Overall, genetic modification activities in forestry occur in at least 35 countries and Populus 
remains the most commonly studied tree genus (52 percent of activities). 
Reported forestry biotechnology activities excluding genetic modification are still largely 
confined to the laboratory (>95 percent), though the application of micropropagation tools in 
field plantings is becoming more common. Notably, though significant effort has been made 
to characterize the genetic diversity of numerous tree species, few if any applications in forest 
tree genetic resource management or conservation have been cited in public-domain literature. 
Large investments in tree genomics, MAS and genetic maps have been made over the last 
5-10 years, particularly in North America (34 percent of activities) and Europe (43 percent). 
As noted in 'SOFA 2004', the most significant breakthroughs in biotechnology are coming 
from research into the structure of genomes and the genetic mechanisms underlying 
economically and adaptively important traits:" .. . genomics is providing information on the 
identity, location, impact and function of genes affecting such traits - knowledge that will 
increasingly drive the application of biotechnology in all agricultural sectors". The science 
of proteomics is gaining some attention as well. The most notable accomplishment in forest 
genomics is the recent completion of a genome sequence for Populus. Identification of and 
partial sequences for nearly all the genes in Pinus are anticipated by many within 5 to 10 
years. The discovery of alleles within candidate genes with measurable effects on quantitative 
traits such as cold tolerance is setting the stage for the application of association genetics, 
possibly within a decade. In this approach, MAS is directed towards the selection of superior 
alleles in candidate genes directly controlling phenotypic variation in traits of interest. 
Nevertheless, while expectations for the application of biotechnologies excluding genetic 
modification for tree breeding and selection remain high, there are virtually no publicly cited 
cases of commercial use except for micropropagation (rooted cutting technology) which is 
developed in at least 63 countries, and for over 80 genera (Pinus, Eucalyptus, Picea, Tectona, 
Acacia, Populus and Larix predominate) . The use of somatic embryogenesis, though 
promising for clonal forestry, and at the advanced field test stage for some species including 
Pinus taeda, has to date provided only limited commercial applications. 
Trends in forest biotechnology can be partitioned into four categories: 
• Biotechnology excluding genetic modification, research: Emphasis appears to be on 
discovering and identifying the function of all the genes in a few model tree species 
(in genera such as Populus, Eucalyptus, Pinus) . Genes are fuelling association genetics 
studies. Investment largely derives from public sources in developed countries . 
• Biotechnology excluding genetic modification, application: Micropropagation tools will 
likely dominate these biotechnology applications worldwide for many years, though 
simple use of markers for fingerprinting, paternity analysis and MAS will grow, rapidly 
for a few selected species, more slowly for others. 
• Genetic modification, research: Genetic modification may be used to evaluate gene 
function in publicly funded programmes. 
• Genetic modification, application: Numbers of publicly funded projects appear to be 
waning, while privately funded projects appear to be increasing, judging by field trials 
established in recent years. Some authors anticipate commercial releases in countries 
besides China within a decade. 
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1. Synthesis: a snapshot of the global status and trends in 
forest biotechnology 
Nicholas Wheeler - Washington State, USA 
This chapter is an updated synthesis of Appendixes 2.1-2.4 of this Working Paper. 
1.1 PURPOSE 
The overall objective of the F AO work programme on forest biotechnology is to contribute to 
a global assessment of the discipline's status and trends. The purpose of this chapter is to 
summarize the findings and conclusions of four individual studies seeking to define the 
current state of forest biotechnology research and application. This 'statistical survey' of the 
types of biotechnologies being used globally will ultimately be coupled with analyses of 
economic and other forces driving biotechnology development in forestry to provide a 
comprehensive view of the current status of and trends in the discipline. This Working Paper 
is not intended to provide descriptive summaries of biotechnology tools, their precise 
classifications, areas of applications, or perceived contributions to forestry development. 
These topics have been extensively treated in other publications (see citations in references 
and annexes in this Working Paper). 
1.2BACKGROUND 
Between 2002 and 2004, the F AO Forestry Department commissioned four studies to 
investigate the extent and patterns of biotechnology research and application on forest trees, 
worldwide. The studies are presented in this Working Paper (the Appendix numbers are 
indicated in brackets). 
• Chaix, G and Monteuuis, 0. CIRAD Forestry Department. Biotechnology in the forestry 
sector. 2004. (Appendix 2.1) 
• Walter, C. and Killerby, S. New Zealand Forest Research. A global study on the state of 
forest tree genetic modification. 2003 . (Appendix 2.2) 
• Wang, H. Chinese Academy of Forestry. The state of genetically modified forest trees in 
China. 2003 . (Appendix 2.3) 
• El-Kassaby, Y. A. University of British Columbia. Anticipated contribution to and scale 
of impact of biotechnology in forestry. 2004. (Appendix 2.4) 
The authors of these reports have compiled comprehensive information sources, including 
databases from questionnaires, systematic searches in CAB Abstracts and associated global 
scientific databases, Internet searches of public and private websites, and personal 
communications with scientists active in the field. 
All attempts to be thorough and accurate have been made but capturing a sense of the status 
and trends of forest biotechnology research and application is a daunting task given the global 
spread of practitioners and the extremely rapid rate of progress in some technological areas 
such as genomics. Despite the authors' best efforts, the F AO-sponsored studies reported here 
are sure to suffer from some largely unavoidable deficiencies such as: 
3 
PR I \11 \R\ RI \II\\ lll lllOTl l 11,()1 Ill,\ I H)RI SlH\ 
• Inability to access, literally or in a timely manner, the vast literature and databases in 
Russian, Chinese and several other languages. 
• Inability to access information on progress of and future plans for research and application 
in the private sector. This is particularly true for, but by no means exclusive to, R&D on 
genetic modification. 
• Inability to stay abreast ofrapid progress, the results of which may have immediate and 
large impacts on the science. 
• Inability to report progress on work currently underway or completed, but not reported 
(often a lag of a few years). 
• Inability to equate the number of citations of particular technologies with the actual 
resources invested in those technologies. 
As an example of the last point, the number of citations and patents noted for somatic 
embryogenesis does not accurately reflect the several millions of dollars invested in the 
technology in North America alone over the last 15 years. In short, this Working Paper is 
likely to be a good indicator and possibly predictor of trends in forest biotechnology activity, 
but is equally likely to be lagging in defining the most current research activities and applied 
results. Future updates of the global status of forest biotechnologies will address many of the 
drawbacks pointed out here. 
1.3 DEFINITIONS 
The current working definition of biotechnology used by the F AO is "any technological 
application that uses biological systems, living organisms, or derivatives thereof, to make or 
modify products or processes for specific use" (Convention on Biological Diversity\ In the 
broadest sense, this definition would include historical or traditional tree improvement 
technologies. For this report, the interpretation is narrowed to consider only modern DNA, 
molecular biology and plant reproductive technologies. Genetic modification or genetic 
engineering is defined here as the use of recombinant DNA and asexual gene transfer methods 
to alter the structure or expression of specific genes and traits. 
1.4 RESULTS 
Over 2 700 references representing the main forest biotechnology activities (publications of 
major research findings, field plantings, propagation programmes, etc.) reported within the 
last decade were compiled and synthesized in project surveys. The majority of these 
references (60 percent) were reported within the last 5 years, suggesting the scope and scale of 
biotechnology research and application is accelerating. Approximately 81 percent of the cited 
activities refer to biotechnologies excluding genetic modification. Chaix and Monteuuis 
(see Appendix 2.1) differentiate three categories of these activities (Figure 1.1): 
• marker development and estimates of diversity (referred to below as 'diversity'); 
• mapping, marker-assisted selection (MAS) and genomics (collectively referred to as 
MMG); 
• micropropagation. 
4 See: www.biodiv.org/. 
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Figure 1.1 Proportion of biotechnology activities, by major categories, indicated in the 
public domain (from Chaix and Monteuuis, Appendix 2.1) 
M icropropagation 
34% 
Maps, MAS & 
Genomics 21% 
Genetic Modification 
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1.5 STATE OF BIOTECHNOLOGIES IN THE FORESTRY 
SECTOR, EXCLUDING GENETIC MODIFICATION 
1.5.1 Overview 
Forest biotechnology research and application is truly global in scope with activities identified 
in 76 countries. A significant majority of cited activities occurs in developed countries 
(68 percent), with the United States (14 percent), France (9 percent) and Canada (8 percent) 
the most active participants represented in the data set (percentages are of total citations of 
main biotechnology activities). India (9 percent) and China (6 percent)5 were far and away the 
most active of the developing countries and countries in transition. Regionally, forest 
biotechnology activities were most numerous in Europe (39 percent), Asia (24 percent) and 
North America (23 percent), and least numerous in Oceania (6 percent), South America 
(5 percent), Africa (3 percent) and the Near East (less than one percent). 
While forest biotechnology research and application has spread to at least 140 genera, the 
great majority of activity ( 62 percent) has been focused on only six genera (Pinus, Eucalyptus, 
Picea, Populus, Quercus and Acacia, in descending order of activity). 
Total activities in biotechnology excluding genetic modification were relatively evenly 
distributed between the categories identified by Chaix and Monteuuis (see above and 
Apppendix 2.1), diversity, MMG and micropropagation (32 percent, 26 percent and 
42 percent, respectively), but became skewed when the number of genera studied was 
considered (diversity, 75 genera; MMG, 36 genera; micropropagation, 78 genera). Each 
category will be discussed at length in the following sections. 
5 Figures should be taken with caution: for example, a significant amount of literature in Chinese is not covered 
by international databases. 
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Biochemical and molecular markers play a significant role in many forest biotechnology 
activities, and marker development for trees has closely followed that for humans and 
agricultural crops. Isozymes, randomly amplified polymorphic DNAs (RAPDs) and 
restriction fragment length polymorphisms (RFLPs) have been widely used for genetic 
diversity and mapping studies, though the current trend favours microsatellites (nuclear and 
cytoplasmic) and AFLPs (amplified fragment length polymorphisms). Currently, ESTs 
(expressed sequence tags) and SNPs (single nucleotide polymorphisms) represent the most 
active area of marker development, though the total number of citations for these markers 
remains small suggesting the literature does not yet reflect the current status of this area of 
research. Work with these markers is being driven by large genomic and association genetics 
projects. 
The vast majority of biotechnology activities in forestry appears to be restricted to the 
laboratory (99 percent, 97 percent and 94 percent for diversity, MMG and micropropagation, 
respectively) with some supporting field trials ( one percent, 2.5 percent and 5 percent, 
respectively). Reported commercial application of biotechnologies appears to be restricted to 
micropropagation (but forms less than one percent ofreported activities for that category), 
though it is known from non-public sources that commercial applications exist to a modest 
degree for all categories. 
1.5.2 Characterization of genetic diversity 
In general, reported activities in this category relate to the use of molecular markers to 
characterize amounts and patterns of genetic diversity in tree populations (studies on 
population structure), and to estimate the influence of human activities on forest genetic 
resources. More specifically, these activities include descriptive studies of (i) measures of 
diversity (57 percent of total activities in this category) and tree conservation with logging 
assessment (8 percent); (ii) tree mating systems, estimation of effective population size and 
gene flow within and among populations ( 15 percent); (iii) paternity analysis and 
fingerprinting applications (14 percent); and (iv) taxonomic and phylogenetic applications 
(6 percent). Most studies targeting genetic diversity appear to be addressing and validating 
population genetic models or providing baseline data for the elaboration of conservation 
strategies. However, the application of these data for conservation purposes at the operational 
level is generally not obvious in the literature. Marker applications for fingerprinting and 
paternity analysis have found considerable utility in both basic science and commercial 
applications, though the commercial applications are not widely publicized ( e.g. Lambeth et 
al. 2001). 
Ninety-nine forest tree genera are represented in this category, though efforts are directed 
largely at the six noted in Section 1.5.1, Overview. In addition, Fagus, Abies, Betula, 
Castanea, Pseudotsuga and Larix have received considerable attention. While 66 percent of 
the studies on genetic diversity characterization occur in Europe or North America, studies of 
species originating from (native to) these regions represent only 3 7 percent of the total 
activities. The remaining distribution, by region, for the origin of species studied is evenly 
divided among Asia (19 percent), Oceania (New Zealand and Australia, 11 percent), South 
America (9 percent), Africa ( 4 percent) and the Near East (less than one percent), with 
19 percent of species of non-ascertained origin, or hybrids. 
Studies on genetic diversity characterization have been largely based on RAPD and AFLP 
markers in the past, with a gradually increasing use of nuclear and cytoplasmic 
microsatellites. Virtually all of these markers are considered neutral (not related to selection 
pressure) and may not be ideal for understanding genetic patterns influenced by evolutionary 
forces. 
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There is a small but growing trend to use SNP markers located in coding regions of candidate 
genes controlling phenotypic expression in adaptive traits to study the influence of 
evolutionary forces on allele frequencies. 
1.5.3 Mapping, marker-assisted selection and genomics (MMG) 
During the decade of the 1990s significant biotechnology activity centred on the development 
of molecular markers, test populations, genetic linkage maps, and statistical means of 
identifying quantitative trait loci (QTLs). QTLs represent statistical associations between 
markers and genes that control some proportion of the genetic and phenotypic variation of a 
quantitative trait (generally less than 10 percent per QTL). QTLs have several potential 
applications including (i) genetic dissection of complex quantitative traits, (ii) providing the 
basis for MAS, and (iii) providing guidance for selection and prioritization of candidate genes 
(discussed later). Linkage and QTL maps have been created for over two dozen tree species6 
and though more maps are likely to appear, most current efforts appear to focus on increasing 
the density and type of markers located on these maps. The current trend in MAS is towards 
the selection of superior alleles in candidate genes directly controlling phenotypic variation in 
traits of interest. This approach, termed association genetics, differs in application from 
traditional QTL studies primarily in the form of the test population being studied. Traditional 
methods use pedigreed populations for within-family selection while association studies rely 
on populations of unrelated individuals. Though MAS using QTLs has found utility for 
specialized populations of commercial species in a few developed and developing countries, 
association genetics holds promise for application across many populations, species and 
countries following appropriate development. 
Over the last half-dozen years tremendous resources have been invested in genomics sciences, 
though this may not yet be reflected in the activities compiled here. Genomics encompasses a 
wide range of activities including gene discovery (ESTs ), gene space and genome sequencing, 
gene function determination (database blast searches, expression profiling using arrays and 
slides, etc.), comparative studies among species, genera and families, physical mapping and 
the burgeoning field of bioinformatics. The ultimate goal of genomics is to identify every 
gene and its related function in an organism. 
The recent completion of a whole-genome sequence for Populus (a project led by the United 
States Department of Energy) has laid the foundation for reaching this goal for a model 
species, and efforts follow to replicate this deed in Eucalyptus, though progress is slower. 
Public and private EST libraries for conifers now probably exceed one million entries. 
The immediate applications of genomics include identification of candidate genes for 
association studies and targets for genetic modification studies. Also, comparative studies of 
ESTs from different trees have revealed the tremendous similarity among taxa throughout the 
conifers, and raise hope that what is learned from one species will benefit many others. 
Finally, this category includes activities in the areas of proteomics and metabolomics, 
disciplines that currently enjoy very modest efforts in Europe and North America, but which 
are likely to expand in level of effort and geographic area in the near future. 
Data set analyses, though confounded by the many technologies noted here, remain useful for 
tracking trends . MMG activities are conducted globally, but are concentrated in Europe 
(43 percent) and North America (34 percent). About 40 genera have been studied, though four 
genera dominate the MMG landscape (Pinus, Populus, Eucalyptus, Picea). 
6 See: http: //dendrome.ucdavis.edu/. 
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Methodological approaches to MMG studies heavily favour gene discovery, functional 
genomics and candidate gene identification (65 percent of total studies), while linkage and 
QTL mapping account for 31 percent of activities. Proteomics activities are modest 
(2 percent). Where identified, MMG studies have targeted primarily genes controlling wood 
property traits (57 percent) and resistance to abiotic (20 percent) and biotic ( 4 percent) 
stresses. Growth rate (6 percent), genetic diversity (8 percent) and flowering (5 percent) make 
up the remaining major categories. 
1.5.4 Micropropagation 
Micropropagation is a term used here to describe methods of in vitro vegetative multiplication 
including rooted cuttings, organogenesis and somatic embryogenesis. Micropropagation is 
used to create large numbers of individual clones or genotypes. Because vegetative 
propagation bypasses the genetic mixing associated with sexual reproduction, it represents an 
ideal way to deliver genetic gain: select individuals are replicated precisely. The majority of 
biotechnology activities excluding genetic modification compiled by Chaix and Monteuuis 
(Appendix 2.1) (42 percent) relate to micropropagation. 
Micropropagation by rooted cutting is commonly used in more than 20 species of commercial 
importance, the majority of which are angiosperms. Many of the activities noted suggest the 
technology is advanced and commercially viable. Conifers are less easily rooted than 
angiosperms, though modest programmes for several genera exist. Somatic embryogenesis is 
defined by an array of steps that result in the creation of embryos from somatic tissues 
(as opposed to zygotic embryos from germinal cell lines). Though technically difficult, the 
technology has the potential to produce literally millions of genetically identical individual 
plants. It has received considerable R&D attention for highly valued conifer species, primarily 
in developed countries, for many years. Though large-scale commercial plantings of somatic 
embryos do not yet exist, progress in the technology appears promising and small-scale field 
testing is increasing (for example, on Pinus taeda in the United States). The delivery of 
somatic embryos to the field remains a significant hurdle to reducing plantlet costs and, 
therefore, large-scale use. Excellent progress in the creation of manufactured seed7 appears to 
provide a solution to this problem, though further research is likely to be needed. 
Organogenesis, or the creation of plantlets from tissues such as cotyledons, has largely fallen 
out of favour in forestry operations and is used infrequently. In the future, the use of 
vegetatively propagated trees for intensively managed, high-yielding plantations is anticipated 
to increase significantly in all regions of the world. It is the author's view that rooted cuttings 
are likely to dominate in angiosperm propagation in developing countries while somatic 
embryos will dominate in conifer propagation in developed countries. 
Micropropagation activities occur in at least 64 countries in all regions of the world, though 
efforts are concentrated in Asia (38 percent of total), Europe (33 percent) and North America 
(16 percent). These activities include more than 80 genera of forest trees, the most commonly 
used being Pinus, Picea, Eucalyptus, Acacia, Quercus, Tectona, Populus and Larix. 
A breakdown of activities within micropropagation suggests most reported work is within 
somatic embryogenesis (65 percent), along with cell and tissue culture (17 percent) and 
microcuttings (13 percent). 
7 Source: Weyerhaeuser Company, Federal Way, WA, USA. 
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1.6 STATE OF BIOTECHNOLOGIES IN THE FORESTRY 
SECTOR: GENETIC MODIFICATION 
1.6.1 Overview 
Few if any technological advancements in crop improvement methods have attracted as much 
attention from the scientific and lay communities as genetic modification. This is as true for 
forestry as it is for agriculture. In fact, genetic modification is so embedded in the public 
conscientiousness, that it is often considered synonymous with the term biotechnology. As 
detailed earlier, biotechnology encompasses much more than genetic modification, and 
publicly cited work on biotechnology activities excluding genetic modification significantly 
outnumbers genetic modification activities in the forestry sector (see Figure 1.1 ). However, in 
view of the intense scrutiny of and interest in genetic modification today, and its potential for 
significant influence on the ecological and economic landscapes, it is given disproportionate 
attention in this review. 
The FAG-commissioned studies reviewed in this Working Paper provide detailed accounts of 
and insights into the state of genetic modification activities in world forestry as of early 2004. 
Walter and Killerby (Appendix 2.2) have summarized results of a detailed questionnaire sent 
to well over 500 institutions and scientists potentially engaged in or concerned with work on 
genetic modification in forestry. In addition, like Chaix and Monteuuis (Appendix 2.1 ), 
Walter and Killerby have searched public Internet databases, such as the APIDS (US 
Department of Agriculture - Animal and Plant Health Inspection Service) website for field 
trial permit applications in the United States, for any reference to work on genetic 
modification not typically reported in the literature. Collectively, these reports, taken together 
with information collated by Wang (Appendix 2.3), provide a reasonably consistent picture of 
the status of and trends in forestry research on genetic modification. 
Forestry genetic modification activities are taking place in at least 35 countries, 16 of which 
host some form of experimental field trials (Figure 1.2). These field trials are generally very 
small (12 to 2 850 plants in reported studies) and typically of short duration. In many 
countries such trials must be destroyed before seed bearing occurs. In the remaining 
15 countries, experimentation is restricted to laboratories or greenhouses. To date, only China 
(see Wang, Appendix 2.3) has reported the establishment of approved, commercial plantations 
of GM trees (discussed in subsequent sections). 
Nearly two-thirds of the 520 reported genetic modification activities in forestry (see Chaix 
and Monteuuis, Appendix 2.1) occur in North America ( 48 percent) and Europe (32 percent). 
Asia follows with 14 percent of reported activities, Oceania with 5 percent, South America 
with one percent and Africa with Jess than one percent. The year 2004 has seen a sharp 
increase in field test applications for GM forest trees in the United States (Figure 1.3). 
Populus was the first tree to be genetically modified (1986) and is by far the most commonly 
studied tree genus for genetic modification purposes today ( 4 7 percent of activities). This is 
no doubt a function of the ease with which some genotypes of the genus can be transformed 
and vegetatively propagated for experimental purposes. Pinus (19 percent), Eucalyptus 
(7 percent), Liquidambar (5 percent) and Picea (5 percent) make up the majority of the 
remaining experimental studies. Field trials of GM trees are restricted largely to four top 
genera (Populus, 51 percent; Pinus, 25 percent; Liquidambar, 11 percent; and Eucalyptus, 
7 percent). 
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Approximately half of all reported genetic modification activities with trees are related to 
methods development (e.g. gene stability, gene expression) or basic biological questions 
( e.g. functional genomics, tissue culture). Of the remaining activities, ostensibly guided by 
commercial deployment objectives, herbicide tolerance (13 percent), biotic resistance 
(12 percent), wood chemistry (9 percent) and fertility issues (6 percent) dominate the most 
studied groups of traits . This area will be discussed in greater detail later. 
1.6.2 Responses to the genetic modification questionnaire 
The questionnaire was designed not only to assess the current status of genetic modification 
in trees worldwide, but also to capture the views of practitioners on future developments and 
means to keep the public informed of their activities. A copy of the questionnaire is available 
from the FAQ. 
Of the 418 questionnaires sent out by Walter and Killerby8, 49 were returned (11.7 percent) 
and of these, 23 respondents were conducting research on genetic modification in forest 
trees9. For simplicity, these 23 respondents will be referred to as the 'core' respondents 
henceforth. Respondents did not include some private companies known to be conducting 
genetic modification activities in trees, most notably in North America where the majority of 
activity is reported. Regardless, the comments and trends noted, while not comprehensive, are 
likely to reflect those of the global research community. Of the core respondents, ten 
represented research institutions, nine universities, two private industries, and two were 
categorized as 'other'. Two of the total respondents represented non-profit organizations 
concerned with appropriate use of biotechnology. Fifty-seven percent of the core respondents 
currently publish information about their work on the Internet. 
1.6.3 Project scope 
The first three questions sought to determine the scope of genetic modification activities in 
contained laboratory experiments (68 reported), field-based experiments (26 reported) or 
commercial plantings (none reported), primarily with respect to traits and species evaluated. 
Of the 68 laboratory projects, all but two were identified as research targeted with the 
remaining two related to commercial applications. Four projects serviced both functions. 
Seventeen different gene/trait groups were identified in the laboratory, the majority of which 
were related to methods development or stability (markers, reporters, antibiotic resistance; 
26 projects), reproductive development ( 19) or herbicide resistance ( 11 ). Other notable traits 
included wood properties (eight), insect resistance (seven) and wood chemistry (eight). 
The species studied were largely as noted in Section 1.6.1 , Overview, though the percentages 
of each varied slightly from the list generated by the complete data set. Most projects were 
reported to be working with more than one species and on more than one trait or gene. Eleven 
respondents reported a total of 26 projects with field trials, 20 of which have been established 
(1-3 per year) over 13 of the last 15 years. Of these 26, 20 (77 percent) involved Populus, 
two Pinus , and one each Betula, Eucalyptus and Picea. Markers (nine projects), herbicide 
resistance (six), lignin biosynthesis (five), insect resistance (three), and reproductive 
development (two) dominated the traits being investigated in field trials. Approximately half 
of the respondents with field trials identified the issues addressed by these trials to be related 
to plant growth/performance (five projects), gene expression stability (four), environmental 
risk assessment (three), horizontal gene transfer (two), herbicide applications (two) and four 
others ( one each). 
8 Other questionnaires were sent out by FAO or posted on mailing lists and biotechnology discussion fora. 
9 Several respondents commented on genetic modification activities in ornamental and fruit trees . Data on these 
will be noted where appropriate. 
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To judge future trends better, respondents were asked whether they had pending plans for 
future trials of GM trees. A total of 12 laboratory and field trials were specified for four 
genera in five countries, with establishment anticipated over the next 3 years . 
One respondent from China reported the commercial release of two transgenic poplar 
genotypes transformed for leaf-eating insect resistance. The largest release was with Populus 
nigra transformed with the Bt gene cry I Ac. Following a successful 1-ha pilot planting in 
1994, 80 ha of field trials were established on eight sites in seven provinces in 1999. 
Subsequent authorization from state regulating agencies pem1itted the establishment of ea 1 
million trees in 2002, on some 300 ha. A smaller release with a hybrid poplar clone 
transformed with both cry I Ac and API followed in 2003. No other respondents to the 
questionnaire reported plans for commercialization. 
1.6.4 Links with breeding, propagation or other research 
The majority of the 68 projects involving GM trees had no or very weak connections to 
traditional breeding programmes (60 percent) or vegetative propagation programmes 
(66 percent), though ongoing development of some links was noted. The remainder noted 
strong links to such efforts. Of the core respondents, 65 percent noted the use of genetic 
modification for underpinning other research goals such as testing gene function, evaluating 
environmental impact, QTL detection, MAS evaluation, microarray and EST mining for 
genes, etc. 
1.6.5 Regulatory framework 
Respondents were asked to identify whether, and from whom, regulatory oversight existed 
for their genetic modification projects. Core respondents representing 15 countries identified 
regulatory agencies (see Appendix 2.1) and categorized their involvement in (i) pre-risk 
assessment (13 countries), (ii) surveillance, monitoring and quarantine (12 countries), or 
(iii) management of failure, redress and control (12 countries). At least nine countries 
regulate all three levels of involvement, and no country is totally unregulated. When asked 
whether the regulatory framework in their country was adequate to assess the benefits and 
risks related to their experiments, 15 of the core respondents (65 percent) indicated it was, 
five thought it inadequate, and three did not answer. Comments on how the process could be 
improved were many, and seemed to focus on how the process could be streamlined and 
made less expensive. Others suggested more risk assessment research was required. None of 
the core respondents indicated they were testing GM trees abroad. 
1.6.6 Intellectual property 
Of the core respondents, eight (35 percent) indicated they owned intellectual property (IP) in 
relation to their production of GM trees, ten did not, and five respondents did not answer. 
Nine of the respondents confirmed they had IP agreements with other institutions. None of 
the respondents indicated they had IP arrangements with institutions in developing countries 
and countries in transition, though some indicated willingness to have these where 
appropriate and required. Eleven areas were noted as being the target for IP ownership 
including, but not restricted to, genes , gene expression, transgene development and testing, 
modulation of lignin biosynthesis, flowering control and embryogenesis . 
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1.6. 7 Future of GM trees 
Many of the 49 respondents contributed suggestions as to how GM trees might be used for 
environmental or health benefits in the future, but only a few respondents predicted further 
field releases, suggesting that high costs and regulatory burdens of conducting such trials are 
too great. Some suggestions for future plans included development of GM trees for tolerance 
to drought and extreme temperatures, candidate gene testing, production of secondary 
compounds (pharmaceuticals), site remediation, fibre quality, etc. The generally dour view of 
the future of genetic modification in forestry can be attributed to a number of factors 
including, but not restricted to: consumer rejection of or unease with GM products; public 
relations risks for companies engaged in research on genetic modification; unpredictable and 
costly government regulations, not only for conducting the research but for international 
trade; inadequate research support; intellectual property costs; and so forth. These factors are 
in contrast to the largely unregulated and less costly biotechnologies excluding genetic 
modification or traditional means of tree improvement. 
1.6.8 Benefits from GM trees 
Respondents were asked what commercial, environmental or human health benefits might be 
attributed to the use of genetic modification technology in forestry. Respondents often 
indicated more than one benefit per category. With respect to commercial benefits, increased 
wood production (15 responses) or improved wood quality (12) were most cited, followed by 
resistance to insects (nine) and disease (seven), reduced production and processing costs of 
wood or chips (five), and reduced chemical costs for pulping (four). Several other responses 
were given once each (a total of 60 possible benefits mentioned). Two notable environmental 
benefits were reduced pressure on natural forests ( 12) and reduced use of chemicals in forests 
and in processing (12). The use of GM trees for phytoremediation and carbon sequestration10 
were also identified as environmental benefits (seven responses each), while increased 
productivity per managed hectare, adaptation to stresses, reduced erosion, and renewable 
energy largely completed the list. Human health benefits from GM forests were mentioned 
least often, though reduction in pollen and allergy problems was identified seven times. 
Reduced environmental pollution (five responses) and environmental protection and 
restoration (five) were also noted. Three respondents felt there were no likely health benefits. 
Benefits of other kinds were also noted. It was noted that genetic modification in forestry 
could lead to potential economic benefits for developing countries and countries in transition, 
and could significantly accelerate conventional breeding programmes. There were indications 
that genetic modification could also provide basic biological knowledge and employment, 
and contribute to reduce global warming. 
1.6.9 Risks of genetic modification in forestry 
Respondents were next asked to identify anticipated commercial, environmental or human 
health risks associated with the use of genetic modification in forestry. Commercial risks 
ranged from public resistance (nine) and large financial investment risks (five), to biological 
risks such as transgene instability (three), plantation failure (two), wood quality issues (two) 
and use of monocultures (two). Ecoterrorism and development of tolerance by insects to GM 
resistance were each mentioned once in a total of 31 suggested risks. Of 16 responses to a 
question about human health risks, 11 suggested these were negligible or non-existent. Two 
votes each were given for potentially new allergens or toxic metabolites being created. 
10 Questionnaires were filled in before the ninth session of the Conference of the Parties to the UN Framework 
Convention on Climate Change in December 2003. 
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Potential environmental risks noted included gene (eight) or plant (seven) escape into natural 
ecosystems, impact of resistance genes on non-target species (two), and clonal failure in 
plantations (two). Four other responses were given once each and eight respondents indicated 
there were no or limited environmental risks. A broad array of general responses was given 
about other potential risks, for example: (i) GM forests may render natural forests valueless; 
(ii) means exist to ameliorate environmental risks such as gene escape; (iii) 
regulatory/legal/commercial constraints will always slow commercialization of best 
technologies; and (iv) genetic modification will encourage clonal plantation forestry, which is 
undesirable. 
When asked how risks involved with GM trees can be best addressed respondents noted most 
frequently the need for increased risk assessments in field and laboratory studies (13 total 
responses), introduction of sterility genes in GM crops (five), and research and education 
(two). Several other comments were given once each. 
Respondents were specifically asked how their own R&D programmes addressed risk. 
Responses were many, varied and constructive. They included anticipated use of flowering 
control in GM products, inclusion and promotion of biodiversity conservation and ecological 
restoration of native/natural forests in association with GM plantations, studies of pollen 
dispersal and ecological interactions between GM trees and herbivores, and use of harmless 
selectable markers (to detect the presence of transgenic cells) rather than antibiotics. 
Finally, respondents were asked about the risks of not using genetic modification technology. 
Seven respondents felt that this would compromise the ability to reduce pressure on the 
world's natural forests , while four felt there was little or no risk at all. Several other answers 
were recorded, including (i) non-users could be at a competitive disadvantage in intensive 
plantation production; (ii) loss of one approach for saving endangered species (e.g. the 
American chestnut, Castanea dentata); (iii) loss of the best, long-term opportunity for 
increasing forest productivity; and (iv) disproportionate loss of the technology could lead to a 
decrease of the timber industry in some countries relative to others. 
1.6.10 Obstacles to genetic modification applications in trees 
The questions of what obstacles to the application of genetic modification technologies in 
trees exist, and what means exist to address those obstacles, were asked. The overwhelming 
response to the first question was that public perception, regulatory issues and adversity 
toward science constituted the major set of obstacles (22 of 49 responses). The remaining 
nine obstacles, which drew 2-4 responses each, included such items as technical hurdles, lack 
of interest and support from the timber industry and growers, lack of funding, environmental 
risks, lack of integration with traditional breeding programmes and scientists, forest 
certification schemes and IP issues. Sixty-five percent ofrespondents (13 of 20) listed better 
education of and communication with the public as ways to overcome obstacles. Several 
other excellent suggestions dealt with both technical and strategic use issues, including: 
(i) target traits with obvious benefit to consumers; (ii) provide technology to ensure gene flow 
does not occur between GM and natural trees; (iii) seek means to certify products from GM 
plantations; (iv) increase R&D funds, particularly from public sources; and (v) eliminate the 
need for GUS (~-glucuronidase) and antibiotic resistant genes in the genetic modification 
process. There was also support for increased field testing to validate benefits and risks, 
possibly even to the exclusion of seeking commercial release until data are solidly supportive. 
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1.6.11 Perception and communication 
The final series of questions in the questionnaire addressed issues of public perception of 
specific programmes and how organizations using genetic modification communicated their 
findings to the public. Twenty-five respondents (22 core, three additional) contributed an 
array of answers summarized by Walter and Killerby (see Appendix 2.2). These covered the 
gamut from very positive to very negative (vandalism of GM trials), and virtually all 
recognized the importance of public perception to their ultimate success. Some respondents 
perceived resistance from local governments while sensing support at the national level, 
while in some countries resistance was experienced from all aspects of society and 
government. Of core respondents, 61 percent reported they have some form of direct public 
communication, either as part of a corporate strategy or as individual communication 
strategies. Three respondents had no form of communication and two relied on collaboration 
with outside agencies for their communication about GM trees. 
1.6.12 Ornamental and fruit tree genetic modification 
Over 70 field trials of GM fruit and ornamental trees, conducted in 13 countries, were noted 
by respondents and from database searches. A significant majority (43 of 73) of the trials are 
located in the United States. Taxa most studied include Carica (papaya, 18), Malus (33), and 
Prunus (13). These trials target fundamentally different suites of genes from the forestry 
sector, concentrating on viral ( 15), fungal ( 17) and insect ( 11) resistance, rooting (five) and 
fruit ripening (11). 
1.6.13 Publicly available information on field trials of GM trees 
While the information provided by respondents to the questionnaire was immensely useful in 
gauging the status of and trends in genetic modification in forestry, it was clear from surveys 
of public databases and regulatory sites that all activities were not accounted for in the formal 
survey. This was particularly true for field trials of GM trees in the United States 11 • 
In general, getting an accurate estimate of the total number of field trials with GM trees is 
difficult. Best estimates place the number at greater than 225 trials, with as many as 150 or 
more in the United States. While the general world trend appears to be a gradual decline in 
the number of field trials being established, the current trend in the United States appears to 
be that field trial establishment is stable or increasing. This is largely a function of one or 
more private organizations focusing on the delivery of GM products to the forestry 
community. 
1.7 CONCLUSIONS: STATUS AND TRENDS OF 
BIOTECHNOLOGY IN FORESTRY 
Biotechnology in forestry, as in agriculture in general, encompasses a wide range of research 
tools used to understand and manipulate the genetic make-up of select organisms. Forest 
biotechnology is much broader than genetic modification, and includes micropropagation, 
molecular marker applications, and the rapidly expanding area of genomics. Indeed, a 
significant majority (81 percent) of all the biotechnology activities in forestry compiled from 
the last 10 years was not related to genetic modification. 
Though most biotechnology tools were originally developed for use with human beings and 
agricultural crops, the forestry research community has been fast to adapt them. 
11 See: www.isb.vt.edu/cfdocs/fieldtestsl.cfm or www.aphis.usda.gov/. 
15 
PRI' "'"\H\" RI \II\\ OFBIU!U.11 ()I (JI, I l()RI ~rrn 
In many respects, forest trees, traditionally considered difficult organisms to study 
genetically, may constitute model organisms for technologies seeking to understand and use 
natural sources of variation. This is due in part to the unparalleled genetic and phenotypic 
diversity common to forest trees, relative to most crop species. 
The global forestry biotechnology community, though small in comparison to agriculture, is 
fairly robust and widely divergent in research, development and application targets. Cited 
activities in forest biotechnology have increased nearly three-fold in the most recent 5-year 
period, compared to the previous 5-year period. Thus, there is an upward trend in the 
development of biotechnologies focused on characterization and utilization of naturally 
occurring genetic variation within species, while publicly funded and reported programmes 
on genetic modification technologies in trees, particularly those targeting field testing and 
deployment, seem flat or diminishing. Private sector genetic modification activities, though 
narrowly based, appear dynamic and the world' s first commercial GM forest plantations have 
been established on a small scale in China. 
Overall understanding of tree molecular biology has advanced dramatically in recent years. 
The completion of genome sequences for model plants such as Arabidopsis and especially 
Populus, along with development of high throughput genomics tools for gene discovery and 
functional assignment have set the stage for continued rapid progress. This includes our 
understanding of the genetic characterization of complex traits such as growth, cold and 
drought tolerance, insect and disease resistance, and so forth. Knowledge of, and access to, 
genes, will, in the author' s view, cease to be a significant hindrance to progress in genetic 
modification or other biotechnology applications, over the next 10 years. To capture fully the 
value of this expanding resource, significant investment in bioinformatics infrastructure is 
needed. Finally, though small steps are appearing in some countries, globally the 
coordination and complementarity of biotechnology tools and conventional applied tree 
breeding programmes seem poorly developed. 
Perceived trends in the development and application of biotechnology tools are highly varied. 
• Molecular markers: The creation of new types of markers has recently declined (in the 
last 5 years), but the development and optimization of specific markers such as 
microsatellites and SNPs for tree species is currently very active. Markers will probably 
continue to enjoy increased application in forest genetic studies (diversity and 
conservation, phytogeography, mating systems) and tree improvement (fingerprinting, 
paternity analysis, breeding and testing, QTL mapping, MAS, association genetics), 
though most effort is likely to be concentrated on a few highly valued species. These 
applications are becoming increasingly commercial in scope. 
• Genomics/proteomics: This is the most rapidly expanding area of publicly funded 
research in forest biotechnology, and centres on gene discovery and function elucidation. 
Whole genome or expressed gene sequences are expected to be largely known for at least 
one conifer (Pinus) and possibly two angiosperms (Populus and Eucalyptus) within 
5 years. Thereafter, functional genomics tools (microarrays, model species comparisons, 
genetic modification) will probably receive most support. Within 10-15 years, virtually 
complete physical and genetic maps are likely to identify and locate most of the genes in 
model conifer and angiosperm tree species and large unigene sets may be available for 
expression studies. Comparative genomics studies suggest this information will be 
applicable across species, genera, and even family boundaries. Applications for this 
information will gradually increase, including technologies complementing traditional 
tree improvement such as association genetics (identification of superior alleles at known 
genes) and identification of genes for studies on genetic modification. 
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• Micropropagation: Vegetative propagation will probably expand concomitantly with 
intensively managed, clonal plantations throughout the world. The development of more 
intensive plantations seems a driving force in micropropagation biotechnology and 
genetic modification. Application will certainly increase if and when genetic modification 
finds acceptance due to the desire to deliver gain through clones in most cases. Research 
in rooted cutting technology is mature and declining, but use of rooted cuttings will 
continue to grow. Somatic embryogenesis (SE) research still enjoys significant support, 
particularly for application in conifers, but some technical hurdles remain to 
commercializing the technology on a large scale. The use of manufactured seed to deliver 
embryos may make SE more widely affordable and open the door to more extensive 
clonal forests for select species, markets and applications. Advances in automation will 
also be necessary in all steps of the SE process. 
• Genetic modification: Globally, publicly funded research in genetic modification 
targeting forest deployment seems to be flat or diminishing, and some scientists have 
expressed mixed feelings about future applications of the technology. A notable exception 
is China, which appears to sponsor a robust R&D programme in several institutes and has 
sanctioned small commercial releases of GM poplar. A relatively few but apparently quite 
active privately funded organizations in the United States, New Zealand, and possibly 
elsewhere, are pursuing R&D with commercial deployment of GM trees in their business 
plans before 2010. Many private forestry products companies are reluctant to engage in 
research on genetic modification, probably as a function of several factors: consumer 
unease, public relations risks for companies engaged in the research, unpredictable and 
costly government regulations, government bans against genetic modification, limitations 
due to fragmented patent estates and stringent intellectual property rights, etc. Despite 
these uncertainties, some authors anticipate an increasing use of GM forest trees in the 
near future (10 years). This will probably occur largely in short-rotation clonal forests, 
where investment can be rapidly recouped, for specialty applications such as saving 
species endangered by pests or, more commonly, as a genomics tool for studying gene 
function. Many of the challenges to securing the benefits of GM crops for the poor, noted 
for agricultural crops (F AO 2004 ), will be equally or more difficult to overcome in 
forestry. 
With the exception of some micropropagation tools, research and application of forest 
biotechnology tools will continue to be primarily sponsored by and used in developed 
countries. With the shifting of industrial, high-yield forestry to semi-tropical climates, 
application of biotechnologies in developing countries is likely to follow relatively quickly. 
The biggest challenge to the forest biotechnology community may be to find ways to enhance 
growth and yield of non-industrial forests for use in developing countries and countries with 
economies in transition. 
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2.1 Biotechnology in the forestry sector 
Gilles Chaix & Olivier Monteuuis - CIRAD Forestry Department, Montpellier, France 
With assistance and inputs from Jean Marc Bouvet, Jean Marc Gion, Yves Prin, Daniel 
Verhaegen and Philippe Vigneron and Antoine Galiana (for the genetic modification section) 
2.1.1 INTRODUCTION 
"Biotechnology provides important tools for the sustainable development of agriculture, 
fisheries and forestry and can be of significant help in meeting the food needs of a growing 
and increasingly urbanized population," reads an FAO press release dated 15 March 2000 12• 
The field of modem biotechnology is indeed often considered as one of the fields of scientific 
research in which the most rapid advances have been made in recent years. 
Several elements can explain the growing interest of forest scientists, conservationists and 
tree growers in modem biotechnologies. They include the unique roles and functions that 
trees, major structural constituents of forest ecosystems have, their special biological 
characteristics, and their importance in the provision of environmental, social and economic 
goods and services. Special features of interest to scientists and geneticists include the low 
level of domestication of forest trees and their rich genetic diversity; their long life cycles, 
long generation times and late sexual maturity; their spatial requirements; the multiplicity of 
species and the low degree of heritability of traits of interest, linked to weak juvenile-adult 
correlations and the importance of genotype-environment interactions. Application of 
biotechnologies in forests has been seen as a unique opportunity for obtaining new 
information on the extent, patterns and functioning of tree genetic diversity; and for providing 
new tree varieties and reproductive materials adapted to changing environmental, social and 
economic environments (Fenning and Gershenzon 2002). 
2.1.1.1 Background and methodology 
Specific developments in biotechnology in the forestry sector have been addressed in a large 
number of conferences, meetings, publications, electronic fora and Internet web pages 13. 
Owing to this abundant literature, this report, commissioned from CIRAD-Foret by F AO in 
December 2003, will not describe the types and classifications of forest biotechnology in 
detail. It aims instead to fill a gap in global data and statistics on research in and applications 
of biotechnology for forest trees. Given the scientific and technical potential created by an 
increasingly accurate knowledge of forest tree species genomic structure, it is important to 
have an overall picture of the current status of forest biotechnology developments, together 
with trends and future prospects. The objective of this document is thus to review and 
summarize research, and the suitability and practical use of biotechnology in the forestry 
sector, and to provide tentative global analyses. 
For the purpose of the study, a simple data set has been developed. The data set gathers major 
biotechnology activity (i.e. a given technology developed or used in a given country, on a 
given tree species or variety, by a given laboratory team, for a given purpose [Appendix 
2.7.1]). 
12 See: www.fao.org/W AlCENT/OIS/PRESS NE/PRESSENG/2000/prenOO 17.htm or www.fao.org/biotech. 
13 See, in particular, Appendix 2. 7 .2 for Internet sites. 
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Data originated from (i) systematic searches in CAB Abstracts and associated global 
scientific databases, (ii) searches on the Internet (including sites of private companies, 
governmental and non-governmental institutions and linked references, and (iii) personal 
enquiries, observations and communications. Most significant publications, including those 
produced by major laboratories and teams, have been included in the data set. The study was 
mainly conducted between February and September 2004. 
The data set included basic fields such as country, type of biotechnology, information source, 
reference or Internet site, stage of development, species or genera involved and, whenever 
available, year when the activity was conducted. These fields were considered to be a 
minimum set of requirements for entering a biotechnology activity in the database. The 
reference period covers approximately the last I O years, although more than 75 percent of the 
data were from between 2000 and 2004. Internet references, however, could not always be 
dated. 
The data set is in no way comprehensive, and some of its limitations reflect the difficulties of 
such information gathering. The study revealed language limitations (international databases 
cover only a fraction of the literature in Chinese and Russian, for example) . International 
databases also tend to reflect past research activities, and only a small share of on-going 
research work. An additional flaw of the data set is related to private (corporate) research and 
commercial applications, for which public-domain information is generally scarce. Despite its 
drawbacks, the data set provides a sample (of unknown global representativeness) of 
materials available in the public domain. No attempt has been made to gather classified 
information. In total, data on 2 716 activities were collected, and their analysis supports the 
present report. Data, statistics and conclusions presented in this report should therefore be 
considered with caution and as general indicators. 
2.1.1.2 Outline of the report 
A quick review of the literature shows that various classification systems have been used to 
categorize modern biotechnologies used in forestry 14. In some countries, the term 
biotechnology refers to genetic modification exclusively. Yanchuk (2001) proposed three 
main categories: (i) biotechnology employing molecular markers, (ii) biotechnology aimed at 
enhancing plant propagation and large-scale production of uniform plant material, and (iii) 
biotechnology for modifying the genome of forest tree species. In the present report, the 
broad categories include: 
1. The characterization of genetic diversity of forestry species, including diversity structure 
studies, gene flow and human impacts on forest stands: characterization, population 
genetics and diversity studies. 
2. The functional and applied aspects of genetic investigation: genetic mapping, marker-
assisted selection (MAS) and genomics (collectively referred to as MMG). 
3. Research and applications in vegetative propagation: micropropagation (in the broad 
sense). 
4. The alteration of genomes by insertion of genes: genetic modification. 
Individual data (biotechnology entries) were categorized according to the above classification 
once they had been entered into the data set. 
14 See: www.fao.org/biotech/sector5.asp. 
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The report presents detailed analyses of the data sets for the categories 1-4 above, and 
provides separate summaries for biotechnologies excluding genetic modification, and genetic 
modification technologies. 
2.1.2 SUMMARY OF THE STATE OF BIOTECHNOLOGY IN 
THE FORESTRY SECTOR, EXCLUDING GENETIC 
MODIFICATION. 
The information compiled in the data set of biotechnology activities excluding genetic 
modification represents 2 196 references ( or 81 percent of all activities reported). Activities 
were reported in 76 countries, broken down by regions as follows: 39 percent of the activities 
were reported in Europe, 24 percent in Asia, 23 percent in North America, 6 percent in 
Oceania, 5 percent in South America, 3 percent in Africa and less than one percent in the 
Near East (Figure 2.1. lA). Both developed countries (24 countries, representing 68 percent of 
biotechnology activities) and developing countries and countries in transition (52 countries, 
or 32 percent of activities) were represented (Figure 2.1. lB). Developing countries and 
countries in transition were mainly represented by India (27 percent of these countries' 
activities), China (17 percent), Brazil (7 percent), South Africa (5 percent) and Malaysia 
( 4 percent). Three countries (India, China and Brazil) accounted for 52 percent of all 
biotechnology work reported in developing countries and countries in transition. 
Species surveyed belonged to 142 botanical genera. Sixty-two percent of the information 
collected in the database regarded research carried out on less than six genera including Pinus 
(20 percent of biotechnology activities excluding genetic modification), Eucalyptus 
(11 percent), Picea (9 percent), Populus (9 percent), Quercus (7 percent) and Acacia 
(6 percent) (Figure 2.1.2). Just four genera (Pinus, Eucalyptus, Picea and Populus) account 
for almost half of the compiled biotechnology activities excluding genetic modification. 
Work was found to be relatively evenly spread between the three main categories of 
biotechnology categories apart from genetic modification: characterization of tree species 
genetic diversity represented 32 percent of biotechnology activities, MMG 26 percent, and 
micropropagation 42 percent (Figure 2. l .3A). Differences were more marked when tree 
genera were considered (Figure 2. l .3B). The forestry sector appears to have rapidly adopted 
markers developed for agricultural crops (Figure 2.1.4). Isozymes and random amplified 
polymorphic DNAs (RAPDs) have been widely used for genetic diversity description 
although the present trend seems to favour microsatellites (nuclear and chloroplast) and 
amplified fragment length polymorphisms (AFLPs). Driven by research on genomics, 
expressed genome banks (ESTs [expressed sequence tags]) are being widely developed. 
The majority of the work reported is still mainly at the experimental stage in the laboratory. 
Genetic diversity characterization has less than one percent of its reported activities in the 
field, MMG 2.5 percent and micropropagation 5 percent (Figure 2.1.5) . Field tests are still 
mainly geared to supporting laboratory research. These results possibly reflect the origin of 
the information in the data set. While research activities in the public sector are relatively 
easy to collect, especially through international research storage databases, information on 
commercial applications is generally restricted and incomplete. 
Commercial applications of micropropagation are, however, generating increasing interest. 
The potential is huge although, up to now, only several thousand hectares seem to have been 
established globally using micropropagated materials . 
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In South America, particularly in Brazil, some companies are reported to be integrating 
micropropagation into the clonal propagation process: micropropagation is used to 'store' 
clones in mother blocks (gene banks) in the laboratory as potential sources ofresponsive 
nursery stock plants for large-scale mass propagation. The use of rooted cuttings has allowed 
the propagation costs to be lowered significantly. 
Great expectations have been raised about the possible contribution of biotechnology to tree 
selection and breeding, and its commercial applications. Genomics and proteomics should 
greatly help breeders in tree selection, in particular in the identification of traits of interests. 
However, it remains difficult to predict when new forest tree varieties selected with 
biotechnology tools will become available on the market. Although genetic diversity 
characterization started some 30 years ago, very limited large-scale commercial application 
has yet been reported in forest tree genetic resources conservation and management. 
Figure 2.1.lA. Distribution of reported forest biotechnology activities (excluding genetic 
modification) by world region 
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Figure 2.1.lB. Distribution of reported forest biotechnology activities (percent of 
activities in the data set, excluding genetic modification) by country (for the 15 countries 
most represented, making up 77 percent of the data set of entries excluding genetic 
modification) 
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Figure 2.1.2. Distribution of reported forestry biotechnology activities, excluding genetic 
modification, by genus 
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Figure 2.1.3A. Distribution of biotechnology activities, excluding genetic modification, 
by broad category (genetic diversity characterization; mapping, marker-assisted 
selection and genomics [MMG]; and micropropagation) 
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Figure 2.1.3B. Distribution of biotechnology activities, excluding genetic modification, 
(genetic diversity characterization; mapping, marker-assisted selection and genomics 
[MMG]; and micropropagation) by number of tree genera 
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Figure 2.1.4. Distribution of molecular markers used in forest biotechnology activities, 
excluding genetic modification 
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Figure 2.1.5. Distribution of reported forest biotechnology activities, excluding genetic 
modification, by category and applications (laboratory studies, field trials and 
commercial deployments) 1 
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2.1.3 CHARACTERIZATION OF GENETIC DIVERSITY: 
POPULATION GENETICS AND DIVERSITY STUDIES 
2.1.3.1 Introduction 
Genetic diversity is sometimes considered to be the invisible dimension of biological 
diversity. The present structure of genetic diversity is the result of the evolutionary history of 
the species exposed to natural selection pressures in variable environmental conditions. 
Natural selection at the local level is an evolutionary force opposed to gene flow. The 
combination of the two forces creates a powerful mechanism for maintaining within-species 
diversity. The use of molecular descriptors (markers) of the genome has allowed the 
measurement of genetic variation between genotypes and within/between populations, as well 
as the effectiveness of seed and pollen dispersal. 
Global review 
Studies carried out on forest tree genetic structure and on reproductive regimes use RAPD 
and AFLP markers, as well as nuclear markers and microsatellites, to increase understanding 
of the relationship between genome variations and genetic diversity. Molecular markers, 
especially neutral markers, provide an important tool for studying the structure of 
populations. However, experience shows that the resulting information on diversity, for 
example in ecology or taxonomic studies, is not always a good indicator of the patterns of 
variation in traits subject to selection pressures. A complementary approach is often required, 
consisting of studying the genetic diversity in specific regions of the genome. For example, 
SNPs (single nucleotide polymorphisms) are used to study the impact of evolutionary forces 
on the variability of allelic forms of a given gene, and their phenotypic expression. 
Work reported on tropical trees often involves studies of the impacts of tree harvesting and 
fragmentation on species' reproductive patterns and changes in genetic diversity at the 
population level (Chase et al. 1996; Dawson et al. 1997; Dick 2001 ; Dutech et al. 2002; 
White et al. 2002). In temperate species, several studies focused on gene flow in natural 
populations (Quercus , Cedrus) and the evolution of genetic diversity under forest 
management (Streiff 1998; Fady et al. 2003). Genetic diversity descriptions are numerous 
and diversified in terms of species and methodologies, and are mainly aimed at verifying 
some theoretical aspects, or at providing elements for the elaboration of conservation 
strategies (Petit et al. 1998; Newton et al 1999). Applications ofresults at operational level 
have been infrequently reported as yet, except in the case of rosewood (Aniba rosaeodora) 
and sandalwood (Santa/um) (J.M. Bouvet, personal communication). 
On-going studies on gene flow and, more specifically, on pollen flow, are based on the use of 
molecular markers, mainly microsatellites (Dow and Ashley 1998; Streiff 1998; Chaix 2003) 
and on paternity analysis (Gerber et al. 2000, 2003). Objectives include: 
• estimating and studying the evolution of genetic variability over time; 
• assessing effective population sizes; 
• studying biological mechanisms of reproduction, either in natural populations or in 
improved populations (in selection programmes); 
• studying pollen pollution in tree seed production areas (seed stands or seed orchards) or in 
the context of GM trees. 
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Data set analysis 
Most of the activities compiled in the data set have the overall objective of conserving and 
managing forest genetic resources in a sustainable way, and providing a better understanding 
of genetic diversity and evolution through the study of gene flow. This includes analyses of 
the consequences of human practices on the evolution of forest tree genetic diversity, as well 
as development and validation of theoretical models of population genetics. 
Work has been reported from all regions of the world (Figure 2. l .6A) including Europe 
( 44 percent), followed by North America (22 percent), Asia (19 percent), South America 
(6 percent), Oceania (6 percent) Africa (3 percent) and the Near East (less than one percent). 
When one considers the origin of the species being studied, the situation shows broadly 
similar patterns (Figure 2. l .6B). 
At least 99 genera are being worked on: Pinus (19 percent), Quercus (12 percent), Eucalyptus 
(8 percent), Acacia (7 percent) and Picea and Populus (6 percent) are the most frequently 
cited genera (Figure 2.1. 7). Reported objectives of genetic diversity characterization studies 
(Figure 2.1 .8) include: evaluation of genetic diversity (57 percent), gene flow studies 
(15 percent), fingerprinting (12 percent), and conservation (6 percent). 
Figure 2.1.6A. Distribution of forest genetic diversity characterization activities by 
region where the work is/was carried out 
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Figure 2.1.6B. Distribution of forest genetic diversity characterization activities by 
region of origin of the species studied; 'unknown' relates to undocumented sources, or 
to hybrid species, varieties and clones 
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Figure 2.1. 7. Distribution of genetic diversity studies by forest tree genus 
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Figure 2.1.8. Main objectives of reported studies on forest tree genetic diversity 
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2.1.3.2 Genetic maps, marker-assisted selection and genomics 
Introduction 
For a long time, forest tree seed has been collected from natural populations and, less 
frequently and only recently, from artificial stands (including planted stands or seed 
orchards). Since genetic information was lacking, most collections were based on phenotypic 
selection. At the beginning of the twentieth century, more attention started to be given to seed 
origin; numerous arboreta were established around the world and international seed 
exchange, documented to a greater or lesser extent, increased significantly. 
Later, growing awareness of the importance of intraspecific variation led to a more 
systematic exploration of the natural distribution of species of proven or perceived interest. 
With the assistance of national and international organizations, comprehensive explorations 
were made in the 1960s and 1970s for several genera and species including Tectona grandis, 
Gmelina arborea, Eucalyptus, Pinus and Acacia. Seeds collected were used in provenance 
tests, which in tum provided basic information and new materials for seed production areas 
or tree seed orchards. Nowadays, biotechnology tools allow more in-depth exploration of 
within-species genetic diversity, through the study of genomic variability. 
Use of biotechnology in tree breeding and selection 
Marker-assisted selection (MAS) has given further impetus to tree breeding and selection. 
Molecular markers are genetically linked to a given allele on a given locus and can therefore 
be used to predict the presence of the allele with great accuracy. The first markers developed 
(RAPDs, RFLPs [restriction fragment length polymorphisms] AFLPs and microsatellites) 
were neutral in the sense that their function, if they had any, was unknown. 
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They have provided a way of estimating genetic diversity and allowed comparison between 
individuals in different growth and development conditions. They have also been used in 
profiling to tag and then single out individual trees. 
Co-segregation of RAPD and AFLP type markers has allowed the construction of genetic 
maps. Genetic maps can be used to assess the degree of evolutionary relatedness of a number 
of species and identify the zones where gene variations are statistically linked to the 
variability of quantitative traits . These zones are called QTLs ( quantitative trait loci). QTL 
research focuses on the genetic architecture of traits of interest. However, QTL research 
results are not easily transferred to other tree populations: the QTLs identified so far are 
closely linked to the populations sampled. The use of QTLs in tree selection is thus 
increasingly questioned. 
For the above reasons, the use of candidate genes became necessary for applying MAS to 
forest trees. The candidate gene approach was made possible by the development of gene 
search methods (AFLP, EST banks and SSR, cDNA), transcriptomics and proteomics. In 
order to use those genes in selection, their molecular variability must be linked to the 
variation of the targeted trait of interest. This requires associating appropriate field 
experiments with genetic mapping. 
Proteomic analysis offers an important field of basic research that many research teams are 
willing to develop. Proteomic studies can find applications in such fields as biotic and abiotic 
stress response, effects of genetic mutations, gene expression regulation, QTL validation and 
genetic variability (Plomion 2000; Pilate et al. 2002). 
Information technology is an important asset since work on biotechnology requires the 
handling of massive catalogues of genes, transcripts and proteins. The use of bioinformatics, 
in particular, to transfer results from one given (model) species to other species, in variability 
studies, fingerprinting or tree breeding, is particularly valuable. 
Database analysis 
Mapping, MAS and genomics (MMG) studies are found in all regions of the world except the 
Near East (Figure 2.1.9). Europe and North America represent 43 percent and 34 percent, 
respectively, of the total MMG activities, followed by Asia (11 percent), Oceania (8 percent), 
South America (2 percent) and Africa (2 percent) . The work documented in Africa (South 
Africa and Congo) and South America (Brazil) relates to Eucalyptus almost exclusively. 
MMG activities are being currently applied to approximately 40 genera (Figure 2.1.10) 
among which Pinus (32 percent), Populus (18 percent), Eucalyptus (12 percent) and Picea 
(9 percent) are the most studied. 
Objectives of the research work (Figure 2.1.11) include wood properties improvement in 
relation to lignin composition (57 percent), abiotic resistance for cold or drought stress 
(20 percent), genetic diversity (8 percent), growth rate (6 percent), flowering (5 percent) and 
phytosanitary aspects of biotic resistance (4 percent). The work is being pursued mainly on 
expressed gene products (53 percent), genetic map construction (27 percent), gene candidate 
research (12 percent) and QTLs (6 percent). More recent proteomics research constitutes 
2 percent of the activities documented (Figure 2.1.12). 
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Figure 2.1.9A. Distribution of research related to mapping, marker-assisted selection 
and genomics (MMG) in forest tree species by region where the work is being carried 
out 
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Figure 2.1.9B. Distribution of research related to mapping, marker-assisted selection 
and genomics (MMG) in forest tree species by region of origin of the species studied 
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Figure 2.1.10. Distribution of mapping, marker-assisted selection and genomics (MMG) 
activities, by genus 
Acacia 
Fagus 
2% 
Betula 
3% 
Cryptomeria 
3% 
Quercus 
3% 
Pseudotsuga 
4% 
Picea 
9% 
2% 
I 
I 
28 other 
genera 
12% 
Pinus 
/ 32% 
Populus 
18% 
Eucalyptus 
12% 
Figure 2.1.11. Distribution of the main traits targeted in marker-assisted selection 
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Figure 2.1.12. Methodological approaches associated with mapping, marker-assisted 
selection and genomics (MMG) in forestry 
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The construction of genetic maps is a prerequisite for MAS. Genetic mapping is currently 
being developed for more than 25 forest species with the main objective of making maps 
denser by positioning a larger number of markers. Genera and species include: 
• Eucalyptus (Grattapaglia & Sederoff 1994; Verhaegen & Plomion 1996; Byrne et al. 
1995; Marques et al. 1998; Brondani & Grattapaglia 1999; Gionet al. 2000; Myburg et 
al. 2003), including E. camaldulensis, E. globulus, E. grandis, E. nitens, E. tereticornis 
and E. urophylla; 
• Populus (Cervera et al. 2001; Yin et al. 2002) in particular P. deltoides, P. nigra and 
P. trichocarpa; 
• Picea (Plomion 2000) including: P. abies, P. glauca and P. mariana; 
• Pinus (Kubisiak et al. 1995; Plomion 2000) including P. brutia, P. edulis, P. elliottii, 
P. palustris P. pinaster, P. radiata, P. strobus, P. sylvestris and P. thunbergii; 
• other species (Plomion 2000; Butcher et al. 2002; 
www.pierroton.inra.fr/genetics/Quercus): Acacia mangium, Cryptomeriajaponica, Larix 
leptolepis [=L. kaempferi], Pseudotsuga menziesii, Quercus robur and Taxus brevifolia. 
Several plant functional genomics programmes have undertaken linkage map construction, 
and significant developments in this area have been made with some forest trees. The search 
for linkages between coding regions and traits linked to wood quality has allowed some gene 
candidates to be identified ( especially in lignin synthesis pathways) although they are not yet 
used in routine selection programmes. There are noteworthy EST bank development 
programmes underway for several species in several genera, including Pinus, Populus, 
Eucalyptus and Betula. The gene candidate approach has been used in a dozen species of 
Pinus (Plomion et al. 2000; Whetten et al. 2001; Brown et al. 2003; Gamier-Gere et al. 2003; 
Le Dantec et al. 2003; McMillan 2004), at least five Eucalyptus spp. including hybrids (Gion 
et al. 2000; Thamarus et al. 2002; De Melis et al. 1998; Plomion et al. 2003; Kirst et al. 
2004; Ranik et al. 2004) and in three Picea spp. (McDougall 2000). 
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More recently, research work has been undertaken on other traits such as water stress 
tolerance (Dubas and Plomion 2003 ; Dubas et al. 2003) . Proteomic studies have been 
initiated on wood properties for a limited number of species: Pinus pinaster, Eucalyptus 
gunnii, Populus spp. and Picea sitchensis. 
2.1.3.3 Micropropagation 
Introduction 
In vitro vegetative propagation or micropropagation is aimed at cloning superior individuals 
or at 'bulk' (in mixture) propagating new genotypes with high genetic potential but available 
in limited quantities (such as materials obtained by controlled pollination). 
Tree species can be micropropagated by microcuttings or by somatic embryogenesis. 
Micropropagation methods 
Micropropagation by microcuttings consists of mass producing vegetative copies of desired 
genotypes by either axillary or adventitious budding. In the latter case, differentiated cells, 
usually from superficial tissues, must undergo a de-differentiating process before new shoot 
formation is initiated. Ultimately, production of independent and self-sufficient individuals is 
completely dependent on the de novo formation of an adventitious root system. 
Somatic embryogenesis, or production of embryos from somatic cells, is in fact a cloning 
technique, as opposed to zygotic embryogenesis in which germinal cells give rise to seedlings 
that are all genetically different. The process of somatic embryogenesis derives usually from 
callus formation induced by applying cytokinic or auxinic exogenous growth regulators to 
very juvenile plant tissues. In the most favourable situations, some undifferentiated cells of 
these calli can evolve into somatic embryos characterized, similarly to zygotic embryos, by a 
shoot-root bipolar structure. This basically distinguishes somatic embryogenesis from 
microcuttings consisting first of a shoot from which an adventitous root must subsequently 
develop. 
The majority of GM trees is likely to be used in the form of clonal materials and will need to 
be vegetatively propagated. In the case of conifers, somatic embryogenesis, especially when 
derived from a single cell, seems the most suitable regeneration and propagation technique. 
In broad-leaved species, vegetative propagation of GM materials is likely to use a 
combination of micropropagation and rooted stem cuttings, at least in the beginning. 
Database analysis 
Asia accounts for 38 percent of documented activities in forest tree micropropagation, 
followed by Europe (33 percent), North America (16 percent), South America (7 percent) , 
Africa (3 percent), Oceania (2 percent) and the Near East (one percent) (Figure 2.1.13A). 
Sixty-four countries active in this field have been identified. A closer look shows that species 
from Asia (27 percent) and Europe (21 percent) predominate (Figure 2.1.13B), which may 
suggest that the activities in Asia are concentrated on indigenous species, while Eucalyptus 
spp. are micropropagated in all continents. Species originating from South America and 
Africa are almost absent from the data set. Micropropagation activities seem to take place 
mainly in countries with significant tree planting programmes. 
Most micropropagation research activities are at a very advanced stage. Germplasm and 
protocols are likely to be available for large-scale deployment soon, if not already 
operational, for species and genera including: 
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• Anogeissus in India (Saxena and Dhawan 2001); 
• Acacia mangium and A. mangium x A. auriculiformis in Malaysia (Galiana et al. 2003), 
Indonesia and Vietnam (0. Monteuuis, personal observation); 
• Eucalyptus in Vietnam, India (0. Monteuuis, personal observation), Australia (Watt et al. 
2003) and South America (Levis W. Handley, personal communication); 
• Pinus in Canada and New Zealand (Lelu and Thompson 2000), and Pinus taeda in the 
USA (Levis W. Handley, personal communication); 
• Tectona grandis in Brazil, Thailand and Indonesia (0. Monteuuis personal observation) 
and Malaysia (Goh et al. in press). 
Micropropagation techniques have been tested on at least 82 forest tree genera (many of them 
of proven or potential interest in forest plantations). Research work has been devoted to Pinus 
(13 percent), Picea (13 percent), Eucalyptus (11 percent), Acacia (7 percent), Quercus 
(6 percent), and Populus, Larix and Tectona grandis ( 4 percent each) (Figure 2.1.14). The 
first five genera account for 50 percent of all activities carried out in forest tree 
micropropagation. Somatic embryogenesis accounts for 65 percent of activities in 
micropropagation followed by cell/tissue culture (17 percent), micropropagation by 
microcuttings in in vitro conditions (13 percent), cryopreservation/conservation ( 4 percent) 
and embryo rescue ( one percent) (Figure 2.1.15). 
Figure 2.1.13A. Distribution of micropropagation activities by region of activity 
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Figure 2.1.13B. Distribution of micropropagation activities by region of origin of the 
species studied 
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Figure 2.1.14. Distribution of micropropagation activities by genus 
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Figure 2.1.15. Categories of biotechnologies used in forest tree micropropagation 
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Micropropagation by microcuttings is carried out on more than twenty species including: 
• Populus alba, P. deltoides, P. tremula and Populus hybrids in Germany and India (Cornu 
1994), Spain (Bueno et al. 2003) and Lithuania (Kuusiene 2002); 
• Eucalyptus camaldulensis, E. globulus, E. grandis, E. nitens, E. tereticornis and 
E. urophylla in South Africa, Spain and Portugal (Watt et al. 2003), India (Watt et al. 
2003; Nadgauda in press), Vietnam and Thailand (0. Monteuuis personal observation), 
and Australia (Bandyopadhyay et al. 1999); 
• Acacia mangium, A. melanoxylon, A. mangium x A. auriculiformis in Malaysia and South 
Africa (Galiana et al. 2003 ; Monteuuis et al. 2003; Quoirin 2003); 
• Tectona grandis in India (Bonga and Von Aderkas 1992; Nicodemus et al. 2001; 
Nadgauda in press), Vietnam, Brazil and Indonesia (0. Monteuuis personal observation), 
Thailand (Kjaer et al. 2000), Costa Rica (Schmincke 2000), Malaysia (Monteuuis & Goh 
1999; Goh & Monteuuis 2001 ; Goh et al. in press) and Australia (Monteuuis, personal 
observation). ; 
• Larix in Canada and France (Charest 1996; Lelu and Thompson 2000); 
• Pinus radiata, P. taeda and P. pinaster in France (Dumas and Monteuuis 1991 ; 
Monteuuis and Dumas 1992), New Zealand 15 and the United States (Rahman et al. 2003); 
• Pseudotsuga menziesii in the United States (Ritchie et al. 1994); 
• Sequoia sempervirens and Sequoiadendron giganteum in France (Bonga and Von 
Aderkas 1992; 0. Monteuuis personal observation) and Germany 
(www.cnr.berkeley.edu/-jleblanc/www/Redwood/rdwd-Micropro.html); 
• Anogeissus latifolia and A. pendula in India (Saxena and Dhawan 2001); 
• Betulapendula in Norway (Saebo et al. 1995) and Finland (Comu 1994); 
15 See: www.forestresearch.co.nz. 
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• Paulowniafortunei in Australia (0. Monteuuis personal observation); 
• Platanus acerifolia in China (Liu and Bao 2003); 
• other species include Gmelina arborea, Artocarpus chaplasha, A. heterophyllus, 
Azadirachta indica and Elaeocarpus robustus in Bangladesh (Sarker et al. 1997; Roy et 
al. 1998). 
The advantages of somatic embryogenesis in comparison with micropropagation by 
microcuttings, especially with regard to multiplication rate and genetic modification 
applications, explain the major research investments in the technique. However, there are still 
serious obstacles to large-scale operational application of somatic embryogenesis to forest 
trees, for example: 
• Only some species and, within these species, only some genotypes can produce somatic 
embryos. 
• Success has been obtained, with few exceptions, mainly with juvenile tissues coming for 
instance from immature zygotic embryos. 
• There are risks that somaclonal variation may decrease the value of the genotypes 
produced by somatic embryogenesis, resulting in a considerable waste of time, material 
and money. True-to-typeness, particularly, may remain a problem for certain genotypes, 
and efforts are still needed for optimizing this technique to make it more reliable, 
especially when using mature selected genotypes. 
Although activities on somatic embryo genesis have been reported in all regions of the world, 
it seems that countries with conifer planting programmes show a stronger interest in this 
micropropagation technique: 
• Larix in Canada (and France) (Charest 1996; Lelu and Thompson 2000); 
• Picea abies, P. glauca, P. mariana and P. sitchensis in Canada, France and Ireland 
(Thorpe 1995; Charest 1996; Park et al. 1998; Lelu and Thompson 2000; Park 2002; 
Sutton 2002; Lelu-Walter and Harvengt 2004); 
• Pinus banksiana, P. patula, P. radiata, P. strobus and P. taeda in Canada (Park 2002), 
South Africa (Jones 2002), New Zealand (Lelu and Thompson 2000), the United States 
(Jones 2002; Sutton 2002) and Chile (Lelu-Walter and Harvengt 2004); 
• Pseudotsuga menziesii in the United States and Canada (Lelu and Thompson 2000, 
Sutton 2002); 
• Eucalyptus globulus (Pinto et al. 2002), E. grandis and E. dunnii (Watt et al. 1999); 
• Gmelina arborea, Artocarpus chaplasha, A. heterophyllus, Azadirachta indica and 
Elaeocarpus robustus in Bangladesh (Sarker et al. 1997; Roy et al. 1998). 
Investments in vegetatively micropropagated species of commercial interest have resulted in 
successful large-scale applications in several countries in Europe, North America, Asia and 
Oceania. Unfortunately, there is a lack of basic information on areas planted with forest 
vitroplants. 
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2.1.4 GENETIC MODIFICATION IN THE FORESTRY 
SECTOR 
2.1.4.1 Introduction 
The first regeneration of a genetically modified (GM) forest tree was achieved in 1986 in 
Populus. Since then, the genus has become a model for genetic modification and related tree 
biotechnology studies. The first attempt to genetically modify a conifer (Larix) was reported 
in 1991 (Huang et al. 1991 ). Introducing targeted genes into the genome of a forest tree is a 
way to obtain GM plants. It is also a basic research tool for a better understanding of gene 
functioning in woody plants. 
Review of objectives and methodologies 
Transformation methods consist of inserting into the genome of the host plant a mutated gene 
or a gene from another organism either by microinjection/projection ( direct transformation), 
or through a vector such as Agrobacterium tumefaciens (indirect transformation). 
Most successful work on genetic modification of forest trees species genomes so far has been 
obtained by using juvenile material, often from explants produced from early germinations 
tissues which have much higher regeneration capacities than older material. Successful 
genome modification reports of adult selected plant material are very rare, except in poplars 
precisely because of its greater capacity to regenerate. 
Traits subject to genetic modification are discussed below. 
Herbicide resistance 
A first method has consisted in introducing a mutated version of the gene encoding the 
enzyme target for various herbicides: glyphosate for Populus alba x P. grandidentata, 
P. trichocarpa x P. deltoides, Eucalyptus grandis, Larix decidua and Pinus radiata (the 
herbicide blocks the synthesis of tryptophan, tyrosine and phenylalanine), or chlorosulfuron 
for Populus tremula and Pinus radiata (the herbicide blocks the synthesis of leucine, 
isoleucine and valine). 
A second and more frequently used strategy consists of introducing a microbial gene 
encoding an enzyme for the detoxification of the herbicide, and has been applied to Populus 
alba, P. alba x P. tremula, P. tremula x P. alba, P. trichocarpa x P. deltoides and 
Eucalyptus camaldulensis (Ho et al. 1998; Moralejo et al. 1998) and Pinus radiata and Picea 
abies (Bishop-Hurley et al. 2001 ). 
Insect resistance 
The first strategy consists of using microprojectiles to insert a gene encoding an endotoxin 
which binds to the receptors in the intestine of Lepidoptera, Coleoptera and Diptera, lysing 
the organ and killing the insect. This was done in Populus alba x P. grandidentata, 
P. tremula x P. tremuloides and Picea glauca. GM Populus trees and Pinus radiata 
expressing the Bacillus thuringiensis endotoxin 'Bt' have been obtained. 
A second transformation method is based on the introduction of a gene coding for a protease 
inhibitor that modifies insect digestion, causing the death of the pest. Studies used potato 
gene pin2, a protease inhibitor introduced into P. alba x P. grandidentata through A. 
tumefaciens (Klopfenstein et al. 1991 ), and the gene of a rice protease inhibitor introduced 
into P. tremula x P. tremuloides (Heuchelin et al. 1997). 
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A third approach focuses on simultaneous modification of two genes for enhanced resistance 
to insects. This was achieved in Liquidambar styracijlua, combining a peroxidase anionic 
enzyme gene involved in cell growth and wall development with a 'Bt' gene (Sullivan and 
Lagrimini 1993). 
Flowering modification 
In order to produce sterile trees and prevent possible dispersal of transgenic pollen in the 
environment, an approach based on genetic ablation has been tested on poplar (Skinner et al. 
2000). This technique, which consists of expressing a cytotoxic gene under the control of a 
very specific poplar floral promoter, resulted in more than 90 percent of transfonned lines 
lacking floral structures. Other approaches, based on the suppression of key flowering genes, 
are being tested. 
Quantitative and qualitative modification of lignin 
Modification of lignin composition or content is being actively pursued because of the 
expected financial gains from pulp processing improvements. Lignins, which enhance cell 
wall mechanical properties and hardness, are difficult to process and are a significant 
limitation in processing wood into paper pulp by chemical treatment. Genetic transformation 
to modify lignin characteristics is a key research feature on species used in the paper industry. 
The aim is to regulate the activity of key enzymes involved in the lignin biosynthesis 
pathway (Lapierre et al. 1999; Jouanin et al. 2000; Li et al. 2003). Active on-going research 
targets the effects of lignin biosynthesis in Populus on soil carbon transformation and 
storage 16. 
Other traits 
Other traits that have been considered for genetic modification include: resistance to diseases 
(Mayer 2004; www.genewatch.org/) in Populus, Betula pendula, Alnus and Jug/ans.; 
bioremediation in Populus; enhanced growth through higher efficiency of nitrogen 
assimilation in Picea and Populus (Gallardo et al. 1999), and modification of gibberellin 
synthesis in Populus. 
2.1.4.2 Data set analysis 
Genetic modification activities represent 520 entries in the data set, or 19 percent of all 
biotechnology activities recorded worldwide. Research is reported in 35 countries and on 
29 tree genera. North America is the lead region, accounting for 48 percent of genetic 
modification activities on forest tree species, followed by Europe (32 percent), Asia 
(14 percent), Oceania (5 percent) and Africa and South America (Jess than one percent each) 
(Figure 2.1.16), while no activity is reported in the Near East. Genetic modification research 
at the country level is led by the United States (219 entries in the data set, or 42 percent of the 
world's recorded activities on GM forest trees) (Figure 2.1.17). Studies carried out by, or in 
cooperation with, agencies or companies from developed countries have been identified in 
Brazil, Chile, China, Indonesia, South Africa and Uruguay. 
Populus accounts for 4 7 percent (Figure 2.1.18) of data set entries, followed by Pinus 
(19 percent), Eucalyptus (7 percent) and Liquidambar and Picea (5 percent each). The 
pedigree of a number of hybrid poplars used in China has not been ascertained. Several 
countries have already established GM tree field trials . 
16 See: www2.ncsu.edu/unity/lockers/project/forestbiotech/news.html 
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Interestingly, while the first GM forest trees were developed some fifteen years ago, about 
three-quarters of the total number of species recorded in the dataset have been genetically 
transformed during the past five years. 
The main studies underpinning genetic modification (Figure 2.1.19) target gene expression 
(21 percent), in vitro regeneration tissue culture (18 percent), herbicide resistance 
(13 percent), biotic resistance (12 percent) and lignin properties (9 percent). 
Figure 2.1.16. Distribution of data set entries on genetic modification by region of the 
world 
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Figure 2.1.17. Distribution of reported forest tree genetic modification research 
activities by country (only those with more than five such activities in the data set are 
included) 
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Figure 2.1.18. Distribution of reported forest tree genetic modification research 
activities by genus 
U/mus 
Larix 2% 
2% 
Casuarina 
2% 
Betula 
3o/o --_; 
Picea 
5% 
Liquidambar 
5% 
Eucalyptus 
7% 
Pinus 
19% 
20 other 
genera 
8% 
Popu/us 
47% 
Figure 2.1.19. Main reported objectives of research activities in forest tree genetic 
modification 
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2.1.4.3 Summary of the state of genetic modification in the forestry sector 
In vitro regeneration of transformed plants is still a technical limitation for many species and 
genotypes. Genetically transformed lines have been regenerated for Populus, Eucalyptus, 
Pinus (including P. taeda 17) and Picea. Technical processes involved in regeneration are not 
always well controlled or even studied; especially in mature tissues where the situation is the 
most critical. No GM tree is reported to be commercialized in international databases to date 
(Mayer 2004; www.agbios.com). 
Insertion of genes controlling traits of interest in a given forest species is limited by 
insufficient knowledge of the molecular control of these traits. Most of the traits important in 
wood production, such as growth rate, adaptability, and stem and wood quality, are under 
polygenic control, and therefore depend on more than a single gene. Biosafety regulations 
governing GM trees are often a concern due to the long period of time necessary to monitor 
environmental effects (including gene stability, pollen and seed dispersal, and impact on 
other elements of the ecosystem). Most existing regulations are both stringent and involve 
high development costs compared to annual crops. Collaborative genomics programmes such 
as those carried out on Populus, Pinus and Eucalyptus, with the on-going characterization of 
genes of interest (including those coding for flowering, and lignin and cellulose biosynthesis ), 
and the identification of specific promoters of transgenic expression, are expected to boost 
advances in genetic modification of forest trees. Studies to assess the stability of GM tree 
growth under abiotic stress, and their environmental impact, have been initiated. 
2.1.5 CONCLUSIONS: STATUS AND TRENDS OF 
BIOTECHNOLOGY RESEARCH AND APPLICATIONS IN 
FORESTRY 
Unlike work carried out on crop or farm animal species, the domestication of forest trees is, 
with few exceptions, very recent. However, within a few decades, knowledge transfer from 
agriculture to forestry has been so fast that genetic knowledge of a few tree model genera, 
such as poplar (Populus), pine (Pinus) and Eucalyptus, is about to become as important, in 
terms of complexity and quality, as the genetic knowledge of the main crop species. Modem 
biotechnologies have potentially outstanding applications in the forestry sector, mainly 
because of the potential genetic gains they could confer. Expected gains for tree breeders 
include new genetic pools and significant reduction in tree selection time. 
Owing to technical difficulties, high costs, and time needed to evaluate forest species, tree 
breeding programmes have long been limited to the mass selection of the best individuals. 
Between the 1970s and 1990s, development of horticultural techniques such as grafting, 
propagation by cuttings and controlled pollination, as well as information technology 
development, contributed to the implementation of sophisticated and efficient tree 
improvement activities. Long-term conventional tree breeding programmes and large-scale 
clonal propagation techniques have resulted in, and will continue to provide, significant 
productivity gains, especially for fast-growing species such as Eucalyptus and Populus. 
While the objectives of tree breeding are clearly defined and address end-users' (tree 
growers ' ) requirements (in terms of yield, wood quality, and biotic and abiotic resistance), 
the situation in biodiversity conservation is less clear. Several issues (including knowledge of 
species biology, ecosystem conservation, restoration of endangered species, and decision-
making tools for ecosystem or forest management) are common to biological diversity and 
forestry. 
17 Source: APHIS; www.aphis.usda.gov/ 
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However, in spite of a considerable number of studies carried out on hundreds of forest tree 
species, there are still very few reported biotechnology applications. Many countries are 
currently engaged in biotechnology-supported forest biodiversity conservation programmes. 
Nonetheless, there are only a few reported direct impacts at policy or technical levels. 
The impact of biotechnology on genetic studies has allowed the use of cutting-edge 
methodologies with forest tree species in spite of the late domestication process compared 
with crop species (Sedjo 2003). The sequencing of the Populus genome has significant 
implications for forestry (Campbell et al. 2003). Eucalyptus gene sequencing, which was 
reported during a IUFRO (International Union of Forest Research Organizations) Tree 
Biotechnology meeting in 2003, has since been pursued by the Eucalypt Genome Initiative 18, 
the Eucalyptus Genome Sequencing Project Consortium 19 and the Brazilian project 
Genolyptus. The Dendrome Project20 is a collection of forest tree genome databases and other 
forest genetic information resources, with a special emphasis on conifers and Pinus. It is in 
genome sequencing that research seems currently most active. 
The development of large-scale vegetative propagation techniques, essentially based on 
micropropagation or somatic embryogenesis, makes it theoretically possible to deploy 
superior planting materials rapidly and effectively. This is already the case for some 
coniferous and broad-leaved tree species including Eucalyptus and teak (Tectona grandis). 
Micropropagation techniques are also necessary to regenerate GM plants. 
Genetic modification has been applied to forest trees mainly during the last two decades, at 
the experimental stage in the laboratory, to alter various traits such as herbicide, metal, salt, 
or insect resistance or cold tolerance. The rationale for producing trees with reduced lignin 
content for the pulp and paper industry is generally based on the expected environmental and 
economic benefits (Christensen et al. 2000). Equally if not more important, genetic 
modification is often considered as a tool to improve knowledge of tree biology and 
functioning, with significant potential applications; for example, for studying cell wall 
properties and wood formation. Since genes regulating secondary tissue and lignin formation 
in the annual plant Arabidopsis thaliana were identified (Goujon and Jouanin 2003), research 
on the genetic basis of wood quality in forest trees has significantly increased (mainly in 
Eucalyptus, Pinus and Populus) . 
With the exception of micropropagation, for which some applications are reported, most 
public domain information relates to research activities. Field applications appear extremely 
limited, according to the literature. Nevertheless, and in spite of unclear economic rationale, 
the use of biotechnology in forestry research has increased and provided new knowledge on 
tree biology and functioning. It also appears that forest biotechnology is increasingly funded 
by the public sector in academic research, while the private sector seems to focus investments 
more on specific traits of commercial interest such as wood quality. 
Commercial deployment of new biotechnology-based forest tree varieties of a limited number 
of taxa (Eucalyptus, Pinus taeda, P. radiata, P. pinaster, Populus) can be expected in the 
near future. The impact of biotechnology applications on global wood supply may, however, 
take longer to materialize (not before 2020, according to Seppala 2003). In this context, 
genetic modification appears to be the most significant and controversial sector of forest 
biotechnology. It is noteworthy that in some countries the terms 'biotechnology' and ' genetic 
modification' are used as synonymously, adding to the confusion. 
18 See: www.up.ac.za/acadernic/fabi/eucgenomics/EGI/. 
19 See: http://forests.esalq .usp.br/. 
20 See: http://dendrome.ucdavis.edu/Gen res.htm. 
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During the last decade, several collaborative groups or consortia have been created by public 
or private partners for applying specific forest biotechnologies in a number of countries, 
including: 
• ArborGen, created in 1999, with the aim of enabling research on genetic modification, 
has been working on herbicide resistance, growth and fibre quality for paper pulp in 
Eucalyptus, Pinus radiata, Populus, Pinus taeda and Liquidambar sp. 
• GenForSA, created in 1999 with the main objective of modifying and testing disease 
resistance of Pinus radiata, while improving wood quality and formation (Owusu 1999). 
• Monfori Nusantra Indonesia, created in 1996, has been involved in mass production of 
tissue cultures of Tectona grandis, Acacia and Eucalyptus for field trial establishment and 
commercialization. 
• The Oregon State University's Tree Genetic Engineering Research Cooperative (TGERC) 
has carried out research on the use of GM poplar in plantations. 
• The Poplar Molecular Genetics Cooperative (PMGC) has been established with the aim 
of improving knowledge of genetic and molecular mechanisms responsible for 
productivity and quality trait variations in hybrid poplars. 
• The North Carolina State University Forest Biotechnology Industrial Research 
Consortium (FORBIRC) mission is to integrate genome technology, metabolic 
engineering, traditional tree breeding and wood and paper science into a research 
organization directed to the creation of superior wood as a raw material and as a product. 
The interest induced by the first genetic modifications of tree species at the end of the 1990s 
has since declined. Regulatory frameworks have been established in many countries for GM 
organism (GMO) field experiment or commercial deployment, with increased testing costs. 
In a number of countries, hostile reaction from the public or/and environmental groups has 
also limited deployment of GM trees. Some authors have questioned the profitability or 
return on investment of MAS techniques, at least in the short term and the medium term 
(Robinson 1999). 
In Europe, forestry research priorities now focus on stronger synergies between 
biotechnology and conventional selection and breeding programmes mainly for wood 
improvement. The aim is to fill the gap between forest trees and agricultural crops in terms of 
the level of domestication. As a result, tree improvement tends to use genomic and proteomic 
approaches for achieving trait selection more rapidly. This is done by taking advantage of the 
advances obtained in model plants such as Arabidopsis (Kirst et al. 2003), and of the 
considerable increase of information exchange resulting from the latest bioinformatics 
progress. More and more effort is devoted to research aimed at better understanding biotic 
and abiotic stress responses. Significant investments have been made in genomics research on 
Populus and Pinus within the framework of the Poplar Genomics Initiative and the Pine 
Mapping Project. 
In the tropics, wood production in volume per hectare is significantly higher than in the 
temperate zone. Several large-scale companies have recently invested in tree planting in 
tropical and subtropical areas. Some paper companies tend to fund their own research 
activities and keep them confidential. More emphasis seems to be put in genomics and 
proteomics, and particularly sequencing, thanks to developments on Arabidopsis thaliana, 
Oryza and Populus. 
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At the same time, there is increasing information coming from genome banks on wood 
quality, growth and stress resistance. Good examples of EST development include 
Eucalyptus in the framework of the Genolyptus project in Brazil, Populus2 1, Pinus taeda22 
and P. pinaster and Quercus23, although applications for practical field selection are very 
unlikely to be operational for at least a decade. 
Some predict that the next few years are more likely to see significant field applications of 
forest genomics research than of genetic transfom1ation research, whose application is 
seriously hindered by strong environmental opposition and stringent regulations. 
Developments in agricultural crops are very meaningful is this respect. Genomics and 
proteomics outcomes are expected to boost conventional tree breeding and improve the 
efficiency of existing programmes. 
The production costs of a new forest tree variety using conventional selection (well-known 
species, with a short juvenile phase) is roughly estimated at about US$400 OOO and requires 
15 to 20 years to be developed (Fenning and Gershenzon 2002). The calculation does not 
include the investment required for the selection of the suitable species. On the other hand, 
genomics, supported by bioinformatics in the framework of MAS, requires substantial 
equipment and running budget (as an indication, a supportive biotechnological platform costs 
several million dollars). In tum, such biotechnologies are expected to enable breeders to 
access more accurate and numerous traits of interest for greater improvements, while 
reducing the new variety production costs thanks to bioinformatics. 
As regards developing countries and countries with economies in transition, there are few 
references available on their involvement in forestry biotechnology. The limited literature 
mainly refers to micropropagation in Vietnam, Malaysia, Indonesia and India. Malaysia has a 
reported strong oil palm molecular biology programme, including genetic modification. 
However, some emerging countries with advanced financial, institutional and human 
capacities (including Brazil, India24, and China) have made significant breakthroughs in 
advanced forest biotechnology. Brazil has been actively involved in research on Eucalyptus 
through the Genolyptus project that constitutes at the moment the cutting edge in research on 
the genus worldwide. China is very active in poplar genetic modification. It can be 
reasonably assumed that after a period of time, results from research in technically advanced 
countries will benefit an increasing number of developing countries and countries in 
transition. 
African countries, with the exception of Kenya and South Africa, are far less advanced in 
forest biotechnology. However, notable development of agricultural crop biotechnology in 
countries like Nigeria, Uganda, Cote d'Ivoire, Morocco and Algeria (particularly through 
AAB25) and even in the forestry sector (ISAAA in Kenya26), constitute positive indicators 
suggesting that the situation is improving. Adoption of well-targeted forest biotechnology, 
possibly for drought-resistance, seems a crucial issue for the future of such activities. 
Micropropagation has for the past several years been the most striking example of forest 
biotechnology applications, at least in terms of numbers of plants produced and acclimatized. 
Applications have been reported mainly in Asian countries, although there is still a lack of 
reliable information as far as operational field planting is concerned. 
21 See: http://Poppel.fysbot.urnu.se, http://mycor.nancy.inra.fr/PoplarDB.html. 
22 See: http://cbc.urnn.edu, http://dendrome.ucdavis.edu. 
23 See: www.pierroton.inra.fr. 
24 See: http://dbtindia.nic.in/ebc/ptc.htm. 
25 See: www.aab.org.dz. 
26 See: www.isaaa.org/Projects/ Africa/trees.htm. 
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2.1.7 ANNEXES 
2.1.7.1 Methodology of data collection 
Data analysed in this study were stored in a simple Excel data set. The data set gathers major 
biotechnology entries (i.e. a given technology developed or used in a given country, by a 
given laboratory team, on a given species or variety, for a given purpose). Since a single 
activity can be reported and published many times in different journals, a significant amount 
of time has been devoted to singling out the activities and selecting the latest ( or most 
comprehensive) reference(= source of information, or activity, or entry, or record). 
Collection dates: February to April 2004 with revisions in September 2004. 
Methodology: *Systematic searches on CAB Abstracts from 1994 to 2004 using 
combinations of key words (including forest trees, MAS, micropropagation, proteomics, 
genomic, EST, lignin, transformation, GMO). Examples: forest trees x genetic diversity, 
forest trees x micropropagation, proteomics x eucalyptus. 
*Research on Google using the key words indicated above. A search in Google provided 
632 OOO references to 'forest biotechnology' in November 2004 (all languages). 
*Team research by topic, on the Internet, through personal contacts, and through reviews of 
literature. Topics included: 
• Micropropagation 
• Genetic transformation 
• Genetic improvement, genomics, etc. 
• Structuration of genetic diversity 
• Mycorrhizae, Rhizobium 
*Review of the proceedings of the latest international conferences 
Confidentiality: *Only public information was gathered, including personal 
communications and observations. 
The following databases and international data sets have been used through CABI: 
AGRICOLA, AGRIS, ASF A, CAB Abstracts, Econlit, FSTA, TROPAG & RURAL, and 
ULRICH International Periodicals. 
Data structure: In total, 2 716 records have been collected. Of these, 2 644 records 
were directly related to forest trees, while 72 records addressed forest trees indirectly: studies 
on mycorrhizae (Frankia and Rhizobium) accounted for 36 records, fruit trees and ornamental 
trees 30 records, and bamboos and rattans six records. 
Information on crop trees has not been searched systematically, and the 
data set is not representative of activities taking place on domesticated trees. However, a 
number of genera that comprise wild populations and cultivated varieties (including Ficus, 
Malus, Marus, Pyrus, Prunus) have been included, when insufficient information was 
available from the source of information to ascertain the degree of domestication of the 
germplasm on which activities were carried out. These classification uncertainties represent 
approximately one percent of the data set. 
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A number of forest tree species cannot be categorized in specific 
regions of provenance. This is the case for most hybrid Populus clones, including 
euramerican poplars (Populus x P. euramericana) and many Asian varieties. 
Eurasian species (including Pinus sylvestris, Populus n;gra . . . ) have 
been categorized as of European origin. 
2.1.7.2 Main Internet sites used 
http: //biotech.jrc.it 
http: //dendrome.ucdavis .edu 
http://elonmerkki.net 
http://fabinet.up.ac .za 
http: //mediaforest.net 
http: //ogm.agriculture.gouv.fr/ 
http ://webdoc.sub.gwdg.de 
http://web.ahc.umn.edu/biodata/ 
www.agbios.com 
www.agnet.org 
www.americanlands.org 
www.aphis.usda.gov/ 
www.arborea.ulaval.ca 
www.arborgen.com/ 
www.beckerunderwood.com 
www.biorize.com 
www.biospace.com 
www.cellfor.com 
www.checkbiotech.org 
www.cirad.fr 
www.cnr.berkeley.edu 
www.cs1ro.au 
www.ctnbio.gov.br 
www.edinburgh.ceh.ac.uk 
www.efi.fi 
www.ermanz.govt.nz 
www.etfrn.org 
www.fao.org 
www.forestresearch.co .nz 
www.fsc.org 
www.fungi .com 
www. gen et-info. org 
www.genewatch.org 
www.greenpeace.org 
www.grolife.com 
. . . 
www.1pgn.cg1ar.org 
www.isb.vt.edu 
www.itto.or.jp 
www.iufro.org 
www.ncl-india.org 
www.nf-2000.org 
www.nrcan-rcan.gc.ca 
www.phcmexico.com.mx 
www.philombios.com 
www.pierroton.inra.fr 
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www.premiertech.com 
www.rbge.org.uk 
www.rti.org 
www.strategis.ic.gc.ca 
www.ucl.ac. be 
www.wrm.org.uy 
PRf·l l\11' \H\ Rf\ 11 \\ lH llfU!H If'.()! Cl(\ I'\ l<llH SIi<\ 
2.1.7.3 Distribution of countries and territories by geographic region as 
used in this study27 
Africa: Cameroon, Congo, Cote d'Ivoire, Ethiopia, Ghana, Kenya, Madagascar, Senegal, 
South Africa, United Republic of Tanzania, Uganda 
South America: Argentina, Brazil, Chile, Costa Rica, Cuba, Guyana, Mexico, Uruguay, 
Venezuela (Bolivarian Republic of). 
North America: Canada, United States of America 
Asia: Bangladesh, China (including the province of Taiwan), India, Indonesia, Japan, 
Republic of Korea, Malaysia, Myanmar, Nepal, Pakistan, Philippines, Singapore, Thailand, 
Viet Nam 
Near East: Egypt, Iran (Islamic Republic of), Kuwait, Saudi Arabia, Tunisia, United Arab 
Emirates 
Europe: Austria, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, 
Finland, France, Germany, Greece, Hungary, Iceland, Israel , Italy, Latvia, Lithuania, 
Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Serbia 
and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom. 
Oceania: Australia, New Zealand. 
27 Note: the distribution of countries and territories by regions of the world is in line with the FAO regional 
classification. See: 
www.fao.org/countryprofiles/physical presence.asp?lang=en. 
56 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
PR! · I I \II' \HY RI \ If,\\ 01 ll!O I H If'.()! cl\,\ 1 "- H lRI S JR \ 
2.2 A global study on the state of forest tree genetic 
modification 
Christian Walter and Sean Killerby - New Zealand Forest Research Institute Ltd, 
Rotorua, New Zealand 
2.2.1 SUMMARY 
The information provided in this report was resourced from practitioners in the area through a 
detailed questionnaire. Particular emphasis was given to the views of practitioners on how 
they see genetic modification contributing to forestry, and how they view future 
development. To complement information from the questionnaire, other publicly available 
information, such as that available on Internet sites, was included in the assessment. 
2.2.2 INTRODUCTION 
Genetic modification in forest trees is widely reported and results from field testing are 
beginning to appear (Pilate et al. 2002, C. Walter, unpublished). In 1999, Owusu reported 
that, despite efforts by national regulatory agencies to keep track of research and applications 
of genetic modification in forest trees, as well as attempts to set up and maintain global 
information systems on GMOs (genetically modified organisms) and genetically modified 
(GM) trees, there was no comprehensive data set recording research and applications of 
genetic modification in forestry (Owusu 1999). The lack of global compilation of forest 
genetic modification makes it difficult to gauge the current status of such a controversial 
issue and to predict future trends. The present report is an attempt to quantify the existing 
situation with regard to developments on genetic modification in forest trees, using 
information and data provided by technology developers. It is, however, acknowledged that 
this approach can provide a snapshot of the situation only, and regular updating is 
recommended. 
2.2.3 GLOBAL STATUS OF TREE GENETIC 
MODIFICATION. THE QUESTIONNAIRE 
A questionnaire was developed to assess the current status of tree genetic modification 
worldwide, and to scope the views of scientists and organizations involved in tree 
biotechnology on the current and future issues related to genetic modification in trees. The 
questionnaire was also designed to capture the views of practitioners on future developments, 
and on strategies required to provide scientific information to the public. A copy of the 
original questionnaire is available from the FAO. Responses were collected by FAO and New 
Zealand Forest Research Institute Ltd (NZFRI) and analysed by the authors. The following 
provides a detailed analysis together with an interpretation of the results. Where appropriate, 
tables or graphics summarize results. 
Some respondents included ornamentals/fruit trees in their responses. These were included in 
the analysis, because it was deemed important to capture the views of individuals and 
organizations practising genetic modification, with tree genetic modification as understood in 
the widest possible sense. 
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2.2.3.1 Response rate 
Based on the NZFRI address list, 418 questionnaires were sent out by the authors to 
institutions possibly involved in genetic modification of woody plants and another 105 
institutions and individuals were contacted by F AO. Further, Internet lists such as ETFRN28 
and METLA29 were used to distribute information, as were the IUFRO (International Union 
of Forestry Research Organizations) Task Force on Biotechnology, the FAO Panel of Experts 
on Forest Gene Resources, the EUFORGEN30 national co-ordinators and colleagues at 
various organizations. It can be assumed that the majority of forest geneticists, breeders and 
molecular biologists worldwide were informed about the study and were asked to contribute. 
Questionnaires were available in English, French and Spanish. 
A deadline of 24 May 2003 was given for receipt of questionnaires, but this was extended, 
mainly owing to the fact that many key organizations had not responded by that date. The 
latter were contacted again directly and a few more questionnaires were returned. As of 
30 September 2003, a total of 49 responses was received and entered onto a spreadsheet. This 
represents a response rate of 11.7 percent (based on 418 questionnaires sent originally). No 
more responses were received as of the end of 2003. 
When data from the responding individuals and organizations were compared with publicly 
available data, it was noticed that not all organizations conducting research or field 
evaluations have made their data available, although much is publicly available from 
websites31 • 
2.2.3.2 Respondents (Q 1.1-1.332 : Name, address, institutional framework, 
Internet) 
The respondents were located in 26 different countries (Table 2.2.1 ). 
Twenty-three of the 49 respondents (47 percent) were conducting research on genetic 
modification in forest trees, with one other being a non-profit organization advocating 
appropriate use of biotechnology. 
Of the 49 respondents, 24 (49 percent) were from research institutes, 14 (29 percent) from 
universities, six ( 12 percent) from private commercial companies, and two ( 4 percent) from 
non-profit organizations. Another three (6 percent) did not state what type of organization 
they belonged to, or else wanted to keep the nature of their organization confidential ( one 
respondent). 
Of the 23 respondents conducting research on genetic modification in forest trees, ten 
(44 percent) were in research institutes, nine (39 percent) in universities, two (8.5 percent) in 
a private industry organization, and two (8.5 percent) in 'other organization' including one 
confidential response. The other 'other organization' was CHH (Carter Holt Harvey) in New 
Zealand, who stated that they are currently only completing work already 'in the pipeline'. 
Fifteen of the 49 respondents (31 percent) are currently publishing information relating to 
genetic modification on the Internet; 21 ( 43 percent) do not publish. 
28 Contact: etfm@iac.agro.nl. 
29 Contact: forestgen@metla.fi . 
30 IPGRI 's European Forest Genetic Resources Programme. 
31 For examples, see the websites ofregulating authorities in Appendix 3.8.1. 
32 Numbering refers to the numbers of the questions in the questionnaire. 
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Thirteen respondents (27 percent) did not answer these questions. However, when only those 
organizations that work with genetic modification were analysed, the picture is different: 
13 of the 23 respondents (57 percent) working with genetic modification of trees publish 
information about genetic modification on the Internet. Ten (43 percent) of them do not use 
this medium for publishing information. 
Internet addresses were submitted (see Appendix 3.8.1) by all respondents answering ' yes', 
but one did not want the Internet address to be published, for reasons of confidentiality. 
Table 2.2.1. Responses by country. Numbers of respondents (total) and respondents 
using genetic modification are listed by country 
Country Number of respondents Number of respondents using 
genetic modification 
Algeria I 0 
Argentina I I 
Australia 1 I 
Austria I 0 
Belgium I I 
Canada 4 2 
China 1 I 
Costa Rica 1 0 
Ireland 2 0 
Finland 1 I 
France 3 2 
Germany 5 2 
Italy 2 0 
Japan 2 2 
Mexico 1 1 
Morocco 1 0 
New Zealand 3 2 
Norway 1 0 
Portugal 2 I 
Romania 1 0 
South Africa 1 0 
Spain 1 0 
Sweden 4 3 
USA 6 2 
Israel 1 1 
Uruguay 1 0 
TOTAL 49 23 
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2.2.3.3 Contained research (Q 2.1: The scope of genetic modification in 
contained laboratory research) 
Of the 23 respondents who reported work on genetic modification of forest trees, 
14 (61 percent) were conducting research on Populus, nine (39 percent) on Pinus, eight 
(35 percent) on Picea and four (17 percent) on Eucalyptus. Three respondents (13 percent) 
were working on Betula, two (9 percent) with Larix, two (9 percent) with Chamaecyparis and 
two (9 percent) with Ulmus. Other species being worked on, by one respondent each, were in 
the genera Pseudotsuga, Robinia, Paulownia, Quercus, Jug/ans and Tectona33. 
When asked whether the genetic modification work was related to a research or commercial 
project, all but two experiments were described as research. The two commercial projects 
were by one organization and the taxa involved were Populus nigra and a hybrid poplar. 
However, three respondents classified a total of four experiments as both research and 
commercial. The species included were in the genera Populus and Eucalyptus (twice each), 
perhaps indicating that there are plans to use those trees for a commercial project in the 
future. 
Many different traits and associated genes were mentioned by respondents as targets. 
Evaluation of these responses is somewhat difficult since different terms were obviously used 
for the same trait. Also, it can be assumed that most if not all transformation events include 
markers, and most probably antibiotic resistance genes, but these were not always mentioned. 
Table 2.2.2 (Figure 2.2.1) lists the traits by the frequency with which they were cited. Names 
of genes (as given in the responses) were used in this evaluation to arrive at a clearer picture 
of what traits were actually meant, and to group some traits. 
The projects associated with commercial goals were in wood properties (three), insect 
resistance (two) and detoxification of pollutants (one). 
A total of 68 projects was referred to and four ( 6 percent) of them were classified as applied 
for (regulatory approval), 50 (74 percent) as ongoing, and four (6 percent) as both. One 
project each ( 1.5 percent) was in development and had been stopped. However, no comments 
were made on eight projects (12 percent). 
33 Note that percentages add to more than 100 because most respondents work on more than one species. 
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Table 2.2.2. Traits targeted in genetic modification projects, in laboratory based 
experiments 
Trait/gene Number of times cited 
Markers/reporters/antibiotic resistance 26 
Reproductive development 19 
Herbicide resistance 11 
Wood properties 8 
Insect resistance 7 
Lignin biosynthesis 6 
Defence traits 3 
Nitrogen metabolism 3 
Pest and disease resistance 2 
Phenotype 2 
Somatic embryogenesis 2 
Cellulose biosynthesis 2 
Hormones 2 
Growth characteristics l 
Metabolism I 
Detoxification of pollutants l 
Bud development l 
Figure 2.2.1. Traits targeted in genetic modification projects, in laboratory based 
experiments 
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2.2.3.4 Field trials (Q 2.2: The scope of genetic modification in field tests) 
Eleven respondents of 49 (22.5 percent) reported projects with GM trees involving field 
analysis and a total of 26 projects were mentioned. Of those, 20 (77 percent) were with 
Populus and two (8 percent) with Pinus. One project each (4 percent each) was reported for 
Betula, Eucalyptus, P;cea and other species in other genera. 
Traits/genes targeted in these projects are listed in Table 2.2.3 (Figure 2.2.2). There are 
significant differences in the relative ranking of traits targeted in laboratory research 
(Table 2.2.2) and traits studied in field trials, in particular with regards to reproductive 
development. 
For 22 projects, respondents provided information on the establishment of the trials. Table 
2.2.4 lists the numbers of GM tree field trials established by year. Two of the 22 projects 
were described as 'ongoing', with no commencement date given. Information on size of trial 
and numbers of trees, where available, is given34 . 
When asked about the issues addressed in field trials, all but five respondents who had trials 
in place provided answers (Table 2.2.5 and Figure 2.2.3). 
Table 2.2.3. Traits/genes targeted in projects with GM trees in field trials 
Trait/gene Number of field trials cited 
Marker 9 
Herbicide resistance 6 
Lignin biosynthesis 5 
Insect resistance 3 
Reproductive development 2 
Wood properties 1 
Metabolism 1 
Detoxification I 
Sterility I 
Transgene stability I 
Metabolism I 
Activation tagging I 
34 These data are probably a vast underestimate of the actual number of trees installed in field trials. 
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Figure 2.2.2. Traits/genes targeted in projects with GM trees in field trials 
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Table 2.2.4. Established field trials of GM trees' 
Year 
1989 
1990 
1991 
1992 
1993 
1994 
1995 
1996 
1997 
1998 
1999 
2000 
2001 
2002 
2003 
' Ongoing ' 
1
-: No data provided. 
2 1 acre - 0.4 ha. 
Number of trials 
I 
-
1 
2 
-
1 
3 
1 
1 
1 
2 
3 
1 
1 
2 
2 
Size of triat2 
0.012 ha 
-
-
0.015 ha each 
-
1.13 ha 
< l acre/-/-
0.5 ha 
-
1 acre 
total 80 ha 
pots/0.1 ha/0.2 ha 
-
1.5 acres 
total 1 ha 
0.004 ha/-
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Table 2.2.5. Issues addressed in field trials with GM trees (number of projects 
addressing a particular issue) 
Issue addressed Number of projects 
Plant growth/perfom1ance 5 
Gene expression stability 4 
Environmental risk assessment 3 
Horizontal gene transfer 2 
Herbicide applications 2 
Mycorrhizal status 1 
Vegetative propagation 1 
Sterility 1 
Insertional tagging I 
Figure 2.2.3. Issues addressed in field trials with GM trees (percentage of projects 
addressing a particular issue) 
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2.2.3.5 Commercial plantations (Q 2.3: Scope of genetic modification in 
commercial plantations) 
Most respondents reported that they had no immediate plans for commercialization, one of 
them commenting that it would take decades of research to test whether desired traits were 
realized and were stable, to assess risks, and to gain public and regulatory backing for 
commercial release. 
One respondent felt that if there were any commercial plantations of GM forest trees in the 
world, those responsible were very successful in keeping it secret. 
However, it has been reported (Su et al. 2003) that there are such plantations and one 
respondent described the commercial release of two GM tree species in China: 
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• Populus nigra, modified with the Bt gene35 for resistance to leaf-eating insects, with 80 ha 
of field trials on eight sites in seven provinces since 1999 and 200-300 ha of commercial 
planting since 2002 ( over one million cuttings have been propagated). 
• Hybrid poplar 741 (P. alba x [P. davidiana + P. simonii] x P. tomentosa) , modified with 
cry 1 Ac36 and API37 for resistance to leaf-eating insects, with field trials since 2001 and 
commercial planting since 2003 ( currently only indicative data available on area planted). 
The respondent further reported that there are significant problems keeping track of the area 
planted, mainly because poplar is vegetatively propagated and there is confusion in nurseries 
as to what is genetically modified and what is not. 
2.2.3.6 Traditional breeding programmes (Q 2.4: On the support for 
genetic modification programmes by traditional breeding programmes) 
Respondents commented on the integration of their tree genetic modification projects with 
traditional breeding programmes. Of a total of 68 projects involving GM trees (in 23 
organizations), 27 (40 percent) reported full integration with traditional breeding projects. 
Nine respondents (13 percent) reported that either connections or the development of an 
integrated approach were weak, 29 (43 percent) indicated that their tree genetic modification 
projects were not integrated at all with traditional breeding projects. A further respondent 
who represented three projects ( 4 percent) made the statement that there are no links seen, 
and no links are anticipated. 
2.2.3. 7 Vegetative multiplication (Q 2.5: On the support for genetic 
modification programmes by vegetative propagation programmes) 
Comments were requested on the integration of tree genetic modification projects with 
vegetative propagation projects. Of a total of 68 projects involving GM trees 
(in 23 organizations), 23 (34 percent) reported full integration with clonal multiplication 
projects. Seventeen (25 percent) respondents reported weak connections or connections in 
development, while 21 (31 percent) had no integration with such programmes. Seven 
( 10 percent) of the respondents did not offer any information under this heading. 
2.2.3.8 Other research (Q 2.6: The scope of genetic modification projects 
underpinning other research goals) 
Under this question, respondents were asked about research projects that use genetic 
modification technology but do not anticipate deploying GM trees in commercial forestry. Of 
the 23 organizations using tree genetic modification, 15 (65 percent) reported underpinning 
research, seven (30 percent) answered 'no' and one (5 percent) did not respond. Of those 
organizations that did not use genetic modification for trees (27 out of 49 respondents, or 
55 percent), 17 (63 percent) did not respond to this question. Eight of them (30 percent) 
reported no non-tree research in genetic modification, while two (7 percent) reported such 
research. 
A total of 17 out of 49 respondents (35 percent) reported underpinning research and 12 gave 
more detailed descriptions of such research. The key areas were: 
35 The cry I Ac gene. 
36 CrylAc codes for a protein that is toxic to a specific class of insects. 
37 Another gene of which the product is toxic to insects. 
65 
!'iii · I 1\11~ ,\ I{ Y R I·\ II \\ OF llf(J l I < lf'\()U H,) f '\. l 'ORl·S J ln 
• testing gene function 
• environmental impact 
• MAS, QTL detection, genetic maps 
• microarray and EST mining for genes 
• flowering-related genes/cone production 
• evaluation of safety, risk assessment, consumer protection 
• fib re-development genes/wood formation 
• biotic and abiotic stresses 
• genomics and proteomics 
• physiological and hormonal studies 
2.2.3.9 The regulatory framework (Q 3.1: What is the regulatory 
framework covering genetic modification work in the respective country?) 
Respondents provided infom1ation on which agency in their country was responsible for 
regulating genetic modification work in contained laboratories, field trials and commercial 
release. This information is summarized in Appendix 3.8.1. Respondents were from 15 
countries and indicated whether the respective authority was involved in pre-risk assessment 
( 13 countries), surveillance, monitoring and quarantine ( 12 countries), and management of 
failure, redress and control (12 countries). For our analysis (Table 2.2.6), only respondents 
involved in some type of research in genetic modification were included. Note that there are 
some discrepancies in responses from the same countries, probably due to misunderstandings 
with the questions, or different viewpoints. The data provided in Table 2.2.6 should therefore 
be taken with caution. 
2.2.3.10 Pending applications (Q 3.2) 
The aim of this question was to understand the immediate future of GM tree testing. 
Respondents listed a total of 12 projects pending. This includes development in containment, 
field testing of GM trees and release of GM trees. Note that some countries distinguish 
between field tests and release, whereas others do not and consider both as a release. Table 
2.2 .7 provides details of 12 projects. 
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Table 2.2.6. Involvement of regulatory agencies in pre-risk assessments of genetic 
modification projects, surveillance, monitoring and quarantine (S/M/Q) and 
management of failure, redress, control (M/R/C), by country1• 
Country Pre-risk assessment S/M/Q M/R/C 
Argentina y y y 
Australia y y y 
Belgium y N y 
Canada - - -
y y y 
China y y y 
Finland y N -
France y N y 
-
y y 
Germany - - -
N y y 
Israel y y -
Japan y y y 
y y y 
Mexico - - -
New Zealand y y y 
y y y 
Portugal y y y 
Sweden y y y 
y y ? 
y y y 
USA y - -
y y y 
1
- : indicates no answer. 
Table 2.2.7. GM tree projects for which regulatory approval is currently sought 
Country Type' Species Numbers Size (area}2 Date 
Belgium D Populus tremula x P alba 7 5 transclones - 2004 
China T Populus tomentosa - - -
France D Picea abies 1000 - 2004 
D Pseudotsuga menziesii 1000 - 2004 
D Pinus pinaster 1000 - 2000 
Germany D Populus tremula hybrids - - 2004 
DIT Populus tremula hybrids - - 2005 
DIT Populus tremula hybrids - - 2006 
USA - Populus sp. - - 2003/04 
R Populus tremula x P. alba 588 < 1 acre 2003 
R Populus tremula x P. alba 300 < 1 acre 2003 
R Populus tremula x P. alba 3000 3.5 acres 2003 
10: Development in contained laboratories; R: Release; T: Field testing;-: no information available. 
2 1 acre - 0.4 ha. 
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2.2.3.11 Adequacy of the existing framework (Q 3.3) 
Respondents were asked about the regulatory framework in their country and whether the 
framework was adequate, from their point of view, to assess the benefits and risks related to 
their experiments. The evaluation of the response includes all respondents that are involved in 
genetic modification projects with trees (a total of 23 respondents). Three respondents 
(13 percent) made no comments, five (22 percent) felt the framework was not adequate and 
15 (65 percent) felt it was. Additional comments were offered on perceived shortcomings of 
the regulatory process and how improvements could be made. These included: 
• process too slow, bureaucratic and costly 
• exceptionally robust process, but too costly 
• overcautious approach by regulatory agencies 
• too many approvals required, often with the same assessment requirements, same 
information requested several times 
• risk assessment is based on process - should be on product 
• no consideration given to comparison with conventional methodology 
• site safety concerns lead to requirement to keep location confidential 
• policies need to be better publicized by regulatory agencies 
• procedures need to be defined more clearly and made more efficient 
• more risk assessment research required 
• rules for contained research need to be relaxed 
• applications need to be simplified for standard genes and promoters that have been 
assessed previously 
• need to ensure that the process cannot be abused by opponents 
2.2.3.12 Testing abroad (Q 3.4: Does the respondent have laboratories, field 
tests or commercial plantations abroad?) 
None of the 23 respondents involved in genetic modification projects answered 'yes' to the 
question about whether they had research facilities abroad. Eighteen (78 percent) responded 
with 'no' and five (22 percent) did not respond at all. The responses were similar for field 
trials and commercial plantations. However, one respondent from Belgium reported that they 
have a field test in France. This respondent also confirmed that the regulatory process abroad 
was appropriate to assess the risk and benefit of the project. 
2.2.3.13 Intellectual property regime (Q 4.1-4.3) 
It is always difficult to obtain information related to intellectual property (IP). Much of this is 
confidential business information; however, respondents were encouraged to share 
information that they consider public. The responses from 23 respondents who use genetic 
modification in their projects were analysed. When asked whether they owned IP in relation 
to their production of GM trees, eight (35 percent) confirmed that they did, ten (44 percent) 
did not and five (22 percent) did not respond. The following list illustrates the broad areas in 
which IP is owned by these respondents: 
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• modulation of lignin biosynthesis 
• transgene development 
• vegetative multiplication 
• testing of transgenes 
• flowering control 
• gene expression 
• fibre development 
• embryogenesis 
• new varieties 
• cell wall control 
Nine of the 23 respondents (39 percent) confirmed that they have IP agreements with other 
institutions, eight (35 percent) did not and six (26 percent) did not respond. One respondent 
commented that since patent protection lasts for only 20 years and most GM trees grow 
slowly (many years to maturity), patent protection does not offer an advantage. 
Eighteen respondents (78 percent) confirmed that they did not currently have IP arrangements 
with institutions in developing countries, five (22 percent) did not respond to this question. 
However, when additional comments were made, there appeared to be a preparedness to enter 
into IP arrangements where appropriate and required. 
2.2.3.14 Future plans on use of genetic modification in trees (Q 5.1) 
Here the organizations were asked for their plans on future use of genetic modification in 
trees. The analysis of responses included all respondents, since many organizations not using 
genetic modification at present made comments under this heading. The following lists 
represent the responses. 
Prospects: 
• 10-year timing horizon is envisaged to commercialization 
• long term views (10-20 years) (20-30 years) 
• "we have a restriction on research in British Columbia, a 10-year moratorium" 
• research only, possibly field trials 
• GM trees as research tools only, no commercialization anticipated 
• concern that government regulation and public perception make tree genetic modification 
uneconormc 
• GM trees as research tools only, no commercialization anticipated 
• concerns related to unpredictability of expression 
Developments: 
• sterility to combat allergies 
• assessment of environmental impacts 
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Potential products/uses: 
• trees producing useful substances (for example pharmaceuticals) 
• GM trees for site remediation (phytoremediation or bioremediation) 
• use of genes for lignin reduction, increased yield and quality 
• saving species (American chestnut, Castanea dentata, for example) 
• assessing gene expression 
• pest and disease resistance 
• adaptive and fitness traits 
• fibre quality 
• resistance to dryness and high temperature 
• candidate gene testing 
• herbicide tolerance 
It is difficult to quantify the responses in this category, but it is still interesting to note that 
many responses indicate an environmental or health benefit is expected from future use of 
GM trees. 
2.2.3.15 Expected field release (Q 5.2: If and when a GM plantation is 
expected) 
Only a few respondents predicted further field releases . One release is expected for 2004 and 
two further projects (potentially including many species) in around 10 years time. One 
respondent did not want to disclose information for reasons of confidentiality. Another 
respondent mentioned that no further tests would be conducted in the near future because of 
extremely high costs associated with field test applications (New Zealand). A respondent 
from Sweden felt that less than one percent of the Swedish forests would contain GM trees by 
2050. However, this respondent also commented that in the long term GM trees will be 
planted more, because their characteristics can be manipulated more effectively. 
Note that the terms ' field test' and 'field release' are not clearly defined. Some respondents 
regarded field tests as releases, others appeared to regard releases as full commercial 
plantations. 
2.2.3.16 Benefits from GM trees (Q 5.3) 
Respondents were asked about commercial, environmental, human health and other benefits 
of genetic modification of trees. 
Several anticipated commercial benefits were mentioned by respondents using or not using 
genetic modification in tree projects. These are listed below in Table 2.2.8 (Figure 2.2.4) 
together with the number of times each expected benefit was cited. 
Environmental benefits mentioned by respondents are listed in Table 2.2.9 (Figure 2.2.5). 
One respondent commented that 35 percent of the value of GM trees will lie in environmental 
benefits. 
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Human health benefits are probably more difficult to identify than commercial and 
environmental benefits. However, respondents made the comments listed in Table 2.2.10 
(Figure 2.2.6) . 
Table 2.2.8 . Commercial benefits anticipated from GM trees 
Benefit Number of times cited 
Increased wood production 15 
Improved quality 12 
Resistance to pests 9 
Resistance to diseases 7 
Reduced production and processing costs 5 
Reduced chemicals for pulping 4 
New products 3 
Adaptability l 
Remediation of toxic sites I 
Sterility l 
Company shares increasing in value I 
Traits not available in current breeding population I 
Figure 2.2.4. Commercial benefits anticipated from GM trees (percentage of 
respondents citing benefit) 
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Table 2.2.9. Environmental benefits expected from GM trees 
Benefit Number of times 
cited 
Take pressure off natural forests 12 
Reduce chemical use in forests and processing 12 
Bioremediation/phytoremediation 7 
Carbon sequestering 7 
Higher productivity per hectare 3 
Adaptation to stress 3 
Reduced erosion 2 
Renewable energy I 
Renewable raw material I 
Figure 2.2.5. Environmental benefits expected from GM trees (percentage of 
respondents citing benefit) 
Reduced ero ion 
4% 
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Table 2.2.10. Human health benefits expected from GM trees 
Benefit Number of times cited 
Pollen/allergy reduction 7 
Environmental protection and restoration 5 
Reduced environmental pollution 5 
None/negligible/indirectly 3 
Toxic site remediation I 
Pham1aceuticals 2 
Recreation I 
Figure 2.2.6. Human health benefits expected from GM trees (percentage of 
respondents citing benefit) 
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Respondents were also asked to make any other comments with regard to benefits they would 
expect from GM trees in forestry. The following list reflects the responses: 
• potential economic benefit to developing countries 
• protection against insects and fungi 
• significant acceleration of conventional breeding 
• shortened breeding cycles 
• focus by environmental groups on genetic modification has reduced their focus on clonal 
and conventional techniques 
• knowledge and employment 
• better forests, general improvements in forestry 
• potentially decreasing global warming 
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2.2.3.17 Risks in GM tree use (Q 5.4) 
Respondents were also asked to comment on potential risks in the use of GM trees in 
forestry. 
Anticipated commercial risks are identified in Table 2.2.11 (Figure 2.2. 7), human health risks 
in Table 2.2.12 (Figure 2.2.8), and environmental risks in Table 2.2.13 (Figure 2.2.9). 
Comments by respondents on other risks are also listed. 
It is notable that the biggest threat to the commercial use of GM trees is seen to be associated 
with social rather than technical issues. 
Table 2.2.11. Anticipated commercial risks of GM trees 
Commercial risk Number of times 
cited 
Public resistance 9 
High financial risk 5 
Monopoly positions 3 
Transgene instability 3 
Lack of operational data 2 
Plantation failure 2 
Quality issues 2 
Monocultures/biodiversity 2 
Resistance development (insects) I 
Ecoterrorism I 
Low risk if managed properly I 
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Figure 2.2. 7. Anticipated commercial risks of GM trees (percentage of respondents 
citing risk) 
Ecoterror i m 
3% 
Resistnnce development (insects) 
3°/o 
Monocultures / Biodiversity 
6% 
Quality i sue. 
6% 
Plantation failure 
6% 
/ 
Lack of operntiooal data -
6% 
Transgene instabilit) 
JO% 
Low ri 'k if managed properly 
3'% 
l\fonopoly positions 
10% 
Public resistance 
300A. 
High financial risk 
17% 
Table 2.2.12. Anticipated human health risks of GM trees 
Health risk Number of times cited 
Limited/none/negligible 11 
Emerging new allergies 2 
Emerging new toxic metabolites 2 
Not exceeding that in conventional 1 
technology 
75 
Pro •U\ll,\R\ Rf \II\\ ()I lll()Tf( HI\()[()(,~ I"- HlRl·Slln 
Figure 2.2.8. Anticipated human health risks of GM trees (percentage of respondents 
citing risk) 
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Table 2.2.13. Anticipated environmental risks of GM trees 
Environmental risk Number of times cited 
Limited/none 8 
Gene escape 8 
Plant escape, eco-disturbance 7 
Impact on non-target species 2 
Clonal failure 2 
GM trees poorly adapted, so risk low I 
Toxic substances 1 
Disturbance of food chains l 
Terrorism 1 
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Figure 2.2.9. Anticipated environmental risks of GM trees (percentage of respondents 
citing risk) 
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Further comments by respondents on ' other risks' (and in some cases their mitigation, which 
is dealt with in more detail in Table 2.2.14 [Figure 2.2 .10]) are represented in the following 
list: 
• GM forests may render natural forests valueless. 
• Sterile trees may be developed to prevent or inhibit transgene spread. 
• Government research priorities take funding and priorities and attention from other 
matters . 
• Spread of competence in genetic modification increases risks connected with 'bad will' 
applications . 
• Genetic modification will redirect resources from biological to legal matters . 
• Legal and commercial matters reduce the potential for combining the best genes into one 
variety. This will delay release of varieties and promote the use of the same variety for a 
longer time, thus increasing the distance between technical progress and what is planted 
in the field . 
• Genetic modification will encourage clonal forestry with a few clones that are not locally 
adapted (and used over a larger area than clones are currently). 
• Radical actions against biotechnology as happened in the United Kingdom (in 1999), 
when extremists removed several crops of GM maize and a GM tree plantation. 
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• Given the invasive traits of some trees planted in commercial forests, there may be 
difficulties in controlling them if they are made genetically resistant to herbicides. 
• Economic consequences are potentially high ifresistance is broken by a new generation 
of parasites (whether resistance is given through genetic modification technology or not). 
This risk seems to be higher when (i) resistance is provided by a single gene, or a limited 
number of genes, (ii) for trees, compared with other plants, given the difference in growth 
times between a pest and its tree host, and (iii) when planted areas are significant (e.g. 
poplar and poplar leaf rust). 
• Perhaps ecoterrorism. 
The questionnaire also tried to gain some insights into how respondents felt risks could be 
addressed and how their R&D programme addressed the risks in particular. The results are 
compiled in Table 2.2.14 (Figure 2.2.10). 
Table 2.2.14. How risks involved with tree genetic modification can be addressed 
Response Number of times given 
Conduct risk assessment 7 
Field-based studies 4 
Introduce sterility 5 
Laboratory-based studies 2 
Research and education 2 
"We can do nothing to influence the public opinion" I 
Scale up slowly I 
Plantation management/multiclonal plantings I 
Develop ecologically healthy perspective for plantation forestry I 
Replace antibiotic resistance genes I 
Controlled commercial releases I 
Pre-examination of GM trees I 
Wait for public opinion to swing I 
Active promotion of genetic modification by NGOs38 I 
38 Non-governmental organizations. 
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Figure 2.2.10. How risks involved with tree genetic modification can be addressed 
(percentage of respondents giving reply) 
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In a further question, respondents were asked to describe how their R&D programme 
addressed risk. The following list summarizes the responses: 
• Research on flowering control. 
• Study of pollen dispersal. 
• Commercial trees will contain sterility genes when required. 
• Use of D-serine resistance as a harmless selectable marker. 
• By promoting biodiversity conservation as an issue to be dealt with within plantation 
forestry. 
• Promoting plantation forestry as a tool for ecological restoration of native/natural forest 
types at risk. 
• Study ecological interactions between GM tree material and herbivores (several insect 
species) and mycorrhizae. 
• Collaboration with researchers working with societal and ethical questions related to GM 
plants. 
• Cautious, step-by-step approach. 
• "Significant R&D issue of the research programme of the Ministry of Consumer 
Protection; five research projects funded by the Ministry of Education and Research." 
• Safety assessment. 
• Promoting forest tree genetic modification as an environmentally sustainable way to 
provide the world with timber, thereby creating the option to leave natural forests alone. 
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• "Even though we do not have an R&D programme, our objective is to serve as a 
facilitator for diverse groups to conduct appropriate research and to put the results into 
practice in an appropriate way." 
• No risk of genetic modification addressed since trees solely used for fundamental 
research. 
At this point, the question was asked "what do you regard as the risks of not using genetic 
modification technology in commercial forestry?" Seven respondents felt that this would 
compromise the ability to reduce pressure on the world's forests, three felt there were no risks 
at all, one regarded the risks as "very few" and another respondent did not foresee any 
economical risks. Further comments were made and they are summarized in the following 
list: 
• Inability to compete at the highly intensive end of plantation production. 
• Shortage of industrial wood during next century. 
• Loss of a major industry in the United States to the tropics. 
• Inability to save a species from extinction if it meets a serious threat (pest) to its survival. 
• Depending on traits that are affected/modified, some environmental benefits are lost. 
• Increases in pollution originating from traditional intensive forestry. 
• Increased degradation of soil quality. 
• "Intensive agriculture including forest plantation and the pulp and paper industries will 
always have a bad effect on the environment due to their intensive use of land resources 
and chemicals. Genetic engineering is the only way we can address these problems and 
reduce the damage." 
• Increased global warming and non-sustainable forestry will continue. 
• Slowing down of traditional breeding programmes, while the demand for delivery of 
standardized products is always more pressing and urgent. 
• "In a perspective of a few decades there is no risk, but in a longer time perspective we 
would abstain from the most powerful way of manipulating trees genetically." 
• "Genetic modification technology is just an extension of traditional tree breeding. To 
jettison the science would be a disservice to Mankind." 
2.2.3.18 The obstacles in the application of genetic modification to trees, 
and ways to overcome those obstacles (Q 5.5) 
Respondents were asked about the obstacles they can see to applying genetic modification to 
forest trees. 
Twenty-nine out of 49 (59 percent) of the respondents explained what they see as the major 
obstacles in using genetic modification in tree plantations, summarized in Table 2.2.15 
(Figure 2.2.11 ). 
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Table 2.2.15. Obstacles to the use of genetic modification in trees. Most respondents 
identified more than one obstacle 
Obstacle Number of times cited 
Public perception/science averseness/regulatory issues 22 
Technical 4 
Long life cycles, long investment cycles 4 
Lack of interest by forest industry and small growers 4 
Environmental risks 4 
Lack of funding 3 
Knowledge gap between 'conventional' and ' molecular' scientists 2 
Difficulties of integrating genetic modification with traditional breeding 2 
Forest certification schemes 2 
Intellectual property issues 2 
Figure 2.2.11. Obstacles to the use of genetic modification in trees. Most respondents 
identified more than one obstacle (percentage of respondents citing obstacle) 
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When asked for suggestions on how to overcome these obstacles, respondents gave very 
complex answers. A total of 20 responses ( 41 percent of total) were received and 13 of them 
(65 percent) suggested better education of the public and communication with the public as a 
way to overcome obstacles. However, a number of other comments were made and they are 
listed below (in slightly edited form, to increase clarity): 
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• In the forestry sector, it would be wiser to tackle important traits, such as 
resistance/tolerance to drought/water stress, and to avoid gene transfer from distantly 
related organisms. 
• Sterile/late flowering trees need to be developed. 
• It might help if genetic modification were used with sterility genes, to limit genetic 
pollution. 
• Implement a strategy for using an 'antifitness-gene ' in combination with the 'gene-of-
interest' to prevent the establishment of the transgenic line in natural ecosystems. 
• Improve genetic modification technology in order to determine genetic transformation 
devoid of GUS (~-glucuronidase) and antibiotic resistant genes. 
• Promote use of genetic modification technology only where there is a clear threat to the 
survival of a species ( e.g. chestnut blight, Cryphonectria parasitica). 
• "Can we increase the amount of conserved natural/old/wild forests/their biodiversity by 
producing the wood we need more effectively?" 
• A void release of 'useless' GMOs, without obvious benefits to the final consumer/user (for 
example: resistance to herbicide). 
• Close collaboration between pulp/paper industry and scientific research. 
• Promote the possibility of certifying GM plantation products. 
• Provide more R&D funds. 
• Do not actively promote ' commercial' applications for GM forest trees over the next few 
decades (e.g. from FAO). Let the experiences from agriculture accumulate a little before 
looking for commercial applications. But do some field experiments to accumulate 
needed experience and knowledge and a better understanding of the consequences when 
commercial applications become interesting. 
• "We need much more field-testing in order to gain experience, both ofrisks and benefits." 
2.2.3.19 Perception of the work done with GM trees (Q 6.1) 
Respondents were asked whether public perception is an issue and whether they had 
experienced positive or negative attitudes towards their work. Out of the 23 working with tree 
genetic modification, 22 (96 percent) responded to this question. Also, three further 
respondents who did not work with tree genetic modification made comments. The following 
list of comments summarizes the responses. Note that the list does not contain all individual 
responses but it captures the main points made. 
• NGOs are opposed to GMOs. 
• "We have not had any negative comments directed at us because of our research, but then 
we are not carrying out field trials." 
• "Public perception is very important. Our institution is very active in science 
communication and has many different means of communication ( website, leaflets, 
brochures, presentations, exhibition, school projects, etc.). GM trees are not a specific 
topic in this communication, but much information is provided on GM plants in general. 
With a transgenic poplar field trial, we experienced negative attitude from green activists. 
The trial was destroyed by these activists in July 1999 ." 
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• Government agencies at local level strongly discourage non-research use of GM trees. At 
the national level, there is more support, but national agencies (Canadian Forest Service) 
have little power in provincial resource base decisions. 
• "Public perception is important; forests are seen as our dear national property! 
Government agencies, I feel , do not understand our research work and its goals. The 
general public is interested and mostly relies on scientific risk assessments that regard 
ongoing research safe (we don't have commercial applications!). Then there is one small 
and very active activist group against GM trees, being also very skilful in getting a lot of 
publicity compared to their actual critical mass." 
• Positive, responsible attitude expressed by local authorities. 
• "In Sweden the attitudes vary. Research was allowed. However, there was not enough 
evidence provided that GM trees are safe for the environment and human health. GM 
plants could not be planted in the field, only in greenhouses and incubators. Also there 
were newspapers reports of genetic modification of Norway spruce with a gene that 
confers freezing resistance. The gene was found in a deep-sea fish, so public opinion was 
that the trees would produce fish instead of cones and seeds. Outside the academic field, 
the perception of GM organisms is the same, as something terrible and evil, not for 
utilizing and even less for eating. This is the overriding opinion in my country." 
• Even though such activities are not under way in Romania, both forest authorities and the 
public have negative attitudes towards work on GM trees . 
• "Yes, I do experience a negative attitude from the department, university and other parts 
of the establishment, because I say that I do not believe in fast application of genetic 
modification or the blessing of genetic patents as far as long-rotation forestry is 
concerned. As a result I get fewer research resources. But I feel that I should give my 
honest opinions on matters within forest genetics, when I feel there is a need to do so. 
From the 'public ' (neighbours and so on) I meet a slightly negative attitude because they 
believe I am part of an ongoing transformation of the Swedish forest to GM forest, in 
spite of the fact that this initiative is a long way off." 
• The need for certification from the Forest Stewardship Council (FSC) has led Swedish 
forest companies to disassociate themselves from transgenic conifers even for research 
purposes ( e.g. by refusing to allow trials of transgenic species on land supervised by the 
research organization). 
• "We have experienced positive and negative attitudes towards our work. Mostly positive, 
except for members of Greenpeace." 
• "We are very concerned about public perception. A couple of years ago nearly 1 OOO of 
our transgenic trees were vandalized by 'eco ' terrorists." 
2.2.3.20 Communication strategy (Q 6.2) 
Respondents were asked whether their organization had a communication strategy to inform 
the public about developments in genetic modification. Nineteen out of 23 (83 percent) 
respondents working with GM trees made comments under this heading. Fourteen (74 
percent) of them reported some form of direct communication, either as part of a corporate 
strategy or as individual communication strategies. Three (16 percent) respondents did not 
have any form of communication in the area of GM trees and two (11 percent) said that they 
relied on collaboration with outside agencies for their communication about GM trees. 
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2.2.3.21 Concluding comments (Q 7) 
The opportunity was provided to make any additional comments that respondents wished to 
be considered in this study. The comments made here were mostly clarifications of what has 
been said earlier, and requests for copies of the study when available, plus requests for 
confidentiality. 
2.2.4 FURTHER INFORMATION COLLECTED FROM 
PUBLIC SOURCES 
To complement responses received to the questionnaire, and assess its overall 
representativeness, further information on field tests was collected from public sources in 
January 2004. They mainly included databases available on the Internet, often maintained by 
regulatory agencies (for detailed information and Internet addresses, see Appendix 3.8.1). 
Unfortunately, there is no database that covers all field tests worldwide and the individual 
databases have their own formats. The amount of data related to a specific trial varies to a 
great extent between the databases. Also, most often it cannot be determined from the 
database whether a specific trial has actually been established or whether its status is 
approved, but the trial not yet planted. However, in the following analysis all field tests listed 
in the databases are included and it is assumed that they have been planted or will be planted 
in the near future. Some databases did not appear to be up to date (they show field trial 
information up to a specific date which is sometimes years ago). 
Both data sets referred to in this study (resulting from (i) the questionnaire and (ii) additional 
searches) were compared in detail to evaluate whether all trials specified in the questionnaire 
were actually covered in the additional analysis as well. Only two trials were not covered in 
the publicly available databases 
All other trials that were reported in the questionnaire were also represented in the data set 
obtained independently from other resources. This indicates that the data in the questionnaire 
are very reliable. However, many (over 100) field trials found in other resources are not 
represented in the data set retrieved from the questionnaire. 
2.2.4.1 Analysis of publicly available information 
Numbers of field tests by country 
In this analysis, a distinction was made between forest trees and a second category including 
both ornamentals and fruit trees (Table 2.2.16). Focusing on forest trees, the United States 
appear to have the majority of field trials active (103 trials reported in January 2004). Next is 
China with nine trials; two of them, a world-first, are commercial plantations. The countries 
in Europe, combined, have a total of 23 trials. For fruit trees and ornamentals, the United 
States is again the frontrunner with 4 7 trials, followed by Italy with eight trials. 
It becomes evident from this analysis that the United States is under-represented in the 
responses to the questionnaire. It is of concern that the views of the major player(s) in forest 
biotechnology are not represented in this study, owing to a poor response from these 
organizations/companies. The views of researchers and organizations in the United States are 
poorly represented in the analysis of data from the questionnaire ( especially from the private 
sector). 
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Table 2.2.16. Field trials of GM forest trees and GM ornamental/fruit trees recorded in 
publicly available databases, by country 
Country Number of trials with Number of trials with 
forest trees cited ornamentals/fruit trees 
cited 
Argentina 0 0 
Australia 1 2 
Belgium 0 2 
Brazil 2 1 
Canada 7 0 
Chile 3 0 
China 9, partly commercial 0 
evaluation 
Finland 5 0 
France 4 0 
Germany 4 I 
India I 0 
Indonesia 1 0 
Ireland 1 0 
Israel 1 0 
Italy 0 8 
Japan 0 1 
Mexico 0 1 
Netherlands 0 3 
New Zealand 3 3 
Norway l 0 
Portugal 1 0 
South Africa 1 0 
Spain 1 0 
Sweden 0 1 
Thailand 0 2 
United Kingdom 6 2 
United States 103 47 
Uruguay 2 0 
GM genera/species involved 
In the following analysis, forest trees were again separated from ornamental/fruit trees. It is 
noted that only a few forest trees are currently of significant interest for inclusion in forest 
biotechnology projects (Table 2.2.17). Populus is most often used in trials (82 trials), 
followed by Eucalyptus and Pinus (34 and 31 trials, respectively). In the fruit 
tree/ornamentals category, Malus is most often used in trials (33 trials), followed by Carica 
papaya and Prunus (18 and 13 trials, respectively). 
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Table 2.2.17. Field trials with GM forest trees and fruit trees/ornamentals 
Category Taxon Number of trials 
cited 
Forest tree Eucalyptus 34 
Populus 82 
Picea 6 
Pinus 31 
Betula 3 
Total 156 
Fruit species/ornamental Carica papaya 18 
Ma/us 33 
Olea 2 
Prunus 13 
Cyphomandra I 
Jug/ans 2 
Belladonna I 
Citrus I 
Persea I 
Castanea I 
Total 73 
Genes/attributes involved 
It is very difficult to extract comprehensive information on genes and traits from field-test 
databases (Table 2.2.18). It appears that those databases often contain some voluntary 
information that was provided by the organizations conducting tests, but this is not 
standardized and often one can only guess at the genes involved from the trait information 
given. Also, in many cases the genes are not specified (confidential business information). 
Further, it can be assumed that, at least at the time of the survey, many GMOs in field trials 
have an antibiotic resistance gene integrated into their genome ('Reporter and marker genes' 
in Table 2.2.18). This is important for selection of the transformed event and most 
researchers still use the nptil gene for this purpose. This gene confers resistance to the 
antibiotics kanamycin or geneticin. However, only 43 trials refer to this or a similar 
gene/trait. When assessing the additional traits of commercial importance to forestry, it is 
evident that herbicide resistance is the most important trait in forest trees ( 41 trials), followed 
by insect resistance (21 trials) and lignin modification ( 15 trials). In fruit trees/ornamentals 
the picture is significantly different with resistance against microorganisms (viruses, fungi, 
bacteria) appearing most important (35 trials), followed by insect resistance (11 trials). 
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I Table 2.2.18. Genes and traits related to field tests Trait involved Trials ornamentals and Trials forest trees Genes 
fruit trees 
I Reporter and marker genes 2 43 nptll; uidA; aphIV Fruit ripening 7 0 
I Viral resistance 15 0 coat protein; PRSV replicase; TaMV coat protein Fungal resistance 17 2 cecropin; chitinase; defensin; npr I; 
I 
STS; oxalate oxidase; osmotin; 
attacin 
Herbicide resistance 1 41 
I 
Lignin modification 0 15 4coumarate CoA ligase; CAD; 
OMT 
Nitrate reductase synthesis 0 4 
I Metabolites 0 3 Heavy metal 0 5 mercuric ion reductase 
phytoremediation 
I Bacterial resistance 3 3 antimicrobial peptide; lysozyme Salt resistance 0 1 
I Rooting 5 0 rol Altered ethylene 4 0 ACC synthase 
production 
I Plant development 2 9 Altered sugar alcohol 4 0 sorbitol dehydrogenase 
levels 
I Metabolism of halogenated 0 I P450 hydrocarbons 
Sterility 0 3 diphtheria toxin A 
I Altered fruit ripening 7 0 S-adenosylmethionine transferase Altered gene expression 0 1 
I Altered polyphenol oxidase 3 
0 polyphenoloxidase 
levels 
Changes in reproduction 0 5 
I 
(not sterility) 
Insect resistance 11 21 cry lAc; cry3A; hyoscamine 6~-
hydroxylase; agglutinin; chitinase; 
chitobiosydase 
I Sugar content 1 0 
I 
I 
I 
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2.2.5 WHERE TO FROM HERE? THE FUTURE OF GENETIC 
MODIFICATION IN FORESTRY 
The future of genetic modification in forestry appears difficult to predict. It is instructive, 
however, to assess the current situation in agricultural crops, where data from a decade of 
commercial application of genetic modification technology are now available (James 2004), 
along with ample reports on the environmental and economic sustainability of this 
technology. Most importantly, during this time the world has witnessed a continued and 
significant increase in GM crop acreage worldwide, with approximately 81 million hectares 
planted in 2004. Once plantations of GM crops were approved for a specified area or country, 
uptake by farmers has been swift, and more studies are forthcoming that substantiate the 
economic and ecological benefit of these crop plantations (FAO 2004). 
Forestry is different in that rotation times are usually in the order of several decades (with the 
exception of short-rotation tree crops such as eucalypts ). Nevertheless, where intensive 
plantation forestry can be practised, there are prospects of genetic modification eventually 
leading to field applications, provided objectives are well targeted and operational risks are 
managed appropriately. Studies have suggested high economic gain (Li et al. 2003), and 
comprehensive field trials with GM poplar with altered lignin composition have indicated 
that economic and environmental gains can be made, at least for producing pulpwood, with 
this technology (Pilate et al. 2002). As another example, field trials with GM Pinus radiata 
are beginning to yield data that demonstrate the continued correct expression of transgenes 
over 4--6 years and without selection for this expression (C. Walter, personal observation). 
The first commercial GM plantation, although relatively small in a plantation forestry sense 
(up to one million trees), is currently growing in China. GM Populus nigra trees have a 
Bacillus thuringiensis toxin gene integrated and the resistance of GM trees to insect attack 
has been demonstrated. More plantation projects using GM forest trees have been reported in 
China. 
A number of issues that need special attention in the near future are detailed below, 
representing the authors' personal analyses. 
Biotechnologies including genetic modification have shown huge potential in the agricultural 
sector, to produce more food on less land, avert or mitigate certain undesirable environmental 
effects, and provide benefit to farmers, producers, consumers and the environment. 
The Gene Revolution on-going in agriculture is fundamentally distinct from the Green 
Revolution of the 1960s and 1970s, in the sense that it is mainly driven by the private 
multinational sector, focuses on a very small number of crops and traits, and is protecting 
intellectual property in plant innovations (FAO 2004). Four countries (Argentina, Canada, 
China and the United States) and two traits (insect resistance and herbicide resistance) 
accounted for 99 percent of the global area planted with GM crops in 2003. 
Molecular biology in forestry is now well advanced. Tree genomes and transcriptomes are 
being analysed and genetic transformation technology is available for many tree species, 
particularly those that are significant or potentially significant species for clonal plantation 
forestry . 
Initial testing of GM trees in the laboratory, glasshouse and field has indicated that tree 
genetic modification can provide some tremendous advantages to growers and processors, 
while at the same time providing environmentally sustainable solutions for wood production. 
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Wood demand worldwide is on the increase, a trend that is likely to continue. The share of 
wood harvesting from natural forests will probably decrease, and be increasingly regulated. 
Forest biotechnology, in combination with plantation forestry, can provide options to protect 
natural forests from detrimental harvest while meeting the world's increasing demand for 
wood. 
New biotechnologies, in particular genetic modification, raise concerns. Admittedly, many 
questions remain unanswered for both agricultural crops and trees, and in particular those 
related to the impact of GM crops on the environment. Given that genetic modification in 
trees is already entering the commercial phase with GM Populus in China, it is very 
important that environmental risk assessment studies are conducted with protocols and 
methodologies agreed upon at a national level and an international level. It is also important 
that the results of such studies are made widely available. 
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2.2.8 ANNEXES 
2.2.8.1 Resources 
Field test approval authorities (as advised by questionnaire responses, plus additional 
resources). 
Country Authority Website 
Argentina CONABIA htto: //si ia12. sag:w .mecon. ar/htm-
hsi/english/conabia/frameing.htm 
Australia Office of the Gene Technology www.health.gov.au/ogtr/ 
Regulator 
Belgium The Minister of Health www.health.fgov.be/ 
Canada Canadian Food Inspection Agency www.insgection.gc.ca/english/toce.shtml 
Agriculture Canada www.agr.gc.ca/index e.ghtml 
China National Committee for Biosafety of www.fao.org/foresta/FO R/FO RM/FOG ENRES/regions/ 
Agricultural GMOs, National Forestry Ugdate/ugdNEa.stm 
Administration 
Finland Finland www.vn.fi/stm/english/ 
National Board for Gene Technology 
Ministry of Social Affairs and Health 
France Commission on Biomolecular www.environnement.gouv.fr/english/default.htm 
Modification 
Ministry of Country Planning and 
Environment 
Commission on Genetic Modification www.recherche.gouv.fr/commis/genetigue/default.htm 
Germany Robert Koch Institut www.rki.de/ 
Israel Plant Protection and Inspection www.moag.gov.il/english/ 
Services, Ministry of Agriculture 
Japan Ministry of Education, Culture, www.mext.go.jg/english/ 
Sports, Science and Technology 
Ministry of Agriculture, Forestry and www.maff.go.jg/eindex.html 
Fishing 
Mexico SEMARNA T (National Ministry for ·www.semamat.gob.mx/ 
the Environment) 
CONAFOR (Comision Nacional www.conafor.gob.mx/ 
Foresta!) 
New Environmental Risk Management www.ermanz.govt.nz 
Zealand Authority (ERMA) 
Portugal Ministry of the Environment 
Sweden Skogsstyrelsen (The National Board www.svo.se/eng/default.htm 
of Forestry) 
USA USDA - Animal and Plant Health www .aphis. usda. gov/ 
Inspection Service (APHIS) 
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Internet addresses of organizations publishing information on the Internet (compiled from 
responses to questionnaires. 
Country Organization Internet address 
Australia CSIRO Forestry and Forest Products, PO Box www.ffu.csiro.au/tigr/molecular/molbiolog 
Kingston, ACT 2604, Australia y.html 
Belgium Department of Plant Systems Biology, Vlaams www.12sb.rug.ac.be/; 
Instituut voor Biotechnologie (VIB), Follow - Research: Research divisions: 
Rijvisschestraat 120, 9052 Zwijnaarde, Belgium Molecular Genetics: Tree Biotechnology to 
find research details 
Canada Atlantic Forestry Centre, PO Box 4000, www.nrcan.gc.ca 
Fredericton, NB, Canada E3B5P7 
Finland Punkaharju Research Station, Finlandiante 18, FIN- www.metla.fi/tutumus/index-en.htrn; 
58750, Punkaharju, Finland search for "biotechnology' or Project 3198 
under the topic 'Forest Genetics and Tree 
Breeding' 
France Unite Amelioration Genetique et Physiologie www.inra.fr/ 
Forestieres, !NRA-Orleans, Avenue de la Pomrne 
de Pin, BP206 I 9 Ardon, 45166, Olivet Cedex, 
France 
AFOCEL Biotech, Domaine de l'Etancon, F-77370 www.afocel.fr/ 
Nangis, France 
Germany Institute for Forest Genetics and Forest Tree www.rrz.uni-hamburg.de/GeneTree/ 
Breeding, Federal Research Centre for Forestry and 
Forest Products, Sieker Landstr. 2, D-22927 
Grossgansdorf, Germany 
Japan Forestry and Forest Products Research Institute, htm://ss.ffori.go.j12/e version/majomrogra 
Matsunosato 1, Tsukuba, Jbaraki-ken, Japan 305- ms/mj12rograms j 
8687 
New Zealand The Horticulture and Food Research Institute of www.hortresearch.co.nz 
New Zealand Ltd, Private Bag 92 169, Auckland, 
New Zealand 
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2.3 The state of genetically modified forest trees in China 
Huoran Wang - Chinese Academy of Forestry, Beijing 
2.3.1 SUMMARY 
The purpose of this paper is to review thoroughly the current status of research on and 
applications of genetically modified (GM) forest trees in China. All research into GM forest 
trees has been carried out with species or hybrids of broadleaved genera, Populus, Eucalyptus 
and Betula using genes conferring resistance to insect pests and disease pathogens and 
tolerance to environmental stress. European black poplar (Populus nigra) and the hybrid 
white poplar clone GM 741 , transformed with genes for insect resistance, were approved for 
commercialization by regulatory authorities, and GM plantations were established in China in 
2002. Research on genetic modification of larch (Larix), targeting reduced lignin content, is 
still in its infancy. China has a regulatory framework and government policies on genetically 
modified organisms (GMOs) in place for agricultural crops, and special regulations for forest 
trees are in the pipeline. 
2.3.2 INTRODUCTION 
A GMO is an organism that has been transformed by the insertion of one or more genes 
(called transgenes) (FAO 2001). Accordingly, GM forest trees can be regarded as trees that 
have been modified by gene technology or have inherited particular traits from the organism 
initially modified by gene technology for the traits (Office of the Gene Technology Regulator 
2002). Genetic modification does not include traditional breeding or natural hybridization, 
i.e. GM trees cannot be obtained through conventional tree breeding methods. Because of 
this, the formulation and use of GM trees in applied forestry has increasingly drawn attention 
from the scientific and non-scientific communities as there is concern about the potential 
impacts on human health, the environment and the international trade (F AO 1999, 2002). 
The ability to transfer new traits rapidly from one species to another has the potential to 
enhance traditional tree improvement and breeding since generation times for forest tree 
species are rather prolonged. Therefore, this technique may be of greater significance in 
forestry than in agriculture. At present, the traits of interest for research on genetic 
modification in forestry in China mainly include insect pest resistance, drought and salt 
tolerance for environmental rehabilitation and soil and water restoration, in particular for 
north western China, and wood property improvement to lower amounts of lignin for the 
paper-making industry. 
The process of creating and using GM trees in China can be outlined as follows: 
• Phase I, GM plants are created through genetic engineering in the laboratory; 
• Phase II, the GM plants are vegetatively propagated in a multiplication area (nursery) to 
form GM lines; 
• Phase III, the GM lines are tested in the field in pilot trials to select clones; 
• Phase IV, the selected clones are deployed to establish commercial plantations. 
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Phases II and III are generally called environmental releases since the GM trees are planted 
out in the field. Assessments of GM trees must be made at phase III in terms of biology, 
including biosafety, and silviculture before they are commercially used in plantations. 
In China, GMOs are regulated by the 'Biosafety Act for GMOs in Agriculture' , which was 
adopted at the 38th Session of the State Council in May 2001. In the act, GMOs are defined 
as organisms that have been modified by gene technology, including all gene-transferred 
plants, animals and micro-organisms and their derived products . In 2002, China had the 
world's fourth largest area of GM crops, over 2.1 million hectares (Yan 2003; FAO 2004). 
According to the Bio-Dec database, six GM commercial crops are cultivated in China, 
including two cotton varieties, two tomato varieties, a green pepper and petunia. 
Research into GM forest trees in China started in the late 1980s and has developed very 
quickly in the last few years. The State Council approved a national programme on research 
and commercialization of GM plants in agriculture for a period of 5 years. The programme 
was launched jointly in 1999 by the Ministries of Finance and Science and Technology, with 
support for 116 projects, three of which were related to forest trees. Most of the research 
activities in forest trees are undertaken in the Chinese Academy of Forestry (CAF) and 
forestry universities as well as at institutes of the Chinese Academy of Sciences (CAS). 
2.3.3 STATUS OF RESEARCH 
2.3.3.1 Insect resistance 
Research into GM forest trees was initiated in late 1980s by the Research Institute of 
Forestry, CAF, in cooperation with the Institute of Microbiology, CAS, with Populus nigra 
for insect resistance. It was first reported (Tian et al. 1993) that the toxin gene of Bacillius 
thuringinensis (Bt) was successfully inserted into the genome of Populus nigra through 
Agrobacterium tumefaciens. A total of 54 GM trees was created. An international field 
project (CPR/88/041, funded by UNDP [United Nations Development Programme] and 
implemented by F AO from 1990 to 1995) assisted CAF in high-yield forestry capacity 
building, technology transfer and laboratory support. The project was instrumental in the first 
confirmation of tree transformation by genetic modification in the country (Gabriel 1992, 
1993, 1994). The 54 regenerated plants were tested by allowing Apochemia cinerarius and 
Lymantria dispar, which were major insect pests attacking poplar in China, to feed on them. 
The results indicated that the mortality of the insect larvae ranged from 80 percent to 96 
percent and 100 percent, respectively, 5 and 9 days after feeding. Survival of field 
transplanted regenerated plants was fairly low. Three GM plants were selected on the bases 
of growth and toxic performance in the experiment. Subsequently, another study on insect 
resistance was carried out with P. nigra into which Bt and Pi genes had been simultaneously 
inserted. The toxicity of this transformed clone was greatly enhanced as the GM ex plants 
contained two insect resistance genes (Li et al. 2000a). 
Chen et al. (1995) reported another experiment on insect resistance in which NPT1I and Bt, 
carried by Agrobacterium tumefaciens strain LBA 4404, were integrated into the 
chromosomes of Populus deltoides. It was found that there was significant variation in the 
number of adventitious buds and rooting rates between GM plants and the control treatment. 
Rooting rates of just 8-9 percent were achieved with GM plants, which placed a considerable 
constraint on propagation. 
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There has been one study reported on resistance to wood-eating insects through genetic 
modification in China. Li et al. (1996) reported that P. deltoides, P. nigra and 
P. x euramericana were genetically modified through the insertion of the antibacterial gene 
Lcl. Results showed that the mortality of the wood borer, Anoplophora glabripennis, reached 
over 75 percent on the GM plants. It was also found that there was significant variation 
between species in the percentage rooting of adventitious buds cultured on a medium of 40 
mg/litre kanamycin for 15-22 days (94 percent, 66 percent and less than 1 percent for P. 
deltoides, 
P. x euramericana and P. nigra, respectively) . 
Tian et al. (2000) and Zheng et al. (2000), respectively, reported a study on GM trees that 
was jointly carried out by the Agricultural University of Hebei Province, China and the 
Institute of Microbiology, CAS with explant materials of hybrid clone 741. The hybrid was 
developed in 1974 from a rather sophisticated combination of (Populus alba x [P. davidiana 
x P. simonii]) x P. tomentosa. However, foliage of the hybrid appears to resemble that of P. 
tomentosa. The hybrid clone 741 was a sterile female plant, which provided the advantage 
that there was no gene flow from GM to non-GM populations. In this study a binary 
expression vector, pBTiA, was first constructed with partially modified Bt Cry 1 Ac gene and 
API gene, then the vector containing the two genes was integrated into the genome of hybrid 
clone 741 throughAgrobacterium-mediated transformation. In this way GM 741 was 
produced. The larvae of Clostera anachoreta and Lymantria dispar were fed on the GM 741 
plants. Three plants were selected and propagated by cuttings because they exhibited greatest 
insect resistance, with mortality of over 70 percent of the total number of larvae tested. 
Finally, PCR (polymerase chain reaction) and Southern blotting analyses were conducted and 
indicated that both the Bt CrylAc and API genes had been integrated into the genome of 
hybrid clone 741. Follow-up research on the technique of vegetative propagation for the GM 
741 poplar was also described (Zheng et al. 2001). 
N-106, a hybrid poplar clone (P. deltoides x P. simonii; Wang et al. 1991), is widely planted 
in the transition from warm temperate to subtropical zones in China. It is tolerant of hardy 
and salty conditions but has been subjected to serious insect damage in recent years. A 
scorpion neurotoxin gene, Aa!T, separated from Androctonus australis which is native to 
northern Africa, was inserted into the genome of N-106 poplar through a binary vector and 
62 GM plants were regenerated. Insect feeding tests indicated that plant AS was significantly 
resistant to Lymantria dispar. ELISA testing revealed that the Aa!T gene was expressed in the 
GM poplar (Wu et al. 2000). 
Lin et al. (2002) reported that the CpTI gene was inserted into the genome of a triploid poplar 
hybrid, ([Populus tomentosa x P. bolleana] x P. tomentosa), and the total soluble protein 
level expressed in the GM plants was increased. The same research group also reported that 
three major insect pests, Malacosoma disstria, Lymantria dispar and Leucoma candida 
[=Stilpnotia candida], which attack poplars in northwestern China, were tested on plants of 
the GM lines, TG04, TG07 and TG71, and larval mortality was perceptibly increased (Zhang 
et al. 2002). 
Transformation of an insect resistance gene into birch was first reported by Zhan et al. 
(2001). GUS (~-glucuronidase) and Southern blotting analyses revealed that the spider 
insecticidal peptide gene was integrated into the genome of Betula platyphylla, though no 
further reports have been published on the propagation or field testing of GM plants. 
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2.3.3.2 Disease resistance 
Compared with research on genetic modification of trees for resistance to insects, little 
research has been undertaken for resistance to disease. Zhao et al. (1999) reported that the 
rabbit alexin gene NP- I had been inserted into the genome of Populus tomentosa. Results 
demonstrated that infection by many micro-organisms was inhibited in GM plants but further 
information on follow-up research has yet to be reported. 
Eucalyptus urophylla is one of the major eucalypt plantation species in southern China. It is 
found, however, that E. urophylla, along with a few other species, is significantly damaged 
by Pseudomonas solanacearum. To develop clones more resistant to the pathogen, the 
cecropin D gene was inserted into the genome of U6, which is a clone locally selected from 
the introduced populations of E. urophylla in southern China. All experimental materials, 
including the gene, were provided by the Forestry College, South China Agricultural 
University in Guangzhou. The GM plants were inoculated with P. solanacearum and results 
showed that, 30 days after inoculation, 56. 7 percent of GM plants were damaged relative to 
86. 7 percent of the control treatment (Shao et al. 2002). 
Another study in GM forest trees, undertaken in Taiwan Forestry Research Institute, is more 
interesting. The gene coding for C4H (cinnamate 4-hydroxylase) isolated from Populus 
tremuloides was transferred into a selected clone of Eucalyptus camaldulensis that had been 
introduced from Australia. Two GM lines, one with sense and the other with anti-sense C4H 
(F AO 2001 ), were obtained with over 100 cuttings regenerated and planted out for further 
characterization. The objective of this research was to regulate lignin content in the wood. 
Assessment of the field trials will be made 2 years after planting (Chen et al. 2001). Similar 
research is being undertaken with larch in the Research Institute of Forestry, CAF, although 
no breakthrough has been made yet. 
2.3.3.3 Tolerance to environmental stress 
Liu et al. (2000) reported that the MtlD gene had been successfully inserted and expressed in 
the genome of a poplar (Populus x Xiao Zhannica cv. 'Balizhuangyang'). The plant material 
was provided by Shandong Agricultural University and the MtlD gene was cloned by the 
Institute of Genetics, CAS. In a subsequent paper it was stated that the GM plants had shown 
strong tolerance to a concentration of 0.4 percent NaCl in the growth medium (Sun et al. 
2002a). The methodology of micropropagation for the GM plants was described by the same 
authors in another paper (Sun et al. 2002b). Unfortunately, the exact identity of the plant 
material used in the study was not clear since various Latinized names were used, perhaps 
inappropriately. In May 2003, the GM poplar was officially registered for the protection of 
breeder's right under a Chinese common name, Taiqing No.1 poplar (PVP Office 2003; 
www.cnpvp.net/anouncement.htm). In June 2003, the environmental release was officially 
approved by the Ministry of Agriculture to establish 100 mu (equal to about 6.6 ha) of 
plantations with 'the transgenic poplar' (without any specific name) in Tianjin City and 
Shandong Province. In December of 2003, the research project was thoroughly reviewed, the 
GM poplar was given another Chinese common name, Zhongtianyang, and assigned a 
cultivar name as (Populus x xiaozhuanica W.Y. Hsu and Liang cv. 'Balizhuangyang-
zhongtian'). The GM poplar, whatever it is, has now been planted in coastal areas in 
Shandong Province, where the soil has been so seriously saline that there is a limited choice 
of tree species for planting. 
Few species are adapted to the severe physical environments of northwestem China. An 
attempt has been made to genetically modify tree species to be more tolerant to 
environmental stresses ( e.g. drought, saline soil and cold). 
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Yang et al. (2001) reported that a salt tolerant gene, Bet-A, was inserted into the genome of 
poplar hybrid, P. simonii x P. nigra, which is widely planted in northern China. However, no 
further information is available about how many GM plants were obtained and or whether 
tolerance was enhanced. 
Another study of gene transformation for tolerance to saline soil was carried out with another 
poplar hybrid (P. deltoides x P. cathayana). MtfD/gutD as fusion genes were integrated into 
the genome of the hybrid and four GM explants were obtained in the experiment. 
Physiological tests indicated that the GM plants showed, to a certain extent, improved 
tolerance to saline medium at a concentration of 0.4 percent NaCl (Fan et al. 2002). 
Some research is still ongoing at the Institute of Populus tomentosa, Beijing Forestry 
University, to improve resistance to low temperature. An attempt is being made to clone a 
cold resistance gene from P. suaveolens and transfer it into the genome of P. tomentosa (Lin 
et al. 2000; Lin 2001 ). 
2.3.3.4 Research into sterility of GM plants 
Genetic-use restriction ( 'Terminator') technology will be useful in relation to the deployment 
of non-sterile forest trees. This is, however, a difficult task. It is almost impossible to reduce 
the risk of gene flow from GM trees to non-GM trees through isolation distances because of 
the ease of natural hybridization between poplars of the same section, and poplar trees are so 
widely planted in northern China that pollen and seed dispersal cannot be prevented. An 
effort was made to develop a sterile mechanism in GM male P. nigra by inserting the 
TA29-Barnase gene (Li et al. 2000a). Another proposal is to breed sterile poplars for urban 
planting to prevent nuisance caused by the cotton-like seed flying around; however, there are 
no successful cases reported yet. 
2.3.4 ENVIRONMENTAL RELEASE AND 
COMMERCIALIZATION 
Most of the research on genetic modification in trees is still at the laboratory stage with no 
further results reported following gene transformation. Only two projects have gone as far as 
environmental release of GM plants. 
In the spring of 1994, a pilot trial on about 1 ha was established with GM plants of P. nigra, 
as described above (Tian et al. 1993), in Manas Forest Farm, Xinjiang Uygur Autonomous 
Region, China. An assessment was carried out, with data collected in 1997 on the 
performance of the GM insect resistance trait and silvicultural parameters. The results 
showed that the average percentage of seriously damaged leaves on the GM trees was only 
10 percent while that of the trees in control plots planted nearby reached 80-90 percent. The 
average number of pupae in the GM plantations was much reduced, down to 20 percent of 
that found in the non-GM control plots. The numbers of pupae and leaves damaged in the 
GM plantation were far below the threshold set for chemical control measures . It was also 
found that the non-GM trees mixed in the plantation benefited much owing to cross 
protection from insects through the presence of the GM trees (Hu et al. 2001). Similar results 
from the same research can be found in another paper by Wang et al. (1996). 
Fallowing this test, in 1998 the first environmental release of GM trees in China was 
approved by the Committee of Biosafety, Ministry of Agriculture, and in the following year 
80 ha of pilot plantations were established with GM P. nigra on eight sites in Beijing, Jilin, 
Shandong, Jiangsu, Henan, Shanxi and Xinjiang provinces. 
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Approved by the Gene Security Committee, the State Forestry Administration, GM trees of 
this species were commercialized for planting in plantation forestry by 2002. It is estimated 
that one million GM P. nigra trees have so far been propagated and used in the establishment 
of plantations (i .e. about 300 ha of commercial plantations should have been established 
using GM materials; Su et al. 2003a). However, the accurate area of GM plantations cannot 
be assessed because of the ease of propagation and marketing of GM trees and the difficulty 
of morphologically distinguishing GM from non-GM trees . A number of individual nursery-
men at markets declare that their planting materials are GM trees produced through high-tech, 
for a higher price. Consequently, a lot of materials are moved from one nursery to another 
and it is difficult to trace them. 
Gao et al. (2003) reported the results of an investigation carried out in a 3-year old GM 
plantation which was established with GM materials of GM 741 in a forest farm close to 
Qinhuangdao, a coastal city 300 km north of Beijing. It was found that there were significant 
differences between the GM and non-GM plantation stands in terms of species composition, 
dominance and community structure of defoliating insects and their natural enemies (Tian et 
al. 2000; Zheng et al. 2000). It is estimated that some 0.4 million cuttings of GM 741 have 
been produced and planted in the field. 
These are the only two cases of GM trees that have so far been reported as environmental 
releases in China. The size of the environmental releases of GM trees is mainly constrained 
by the quantity of selected GM plants which develop normally. Often, the number of GM 
plants regenerated from transformation events is too small to establish trials in the field. 
Another likely constraint is the time and effort required to get governmental approvals to 
release GM trees into the environment. 
At present, only these two types of GM trees have gone through field testing and, following 
that, entered into commercialization. However, it is almost impossible to work out the exact 
area of commercial plantations that are established with GM materials in the country. A 
system should be established to monitor the status of the GM plantations and other associated 
components living in or impacted by the ecosystems containing GM trees. 
2.3.5 REGULATORY FRAMEWORK 
The Chinese government has made a large effort to establish a regulatory framework for GM 
plants, including GM forest trees. Regulations have been put in place or are currently being 
developed since there is concern about the potential impacts on human health and the 
environment as well as the trade of products derived from GM forest trees (Lu et al. 1999). 
The regulations are, with relevance to the existing international instruments, legally binding 
for GM trees from laboratory work to field testing, environmental release and seeking for 
approval for commercialization. The process of field release approval that must be gone 
through is a technical assessment which is made by an expert panel, organized by the State 
Forestry Administration and then a report to the National Committee for Biosafety of GMOs 
in Agriculture for approval. 
Presently, China has committees and procedures in place to carry out evaluations involving 
the development, release or commercialization of GM forest trees in terms of benefits and 
biological safety. The regulations binding the R&D and commercial application of GM forest 
trees are as follows (See Yan 2003): 
• Act of Biosafety for the Genetically Modified Organisms in Agriculture, adopted by the 
38th Session of the State Council, China in May 2001 which came into force in June 
2001. 
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• Regulation of Assessment on Biosafety of GMOs in Agriculture, issued by the Ministry 
of Agriculture, China in January 2001 which came into force in March 2002. The 
assessment of the biosafety of GM plants, animals and micro-organisms and the control 
measures of security for GMOs and their derived products in agriculture are all included 
in a separate annex to this regulation. The R&D of GM forest trees must, of course, 
follow this regulation. 
• Regulation of Security for Imported GMOs in Agriculture, issued by the Ministry of 
Agriculture, China in January 2002 which came into force in March 2003. 
• Regulation of Labelling GMOS in Agriculture, issued by the Ministry of Agriculture, 
China in January 2002 which came into force in March 2003. 
At the current time, a specialized regulation for GM forest trees is being drafted by the State 
Forestry Administration as an addition to the regulations above that forestry has to follow. 
Very recently, scientists ofHebei Agricultural University who produced the GM 741 trees 
have applied for breeders' rights to the new plant variety, and their application has been 
reviewed by a technical panel. It would be the second case to be granted intellectual property 
(IP) for GM forest trees in China, following 'Taiqing No. I', if their application were to be 
approved. 
2.3.6 REMARKS AND PERSPECTIVES 
In China all GM forest trees are fast growing, vegetatively propagated broadleaved species 
(poplars and eucalypts) managed in short-rotation plantations. There would be less risk of 
genetic contamination of non-GM populations if plantations were harvested before 
reproductive maturity; however, environmental risks must be closely monitored (as reported 
in an email conference by F AO (F AO 2002). 
It will be a long time before GM conifer trees are produced even though scientists are 
working on larch in a few laboratories in research institutions and universities in China. 
Research into GM forest trees aimed at increasing tolerance to environmental stress, for 
instance drought and salt, and to lower the proportion of lignin in wood formation has 
attracted great support with huge government resources; however, very few results have yet 
been obtained since this study is still in its infancy in China. Currently, research projects on 
such subjects are being carried out by several research groups in the Research Institute of 
Forestry, CAF and other research organizations. 
The methodology of gene transformation has almost become routine in the laboratory and 
many laboratories can currently carry out genetic modification of trees. Unfortunately, most 
of the research stops after the laboratory stage. Study of genetic modification of forest trees is 
bottlenecked by basic research in tree molecular genetics, which lags far behind that for 
agricultural crops, as pointed out by Su et al. (2003b ). The regeneration of explants of most 
tree species is so low that materials for field testing and environmental release are limited. 
Additionally, a large proportion of explants are abnormal. A number of economic traits are 
changed by the insertion of pleiotropic effect genes or gene silencing. Furthermore, field 
testing and environmental release take quite a long time. General information on GM forest 
trees in China is summarized in Table 2.3.1. 
There is a knowledge gap to be bridged between scientists doing research in traditional tree 
breeding and those in biotechnology. Scientists who work on biotechnology are mostly from 
the younger generation with less experience in practical forestry and little interest in tree 
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breeding and improvement programmes. On the other hand, people who are used to 
traditional tree breeding are lagging behind or not familiar with biotechnology. This is 
probably why GM forest trees have not been used effectively to develop a strategy for tree 
breeding programmes, or in combination with conventional breeding techniques. 
Table 2.3.1. Summary of species and status of R&D on genetic modification in forest 
trees in China 
Tree species Status of Traits targeted Gene(s) Stage of References 
project1 inserted development 
Betula R Insect resistance Spider On going Zhan et al. 
platyphy lla insecticidal 2001 
peptide gene 
Eucalyptus R Lowering lignin C4H On going Chen et al. 
camaldulensis content 2001 
Eucalyptus R Resistance to cecropin D On going Shao et al. 
urophy lla disease caused by 2002 
Pseudomonas 
solanaceanum 
Poplar hybrid E, C Resistance to leaf- Bt C,y l and Applied for; Zheng et al. 
741 (P. alba x eating insects API Commercial 2000 
[P. davidiana + plantings in 
P. simonii] x P. 2001 
tomentosa) 
Populus x E Salt tolerance mt!D Approved for Liu et al. 
x iaozhuanica environment 2000, Sun et 
W.Y. Hsu et release in al. 2002a, b, 
Liang cv. 2003 . PVP Office 
' Balizhuangyang- Granted 2003 
zhongtian ' breeder' s 
right in 2003 
Populus deltoides R Insect resistance Bt On going Chen et al. 
1995 
Populus deltoides R Resistance to leaf- mt!DlgutD On going Fan et al. 
x P. cathayana eating insects 2002 
Populus deltoides R Resistance to leaf- AalT On going Wu et al. 2000 
x P. simonii (N- eating insects 
106) 
Populus nigra E, C Resistance to leaf- Bt Applied for Hu et al. 
eating insects commercial 2001 , Li et al. 
plantings in 2000a, b, 
2002 
Populus simonii R Salt tolerance. Bet-A On going Yang et al. 
x P. nigra 2001 
Populus R Resistance to NP-1 (rabbit On going Lin et al. 
tomentosa disease and stress alexin) 2000, 2001 
1R: Research; E: Environmental release; C: Commercial planting. 
Another gap lies in research planning. Research projects on GM trees are developed 
separately from those of applied tree breeding and improvement projects . Study on GM trees 
should be aimed at species of proven economic value for commercial forestry rather than 
species which are relatively technologically easier to work with for genetic modification. The 
superb genetic materials selected by traditional breeding programmes should be used as a 
priority in genetic engineering. This is the real reason, perhaps, that work on a number of GM 
trees stopped at the laboratory stage with no further activities as a follow up. 
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Resource allocation is not balanced for research programmes on traditional breeding and on 
biotechnology, with most of the governmental funds going to the development of 
biotechnology. Few research projects on traditional tree breeding can survive today, 
including seed orchards and provenance trials. 
There is a theoretical debate among scientists in China on whether or not forest trees should 
be genetically modified for resistance to diseases and insects. The adaptation of insects and 
micro-organisms to changing environments and host trees is faster than the production cycle 
of GM trees. In other words, natural evolution never stops as the ecological balance is being 
broken up. Given the potential risks and impacts that GM trees would bring, it is argued by 
some that diseases and insects can be effectively controlled through the art of silviculture and 
forest management to keep them below outbreak levels. 
On the other hand, GM forest trees are regarded differently from GM plants for food and 
agriculture. The latter raises issues of direct effects on human health or impacts on the 
environment, but many people think that 'wood is not food'. It can be foreseen that R&D of 
GM forest trees will develop even faster in the near future and there is no doubt that GM 
forest trees will be grown on a large scale in plantation forestry and for land reclamation in 
China as long as some technical obstacles, mentioned above, are overcome in the coming 
years. 
The Chinese government has set a lofty target for forestry development: that forest coverage 
will reach 19 percent of the total land area by 2010 and 23 percent by 2020, which is 
definitely a great challenge facing forest science today and tomorrow. Forest genetics, genetic 
modification and domestication of forest trees will, beyond all doubt, be asked to make 
contributions to the goal. 
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2.4 Anticipated contribution to and scale of impact of 
biotechnology in forestry 
Yousry A. El-Kassaby - University of British Columbia, Canada 
2.4.1 SUMMARY 
Developments in and applications of forest biotechnology are rapidly expanding. They are 
becoming both more complex and more accessible throughout the world. There are 
fundamental differences in public perception and potential applications of biotechnology in 
forestry relative to agriculture. These differences stem from the multifaceted cultural and 
utilitarian role forests play, and their relatively recent history of domestication compared to 
that of agricultural crops. This report represents an attempt to describe these activities and 
anticipate their contribution in forestry. 
2.4.2 INTRODUCTION 
Many recent publications, including working groups and conferences of the F AO, have dealt 
with various aspects of biotechnology in the forestry context (e.g. Krutovskii and Neale 2001; 
Yanchuk 2001; F AO 2002). During the past 15 years, this field has seen rapid development 
of new technology and a large increase in the number of groups involved in research and 
applications around the world (Ellis et al. 2001; Campbell et al. 2003). Research and testing 
of modem biotechnology in the initial stages requires up-to-date laboratory facilities. While 
the technological tools for forest biotechnology are typically adapted from an agricultural 
background, the subsequent applications and impacts differ substantially when applied to 
trees (Owusu 1999; F AO 2002). Biotechnology in forestry, for example its use in intensively 
managed plantations, engenders a host of issues not addressed by agricultural models, and 
central to those is the relatively long rotation required for forest crops to reach economic 
maturity. The majority of these differences originate from the fundamental life history 
characteristics of trees as sessile, long-lived, outcrossing organisms which can disperse pollen 
and seed across very long distances, and would likely be planted in potential mating 
proximity to wild, compatible populations or related species (DiFazio et al. 1999). Other 
differences between agriculture and forestry which must be taken into account stem from 
public perception: people often regard trees as essential components of forest ecosystems 
which perform many functions and provide many tangible and metaphysical values 
simultaneously, unlike most crop plants (Owusu 1999; F AO 2002). 
Although anthropological influences are traceable in most of the world's forests, and 
managed forests have been the norm in parts of the world for centuries, trees have been partly 
domesticated only in the past half century. In effect, very few of these trees are removed 
more than two or three generations from their wild congeners (Libby 1973). Since trees have 
fairly long generation times, breeding and deployed populations and even clonal lines 
produced through various vegetative propagation techniques, including biotechnological 
methods, are still very similar to their wild contemporaries, unlike many agricultural crop 
plants (Campbell et al. 2003). For example, teosinte has been transformed through millenia of 
traditional and intensive breeding into a narrow range of maize or corn lines, with a 
drastically different mating system, range, phenology, physiology and associated genetic 
characteristics. 
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2.4.3 CATEGORIES OF FOREST BIOTECHNOLOGY 
Recent literature varies in how it categorizes forest biotechnology ( e.g. Haines 1994; 
Yanchuk 2001 ; F AO 2001 ). Owing to the gradual evolution of our understanding of genetics, 
and the consequent development of new tools and technologies by refining and combining 
new knowledge with prior research, these categories overlap to some degree. The author used 
five major categories, each of which can be applied to a characteristic subset of applications 
(see Tables 2.4.1 and 2.4.2): 
1. Markers (biochemical and molecular). 
2. Propagation and multiplication. 
3. Genomics (functional, structural, comparative, associative, statistical). 
4. Marker-assisted selection (MAS) and breeding. 
5. Genetic modification. 
These tools and their utility are applicable on different scales, from the individual cell or 
plant to the landscape level (see Table 2.4.1 ). The only category which results in genetic 
manipulation ofliving trees is number 5, although development of some markers and DNA 
libraries for genomics may involve transformation of bacteria in the laboratory. The impact of 
these biotechnologies will therefore vary with the specific use, as will the associated benefits 
and risks (see Table 2.4.2; Arntzen et al. 2003). Certification of forest products, forest 
companies and lands is also potentially affected by the application of biotechnology. There 
are many certification agencies around the world, and some, such as the Forest Stewardship 
Council (FSC), have specifically excluded genetically modified (GM) trees from 
certifiability, or the land on which they grow, or other products obtained from stands 
containing these trees (FSC 1996). Some clonal forestry operations are certified, but most 
agencies have no explicit guidelines concerning genetic applications. Industrial processes 
which utilize genetic transformation of enzymes to chemically break down lignin in the 
harvested wood, e.g. pulping using enzyme digestion, have been certified on the grounds that 
this reduces toxic chemical use and discharge. Thus, certification standards vary among 
agencies, countries, products, processes and applications. Public opinion regarding genetic 
modification is more amenable to downstream (post-harvest) than upstream (pre-harvest) 
applications; the main cause for concern appears to be the potential for release of GM trees 
into the environment, which is an issue only for the latter (Pew Initiative on Food and 
Biotechnology 2001 ; Gartland et al. 2002). 
Developed countries and developing countries or countries in transition have different 
priorities and applications for biotechnology (see Table 2.4.2; Anonymous 2003). DNA-
based applications (some markers, genomics and genetic modification) require a large initial 
outlay ofresources, may have continuing high costs depending on the project, and entail a 
highly trained work force (Ritland and Ritland 2000; Industry Canada - Life Sciences Branch 
2001 ). Developed nations have so far been leaders in developing and applying these 
technologies for a variety of purposes (breeding, commerce and conservation; public and 
private uses), but it should be noted, based on the agriculture model, that barriers to the flow 
of capital and expertise associated with the introduction of biotechnology to new territories 
are virtually non-existent. In other words, the introduction of forest biotechnology tools to 
developing countries and countries in transition could be rapid as long as economic 
opportunities are present. Government agencies in developed countries typically provide 
much of the funding and infrastructure for the development of basic biotechnology research; 
however, it should be noted that applied research and development associated with any 
potential commercialization are mainly driven by the private sector. 
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The shift of funds supporting biotechnology from the public to the private sectors requires a 
new way of viewing the introduction of these tools into the forest sector. Thus, published 
inforn1ation indicates that the majority of known forest biotechnology activities in developing 
countries and countries in transition have been more restricted in their scope, primarily to the 
use of markers and propagation, although other tools may have been introduced into the 
private sectors but, if so, inforn1ation on the types of biotechnology application, their places 
of introduction and their frequency are unknown. The F AO Biotechnology in Developing 
Countries (F AO-BioDeC) database39 could be a useful storage facility for such forestry 
biotechnology information. 
The flow of some biotechnology through teams including partners both from developed 
countries and from developing countries and countries in transition, such as CAMCORE 
(International Cooperative for Tree Conservation and Domestication), have provided 
increased access to these resources and tools. 
Risk assessment is a critical application of many of the new biotechnological tools, and must, 
in tum, be applied to innovations as they are developed (Government of Canada 1985; 
Owusu 1999). Targeted gene engineering is of key concern, both with respect to inserting and 
eliminating gene function. Gene flow assessments are being conducted for poplars ( e.g. 
DiFazio et al. 1999), but much more inforn1ation is required to allay public concerns and deal 
with ecological hazards surrounding the potential for gene escape (Pew Initiative on Food 
and Biotechnology 2001; FAQ 2002; Giles 2003). This applies to pollen and seed dispersal, 
as well as the ability of species to sprout via roots or stumps, become vigorous weeds, or 
hybridize with wild sympatric congeners (Government of Canada 1985; Crawley et al. 2001 ; 
Dalton 2002; Pi late et al. 2002; Adam 2003). Escapes and introgression of agricultural genes 
have been documented, as has unauthorized planting of GM crop seeds, leading to 
assessment, monitoring and regulatory problems. The relative fitness effects conferred by 
each novel trait must be evaluated in the environmental and genetic context of the field in 
order to assess risks properly (Johnson and Kirby 2001; Dalton 2002; Pi late et al. 2002; 
Anonymous 2003). Promoter genes and other biosensors are being investigated as means of 
tracking GM material, a necessary precondition prior to approval for field testing or 
deployment. Experts have widely concurred that a case-by-case examination is necessary for 
approval of GM trees (Government of Canada 1985; Heron and Kough 2001 ; FAQ 2002; 
Arntzen et al. 2003). 
2.4.4 APPLICATIONS 
The high cost of biotechnology will probably steer its commercial use towards short-rotation 
plantations as opposed to less intensively managed forests, but some applications are suitable 
for all forest types and can guide forest conservation activities (see Tables 2.4.1 and 2.4.2) 
(Sedjo 1999; Yanchuk 2001 ). An attempt to indicate the status of each tool and likely future 
trends in its use will be made in the following sections. 
2.4.4.1 Markers (biochemical and molecular) 
Biotechnology has progressed from phenotype to genotype, and has been trying to quantify 
relationships between the two ever since. Early work focused on biochemistry ( e.g. terpene 
analysis), progressed to biosynthetic constitutive or induced protein expression (isoenzymes) 
and is now utilizing DNA-based tools (e.g. microsatellites, quantitative trait loci [QTLs]) 
since the advent of PCR (polymerase chain reaction) technology. 
39 See: www.fao.org/biotech/inventory admin/dep/default.asp. 
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Molecular markers can be either dominant (only the dominant allele is expressed if both 
parents are genetically different at a given locus) or codominant (the genotypes of both 
parents are quantifiable at a locus) . Dominant markers (amplified fragment length 
polymorphisms [AFLPs], randomly amplified polymorphic DNAs [RAPDs]) require larger 
sample sizes for statistical analysis than codominant markers (isoenzymes, 
microsatellites/simple sequence repeats [SSRs] , restricted fragment length polymorphisms 
[RFLPs], sequence-tagged sites [STSs] , expressed sequence tags [ESTs], single nucleotide 
polymorphisms [SNPs]). 
The different markers all have varying benefits, drawbacks, costs and ease of development 
and all can be applied to a limited range of optimal applications, generally focused on neutral 
or non-adaptive genetic variation (see Table 2.4.1, Ritland and Ritland 2000, Krutovskii and 
Neale 2001 , and others for reviews). Molecular tools have been widely used to measure gene 
flow and genetic diversity of natural and artificial populations of forest trees and associated 
species, and the impacts of anthropogenic disturbance on their evolutionary potential (Haines 
1994; Ritland and Ritland 2000; Yanchuk 2001 ). The long-term viability of species and 
endemics subject to influences such as pollution or climate change can be modelled using 
genetic data. There are still no highly repeatable, easily assayed markers directly linked to 
quantitative traits. Although progress has been made in identifying QTLs for some adaptive 
traits in some species, a good genomic linkage map is essential, as are breeding and 
identification and sequencing of candidate genes for quantitative traits of interest. The 
application of marker technology in forestry is by far the most extensive use of other tools. It 
is not restricted to either developed countries or developing countries and countries in 
transition, but the type of markers, the speed of use and the frequency of utilization differs 
with the status of marker development and the biometrical methods needed for data analyses 
(see Tables 2.4.1 and 2.4.2). 
2.4.4.2 Propagation and multiplication 
Clonal forestry using both broadleaves and conifers is gaining in popularity due to the 
resulting uniformity and ease of silviculture, harvesting and processing. More importantly, it 
allows the capture of levels of genetic gain that cannot be attained through sexual 
reproduction. This technology is restricted to organogenesis and somatic embryogenesis, 
which require extremely detailed understanding of cell biology, multiplication, biochemical 
signalling, differentiation and the production of copies or clones in a laboratory setting. Both 
of the above methods capitalize on plant species' ability to regenerate an entire genetically 
identical individual from a single cell or group of differentiated or undifferentiated cells via 
in vitro tissue culture. Individuals with selected traits or the highest performers from testing 
trials or breeding programmes can be replicated on a large scale, capturing both additive and 
non-additive genetic variation from traditional breeding. The advantage of these methods is 
the ability to store regenerated tissues indefinitely in liquid nitrogen or under laboratory 
conditions (i.e. hold the genotype constant) while field testing is underway to identify elite 
lines. This allows selected lines with desirable attributes to be further multiplied for 
operational deployment. Currently some operational scale production is underway both in 
developed countries and in developing countries and countries in transition, but it should be 
noted that the scale of production in broadleaves is larger than that in conifers. 
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2.4.4.3 Genomics 
Our understanding of fundamental biology and evolution is also being enriched through 
collaborative efforts using model species in genomics research around the world (Krutovskii 
and Neale 2001). Evolutionary synteny among taxa, even those as distantly related as algae 
and angiosperms, can be quantified and candidate genes or groups of proteins (microarrays) 
involved in biochemical pathways of interest can be identified easily: this process of 
identifying putative genes controlling certain traits is called gene discovery. Expression of 
key gene families or microarrays and their relative up- or down-regulation following stress or 
environmental changes can be gauged, possibly leading to identification of compounds of 
significance, and their interactions with genotype and the environment. Characterization of 
genetic components of disease or pest resistance is a rapidly expanding field (Ellis et al. 
2001; Gartland et al. 2002). Genomics is a fairly new field with many subdisciplines 
(Krutovskii and Neale 2001), which requires substantial investment for start-up and 
maintenance: high-technology automata, costly supplies and chemicals, PCR and other 
machines, highly trained laboratory staff, marker (EST, SNP) development, as well as vast 
bioinformatics and associated statistical capacity are necessary. At present, the majority of 
activity in this area is at the research level. 
2.4.4.4 Marker-assisted selection and breeding 
While the phenotype is the desired end result of breeding, variation associated with 
differences in expression, genotype-by-environment interaction and non-additive or epistatic 
genetic variability necessitates large, costly and time-consuming field trials for trees with 
traits of interest (Haines 1994; Yanchuk 2001 ). Mendelian inheritance and our increasing 
ability to understand and target specific genes have enabled the development of MAS to 
complement traditional breeding (Haines 1994; Campbell et al. 2003). This technique has 
been used with tremendous success in agricultural crop breeding for various genes and traits 
over the past two decades, and is increasing in importance as more comprehensive genetic 
maps, and the locations of QTLs on those maps, are developed for each species. IfMAS can 
be used to characterize and select tree genotypes, substantial cost savings may be realized by 
a much shorter breeding cycle (i.e. more rapid turnover between generations) (Haines 1994; 
Sedjo 1999). Although based on tools developed using markers, it requires the use of material 
of known pedigree and integrates the study of specific structural, functional and 
morphological attributes of species' genomes. Although this work is experimental at this 
stage, several studies both in developed countries and in developing countries and countries 
in transition on broad leaves and conifers are underway. Information on the progress of these 
studies is sketchy owing to their often mixed funding nature (i.e. public and private). 
2.4.4.5 Genetic modification 
Research on and the potential for deployment of GM trees have caused widespread public 
concern. Regulatory agencies have called for more research on gene flow, likelihood of 
horizontal and vertical gene transfer via escapes, hybridization and introgression, and a range 
of ecological impacts of GM material in the field (Owusu 1999; Johnson and Kirby 2001 ; 
Pew Initiative on Food and Biotechnology 2001; Gartland et al. 2002; Anonymous 2003). 
Concerns about GM trees share similarities with those about agricultural crops, but while the 
latter are grown and used for research and consumer products throughout many developed 
and developing nations, transforming trees has only recently begun, and is currently mainly at 
the experimental stage. In the laboratory, transformation has been achieved using biolistics 
and Agrobacterium species for conifer and broad-leaved genera of commercial importance. 
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Specific genes and regions, primarily conferring insect or disease resistance, sterility, and 
wood quality attributes, have been the focus of nearly all of the research (Pi late et al. 2002; 
Campbell et al. 2003). Some promoter and marker genes have also been tested. In some 
regions, pulp and paper processing has achieved dramatic reductions in the use of highly 
toxic chlorine and other chemicals by employing enzymes genetically modified to digest 
lignin (Ellis et al. 2001; Pilate et al 2002; Campbell et al. 2003). The use of genetic 
modification during industrial processing does not currently appear to cause public concern, 
especially when the outcome includes substantial environmental benefits. It is difficult to 
give an accurate account of this type of work since the majority of it is being conducted by 
the private sector. 
2.4.5 SUMMARY TABLES 
Table 2.4.1 summarizes the anticipated contribution to and scale of impact of each broad area 
of biotechnology on elements of forest populations. For instance, the table shows the various 
forestry practices in which these tools will play a significant role as well as the spatial scale 
of their use (from the individual tree to population to landscape) . Additionally, the specific 
component activities that these tools will contribute to are broken down into individual 
activities that are associated with knowledge accumulation in terms of the forest resource, 
selection, breeding, testing, forest management, IPM (integrated pest management), and 
downstream activities such as pulping. This table highlights biotechnology categories that are 
in frequent use, and the development and/or research status of the remaining categories (El-
Kassaby and Krakowski 2005). 
A summary of the various broad technologies where biotechnology is expected to play a 
significant role is presented in Table 2.4.2. It shows the broad application and overlapping 
functions of these categories in relation to various activities. For instance, each broad 
biotechnology category encompasses its use and a description of its specific tools (markers, 
tools, traits, areas of use), their frequency of use (from no use to very common), and a brief 
description of how they are used. 
2.4.6 CONCLUSION 
There is, to date, no single system systematically collating the different forest biotechnology 
activities around the world . This would be necessary to gauge current concerns and predict 
future trends, impacts and needs in this rapidly expanding field . International regulation of 
biotechnology is inconsistent, and even varies between jurisdictions. Research and 
development being done in the private sector subject to confidentiality or intellectual property 
agreements, patent protection and corporate competition preclude or prevent dissemination of 
some types of information. Other forestry biotechnology applications occur on private lands, 
or in areas where there is no requirement or framework to report their implementation or 
extent. 
Technical development of forestry, in most cases, mirrors that of agriculture. The use of 
biotechnology tools in forestry has already caused confusion. As stated above, only one out 
of five possible biotechnology categories in forestry involves genetic modification and its 
state-of-the-art is mainly experimental (however, see Section 2.4.4.5, above) . Nonetheless, 
public perception may preclude the use or affect the usefulness of the other biotechnology 
categories in forestry. The diversity of topics and the variable levels of competence in the 
field of forestry biotechnology require cross-functional team effort at national and 
international levels. Wide-ranging contributions that give species and geographic 
representation are required to ensure accuracy and balance. 
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is
m
; P
CR
: 
po
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Table 2.4.2. Anticipated contribution to and scale of impact of each broad area of 
biotechnology on elements of natural and artificial forest populations 
Broad technologies 
Molecular applications 
"' Applicable 
"' 
;., ... 
Development elements relevant ; - ... C 0 forestry Spatial scale C "' "' c"' .. 0 C to biotechnology ~ <J ·- "' 
·- E 0 ·- -component E "' "' <J ~ "' .,.. <J 0 ... ......
"' C t=: :c ~ 
.; ~ :a .,.. ·-C .,.. c., "C ., Q a1 ·; C 0 c. 
i:i:i E 
., E E c., en 
tree- population genetic resources characterization X X X 
Natural population tmating system/gene flow X 
populations population- landscape !conserving diversity X 
population- landscape silvicultural impact assessment X 
tree selection X X X 
tree- population mating designs X 
Breeding 
tree progeny testing X X X populations 
tree attribute assessments X X X X 
population diversity management X X 
population mating system X X 
population gene flow/contamination X X 
Production population seed orchard management X X populations 
population seed orchard design X X 
population- landscape silvicultural impact assessment X X 
Regeneration stand natural X X 
stand artificial X X X 
population native species diversity X X X X 
Domestication population- landscape native species growth/yield X X 
population exotic species risk assessment X X X X 
population- landscape exotic species growth/yield X X 
population ldiversity assessment X X 
Gene population jgene flow/contamination X X 
conservation population !effective population size X 
tree !reproduction X X X 
tree- stand !risk/hazard assessment X X X 
Forest health tree !resistance screening X X X X X 
stand !PM options X 
tree- landscape other pest control X X X X 
Processing/ stand pulp processing X X X X 
Value added stand !wood treatment X X X X 
tree !chain of custody X X 
Marketing stand- landscape !Certification X X X 
stand product description X X X 
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2.5 Acronyms 
AAB 
AB 
AFLP 
AFOCEL 
AGRICOLA 
AGRIS 
APHIS 
ASFA 
BioDeC 
Bt 
C4H 
CAF 
CAMCORE 
CAS 
cDNA 
CHH 
CIRAD 
CONABIA 
CONAFOR 
cpDNA 
CSIRO 
ELISA 
ERMA 
EST 
ESTP 
ETFRN 
EUFORGEN 
FSC 
FSTA 
GM 
GMO 
GUS 
African Agency of Biotechnology (Agence Africaine de Biotechnologie) 
Antibiotic 
Amplified fragment length polymorphism 
Association Foret-Cellulose, France 
US National Agricultural Library - Article Citation Database 
International Information System for the Agricultural Sciences and 
Technology (F AO) 
US Animal and Plant Health Inspection Service 
Aquatic Fisheries and Science Abstracts (F AO) 
Biotechnology in Developing Countries (F AO) 
Bacillus thuringiensis 
Cinnamate 4-hydroxylase 
Chinese Academy of Forestry 
International Cooperative for Tree Conservation and Domestication 
Chinese Academy of Sciences 
Complementary DNA 
Carter Holt Harvey, New Zealand 
Centre de Cooperation lnternationale de Recherche Agronomique pour le 
Developpement (Agricultural Research Centre for International 
Development), France 
Comisi6n Nacional Asesora de Biotecnologia Agropecuaria (The National 
Advisory Committee on Agricultural Biosafety), Argentina 
Comision Nacional Foresta! (National Forestry Commission), Mexico 
Chloroplast DNA 
Commonwealth Scientific and Industrial Research Organisation, Australia 
Enzyme-linked immunosorbent assay 
Environmental Risk Management Authority, New Zealand 
Expressed sequence tag 
Expressed sequence tag polymorphism 
European Tropical Forest Research Network 
European Forest Genetic Resources Programme 
Forest Stewardship Council 
Food Science and Technology Abstracts 
Genetically modified 
Genetically modified organism 
~-glucuronidase 
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INRA 
IP 
IPM 
ISAAA 
IUFRO 
MAS 
METLA 
MMG 
mtDNA 
NGO 
NZFRI 
PCR 
PMGC 
QTL 
RAPD 
RFLP 
RURAL 
SE 
SEMARNAT 
SNP 
SOFA 
SSH 
SSR 
STS 
TGERC 
TROPAG 
UNDP 
USDA 
VIB 
PRlll\11, .\ln Rl\11\\(Jl·lllUll(ll'\tlllll' l'l()RJ·<;lln 
Institut National de la Recherche Agronomique (National Institute for 
Agricultural Research), France 
Intellectual property 
Integrated pest management 
International Service for the Acquisition of Agri-biotech Applications 
International Union of Forest Research Organizations 
Marker-assisted selection 
Finnish Forest Research Institute 
Mapping, marker-assisted selection and genomics 
Mitochondrial DNA 
Non-governmental organization 
New Zealand Forest Research Institute Ltd 
Polymerase chain reaction 
Poplar Molecular Genetics Cooperative 
Quantitative trait locus 
Random amplified polymorphic DNA 
Restriction fragment length polymorphism 
Database of social and economic development in rural areas of developing 
countries, Royal Tropical Institute, Netherlands 
Somatic embryogenesis 
Secretaria de Medio Ambiente y Recursos Naturales (Ministry of the 
Environment), Mexico 
Single nucleotide polymorphism 
The State of Food and Agriculture 2003-2004 (an F AO publication) 
Suppressive subtractive hybridization 
Single sequence repeat 
Sequence-tagged site 
Tree Genetic Engineering Research Cooperative, Oregon State University, 
USA 
Database of agriculture and environment for developing regions, Royal 
Tropical Institute, Netherlands 
United Nations Development Programme 
United States Department of Agriculture 
Vlaams Instituut voor Biotechnologie, Zwijnaarde, Belgium 
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